Amedeo Smart

Free Medical Literature Service


 

Amedeo

Alzheimer's Disease

  Free Subscription

Articles published in
Alzheimers Dement
    June 2024
  1. YERRAMALLA MS, Darin-Mattsson A, Udeh-Momoh CT, Holleman J, et al
    Cognitive reserve, cortisol, and Alzheimer's disease biomarkers: A memory clinic study.
    Alzheimers Dement. 2024 Jun 4. doi: 10.1002/alz.13866.
    >> Share

  2. SIRKIS DW, Warly Solsberg C, Johnson TP, Bonham LW, et al
    Expansion of highly interferon-responsive T cells in early-onset Alzheimer's disease.
    Alzheimers Dement. 2024 Jun 3. doi: 10.1002/alz.13892.
    >> Share

  3. GUPTARAK J, Scaduto P, Tumurbaatar B, Zhang WR, et al
    Cognitive integrity in Non-Demented Individuals with Alzheimer's Neuropathology is associated with preservation and remodeling of dendritic spines.
    Alzheimers Dement. 2024 Jun 3. doi: 10.1002/alz.13900.
    >> Share

  4. LIU ZT, Liu MH, Xiong Y, Wang YJ, et al
    Crosstalk between bone and brain in Alzheimer's disease: Mechanisms, applications, and perspectives.
    Alzheimers Dement. 2024 Jun 2. doi: 10.1002/alz.13864.
    >> Share

  5. ARBER C, Belder CRS, Tomczuk F, Gabriele R, et al
    The presenilin 1 mutation P436S causes familial Alzheimer's disease with elevated Abeta43 and atypical clinical manifestations.
    Alzheimers Dement. 2024 Jun 2. doi: 10.1002/alz.13904.
    >> Share

    May 2024
  6. PANYARD DJ, Reus LM, Ali M, Liu J, et al
    Post-GWAS multiomic functional investigation of the TNIP1 locus in Alzheimer's disease highlights a potential role for GPX3.
    Alzheimers Dement. 2024 May 29. doi: 10.1002/alz.13848.
    >> Share

  7. BISKADUROS A, Glodzik L, Saint Louis LA, Rusinek H, et al
    Longitudinal trajectories of Alzheimer's disease CSF biomarkers and blood pressure in cognitively healthy subjects.
    Alzheimers Dement. 2024 May 29. doi: 10.1002/alz.13800.
    >> Share

  8. SOSA AL, Brucki SM, Crivelli L, Lopera FJ, et al
    Advancements in dementia research, diagnostics, and care in Latin America: Highlights from the 2023 Alzheimer's Association International conference satellite symposium in Mexico City.
    Alzheimers Dement. 2024 May 27. doi: 10.1002/alz.13850.
    >> Share

  9. GARCIA RATES S, Garcia-Ayllon MS, Falgas N, Brangman SA, et al
    Evidence for a novel neuronal mechanism driving Alzheimer's disease, upstream of amyloid.
    Alzheimers Dement. 2024 May 23. doi: 10.1002/alz.13869.
    >> Share

  10. LATIF-HERNANDEZ A, Yang T, Raymond-Butler R 3rd, Losada PM, et al
    A TrkB and TrkC partial agonist restores deficits in synaptic function and promotes activity-dependent synaptic and microglial transcriptomic changes in a late-stage Alzheimer's mouse model.
    Alzheimers Dement. 2024 May 23. doi: 10.1002/alz.13857.
    >> Share

  11. TOSUN D, Hausle Z, Iwaki H, Thropp P, et al
    A cross-sectional study of alpha-synuclein seed amplification assay in Alzheimer's disease neuroimaging initiative: Prevalence and associations with Alzheimer's disease biomarkers and cognitive function.
    Alzheimers Dement. 2024 May 21. doi: 10.1002/alz.13858.
    >> Share

  12. MOGUILNER SG, Berezuk C, Bender AC, Pellerin KR, et al
    Sleep functional connectivity, hyperexcitability, and cognition in Alzheimer's disease.
    Alzheimers Dement. 2024 May 19. doi: 10.1002/alz.13861.
    >> Share

  13. ZHANG Y, Ferreira PCL, Jacobsen E, Bellaver B, et al
    Association of plasma biomarkers of Alzheimer's disease and related disorders with cognition and cognitive decline: The MYHAT population-based study.
    Alzheimers Dement. 2024 May 16. doi: 10.1002/alz.13829.
    >> Share

  14. HOU Y, Chu X, Park JH, Zhu Q, et al
    Urolithin A improves Alzheimer's disease cognition and restores mitophagy and lysosomal functions.
    Alzheimers Dement. 2024 May 16. doi: 10.1002/alz.13847.
    >> Share

  15. BROWN C, Das S, Xie L, Nasrallah I, et al
    Medial temporal lobe gray matter microstructure in preclinical Alzheimer's disease.
    Alzheimers Dement. 2024 May 15. doi: 10.1002/alz.13832.
    >> Share

  16. RUDOLPH MD, Sutphen CL, Register TC, Whitlow CT, et al
    Associations among plasma, MRI, and amyloid PET biomarkers of Alzheimer's disease and related dementias and the impact of health-related comorbidities in a community-dwelling cohort.
    Alzheimers Dement. 2024 May 15. doi: 10.1002/alz.13835.
    >> Share

  17. KWAPONG WR, Tang F, Liu P, Zhang Z, et al
    Choriocapillaris reduction accurately discriminates against early-onset Alzheimer's disease.
    Alzheimers Dement. 2024 May 15. doi: 10.1002/alz.13871.
    >> Share

  18. SUCHY-DICEY AM, Domoto-Reilly K, Nelson L, Jayadev S, et al
    Epidemiology and prevalence of dementia and Alzheimer's disease in American Indians: Data from the Strong Heart Study.
    Alzheimers Dement. 2024 May 15. doi: 10.1002/alz.13849.
    >> Share

  19. KOTREDES KP, Pandey RS, Persohn S, Elderidge K, et al
    Characterizing molecular and synaptic signatures in mouse models of late-onset Alzheimer's disease independent of amyloid and tau pathology.
    Alzheimers Dement. 2024 May 12. doi: 10.1002/alz.13828.
    >> Share

  20. VALLETTA M, Vetrano DL, Rizzuto D, Winblad B, et al
    Blood biomarkers of Alzheimer's disease in the community: Variation by chronic diseases and inflammatory status.
    Alzheimers Dement. 2024 May 8. doi: 10.1002/alz.13860.
    >> Share

  21. WOJTAS AM, Dammer EB, Guo Q, Ping L, et al
    Proteomic changes in the human cerebrovasculature in Alzheimer's disease and related tauopathies linked to peripheral biomarkers in plasma and cerebrospinal fluid.
    Alzheimers Dement. 2024 May 7. doi: 10.1002/alz.13821.
    >> Share

  22. FU J, Lai X, Zhang C, Wei Q, et al
    Correlation analysis of peripheral platelet markers and disease phenotypes in Alzheimer's disease.
    Alzheimers Dement. 2024 May 7. doi: 10.1002/alz.13841.
    >> Share

  23. GALVIN JE, Cummings JL, Benea ML, de Moor C, et al
    Generating real-world evidence in Alzheimer's disease: Considerations for establishing a core dataset.
    Alzheimers Dement. 2024 May 6. doi: 10.1002/alz.13785.
    >> Share

  24. AHMED C, Greve HJ, Garza-Lombo C, Malley JA, et al
    Peripheral HMGB1 is linked to O(3) pathology of disease-associated astrocytes and amyloid.
    Alzheimers Dement. 2024;20:3551-3566.
    >> Share

  25. PETKUS AJ, Wang X, Younan D, Salminen LE, et al
    20-year depressive symptoms, dementia, and structural neuropathology in older women.
    Alzheimers Dement. 2024;20:3472-3484.
    >> Share

  26. XHIMA K, Ottoy J, Gibson E, Zukotynski K, et al
    Distinct spatial contributions of amyloid pathology and cerebral small vessel disease to hippocampal morphology.
    Alzheimers Dement. 2024;20:3687-3695.
    >> Share

  27. BOLLACK A, Collij LE, Garcia DV, Shekari M, et al
    Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History Study.
    Alzheimers Dement. 2024;20:3429-3441.
    >> Share

  28. CHO S, Olm CA, Ash S, Shellikeri S, et al
    Automatic classification of AD pathology in FTD phenotypes using natural speech.
    Alzheimers Dement. 2024;20:3416-3428.
    >> Share

  29. CHEN T, O'Gorman J, Castrillo-Viguera C, Rajagovindan R, et al
    Results from the long-term extension of PRIME: A randomized Phase 1b trial of aducanumab.
    Alzheimers Dement. 2024;20:3406-3415.
    >> Share

  30. QIU T, Liu ZQ, Rheault F, Legarreta JH, et al
    Structural white matter properties and cognitive resilience to tau pathology.
    Alzheimers Dement. 2024;20:3364-3377.
    >> Share

  31. JONAITIS EM, Hermann BP, Mueller KD, Clark LR, et al
    Longitudinal normative standards for cognitive tests and composites using harmonized data from two Wisconsin AD-risk-enriched cohorts.
    Alzheimers Dement. 2024;20:3305-3321.
    >> Share

  32. CORONEL-OLIVEROS C, Gomez RG, Ranasinghe K, Sainz-Ballesteros A, et al
    Viscous dynamics associated with hypoexcitation and structural disintegration in neurodegeneration via generative whole-brain modeling.
    Alzheimers Dement. 2024;20:3228-3250.
    >> Share

  33. MELCHER EM, Vilen L, Pfaff A, Lim S, et al
    Deriving life-course residential histories in brain bank cohorts: A feasibility study.
    Alzheimers Dement. 2024;20:3219-3227.
    >> Share

  34. KAPASI A, Yu L, Leurgans SE, Agrawal S, et al
    Association between hippocampal microglia, AD and LATE-NC, and cognitive decline in older adults.
    Alzheimers Dement. 2024;20:3193-3202.
    >> Share

  35. MEYER MR, Kirmess KM, Eastwood S, Wente-Roth TL, et al
    Clinical validation of the PrecivityAD2 blood test: A mass spectrometry-based test with algorithm combining %p-tau217 and Abeta42/40 ratio to identify presence of brain amyloid.
    Alzheimers Dement. 2024;20:3179-3192.
    >> Share

  36. HILLERSTROM H, Fisher R, Janicki MP, Chicoine B, et al
    Adapting prescribing criteria for amyloid-targeted antibodies for adults with Down syndrome.
    Alzheimers Dement. 2024;20:3649-3656.
    >> Share

  37. HE K, Li B, Wang J, Wang Y, et al
    APOE epsilon4 is associated with decreased synaptic density in cognitively impaired participants.
    Alzheimers Dement. 2024;20:3157-3166.
    >> Share

    April 2024

  38. 2024 Alzheimer's disease facts and figures.
    Alzheimers Dement. 2024 Apr 30. doi: 10.1002/alz.13809.
    >> Share

  39. SASNER M, Preuss C, Pandey RS, Uyar A, et al
    In vivo validation of late-onset Alzheimer's disease genetic risk factors.
    Alzheimers Dement. 2024 Apr 30. doi: 10.1002/alz.13840.
    >> Share

  40. EARNEST T, Bani A, Ha SM, Hobbs DA, et al
    Data-driven decomposition and staging of flortaucipir uptake in Alzheimer's disease.
    Alzheimers Dement. 2024 Apr 29. doi: 10.1002/alz.13769.
    >> Share

  41. PANDEY RS, Arnold M, Batra R, Krumsiek J, et al
    Metabolomics profiling reveals distinct, sex-specific signatures in serum and brain metabolomes in mouse models of Alzheimer's disease.
    Alzheimers Dement. 2024 Apr 27. doi: 10.1002/alz.13851.
    >> Share

  42. HU HY, Hu H, Jiang J, Bi YL, et al
    Echocardiographic measures of the left heart and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in cognitively intact adults: The CABLE study.
    Alzheimers Dement. 2024 Apr 27. doi: 10.1002/alz.13837.
    >> Share

  43. LEVIN J, Baiardi S, Quadalti C, Rossi M, et al
    alpha-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burden.
    Alzheimers Dement. 2024 Apr 26. doi: 10.1002/alz.13818.
    >> Share

  44. ZHANG J, Chen H, Wang J, Huang Q, et al
    Linking white matter hyperintensities to regional cortical thinning, amyloid deposition, and synaptic density loss in Alzheimer's disease.
    Alzheimers Dement. 2024 Apr 22. doi: 10.1002/alz.13845.
    >> Share

  45. SAADMAAN G, Dalmasso MC, Ramirez A, Hiltunen M, et al
    Alzheimer's disease genetic risk score and neuroimaging in the FINGER lifestyle trial.
    Alzheimers Dement. 2024 Apr 22. doi: 10.1002/alz.13843.
    >> Share

  46. TESI N, van der Lee S, Hulsman M, van Schoor NM, et al
    Cognitively healthy centenarians are genetically protected against Alzheimer's disease.
    Alzheimers Dement. 2024 Apr 18. doi: 10.1002/alz.13810.
    >> Share

  47. MOLINA-HENRY DP, Raman R, Liu A, Langford O, et al
    Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer's disease trial.
    Alzheimers Dement. 2024 Apr 17. doi: 10.1002/alz.13803.
    >> Share

  48. LOPEZ DC, White ZJ, Hall SE
    Anxiety in Alzheimer's disease rats is independent of memory and impacted by genotype, age, sex, and exercise.
    Alzheimers Dement. 2024 Apr 16. doi: 10.1002/alz.13813.
    >> Share

  49. HOMANICS GE, Park JE, Bailey L, Schaeffer DJ, et al
    Early molecular events of autosomal-dominant Alzheimer's disease in marmosets with PSEN1 mutations.
    Alzheimers Dement. 2024 Apr 4. doi: 10.1002/alz.13806.
    >> Share

  50. LEE S, Hecker J, Hahn G, Mullin K, et al
    On the effect heterogeneity of established disease susceptibility loci for Alzheimer's disease across different genetic ancestries.
    Alzheimers Dement. 2024 Apr 2. doi: 10.1002/alz.13796.
    >> Share

  51. MUIR RT, Hill MD, Black SE, Smith EE, et al
    Minimal clinically important difference in Alzheimer's disease: Rapid review.
    Alzheimers Dement. 2024 Apr 1. doi: 10.1002/alz.13770.
    >> Share


  52. Critical Alzheimer's disease legislation advances in Congress.
    Alzheimers Dement. 2024;20:3141-3142.
    >> Share

  53. ISLAM T, Kvartsberg H, Sehrawat A, Kac PR, et al
    Novel ultrasensitive immunoassay for the selective quantification of tau oligomers and related soluble aggregates.
    Alzheimers Dement. 2024;20:2894-2905.
    >> Share

  54. KATSUMATA Y, Fardo DW, Shade LMP, Wu X, et al
    Genetic associations with dementia-related proteinopathy: Application of item response theory.
    Alzheimers Dement. 2024;20:2906-2921.
    >> Share

  55. DATTA D, Perone I, Wijegunawardana D, Liang F, et al
    Nanoscale imaging of pT217-tau in aged rhesus macaque entorhinal and dorsolateral prefrontal cortex: Evidence of interneuronal trafficking and early-stage neurodegeneration.
    Alzheimers Dement. 2024;20:2843-2860.
    >> Share

  56. DESIMONE JC, Wang WE, Loewenstein DA, Duara R, et al
    Diffusion MRI relates to plasma Abeta42/40 in PET negative participants without dementia.
    Alzheimers Dement. 2024;20:2830-2842.
    >> Share

  57. ARMSTRONG MJ, LaBarre B, Sovich K, Maixner SM, et al
    Patient- and proxy-reported quality of life in advanced dementia with Lewy bodies.
    Alzheimers Dement. 2024;20:2719-2730.
    >> Share

  58. JOSEPH-MATHURIN N, Feldman RL, Lu R, Shirzadi Z, et al
    Presenilin-1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stage.
    Alzheimers Dement. 2024;20:2680-2697.
    >> Share

  59. YOUNG CB, Smith V, Karjadi C, Grogan SM, et al
    Speech patterns during memory recall relates to early tau burden across adulthood.
    Alzheimers Dement. 2024;20:2552-2563.
    >> Share

  60. FONSECA CS, Baker SL, Dobyns L, Janabi M, et al
    Tau accumulation and atrophy predict amyloid independent cognitive decline in aging.
    Alzheimers Dement. 2024;20:2526-2537.
    >> Share

  61. CHEN KL, Wang MY, Wu J, Zuo CT, et al
    Incremental value of amyloid PET in a tertiary memory clinic setting in China.
    Alzheimers Dement. 2024;20:2516-2525.
    >> Share

  62. RITCHIE M, Salazar CR, Gillen DL, Grill JD, et al
    Post-disclosure distress among racial and ethnic groups in a preclinical AD trial.
    Alzheimers Dement. 2024;20:2508-2515.
    >> Share

  63. KLEIN EG, Schroeder K, Wessels AM, Phipps A, et al
    How donanemab data address the coverage with evidence development questions.
    Alzheimers Dement. 2024;20:3127-3140.
    >> Share

  64. EDISON P
    Astroglial activation: Current concepts and future directions.
    Alzheimers Dement. 2024;20:3034-3053.
    >> Share

  65. ALBRECHT JS, Scherf A, Ryan KA, Falvey JR, et al
    Impact of dementia and socioeconomic disadvantage on days at home after traumatic brain injury among older Medicare beneficiaries: A cohort study.
    Alzheimers Dement. 2024;20:2364-2372.
    >> Share

  66. HINTON L, Tran D, Peak K, Meyer OL, et al
    Mapping racial and ethnic healthcare disparities for persons living with dementia: A scoping review.
    Alzheimers Dement. 2024;20:3000-3020.
    >> Share

    March 2024
  67. DUCHATEAU L, Wawrzyniak N, Sleegers K
    The ABC's of Alzheimer risk gene ABCA7.
    Alzheimers Dement. 2024 Mar 31. doi: 10.1002/alz.13805.
    >> Share

  68. BUCHHOLZ S, Zempel H
    The six brain-specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes.
    Alzheimers Dement. 2024 Mar 31. doi: 10.1002/alz.13784.
    >> Share

  69. DAKTERZADA F, Jove M, Cantero JL, Mota-Martorell N, et al
    The shift in the fatty acid composition of the circulating lipidome in Alzheimer's disease.
    Alzheimers Dement. 2024 Mar 27. doi: 10.1002/alz.13792.
    >> Share

  70. RAHIMZADEH N, Srinivasan SS, Zhang J, Swarup V, et al
    Gene networks and systems biology in Alzheimer's disease: Insights from multi-omics approaches.
    Alzheimers Dement. 2024 Mar 27. doi: 10.1002/alz.13790.
    >> Share

  71. VAN VELUW SJ, Young MJ
    Ethical considerations for the use of anti-amyloid immunotherapy in patients with early Alzheimer's disease.
    Alzheimers Dement. 2024 Mar 25. doi: 10.1002/alz.13795.
    >> Share

  72. SINTINI I, Singh NA, Li D, Mielke MM, et al
    Plasma glial fibrillary acidic protein in the visual and language variants of Alzheimer's disease.
    Alzheimers Dement. 2024 Mar 25. doi: 10.1002/alz.13713.
    >> Share

  73. WANG Y, Sarnowski C, Lin H, Pitsillides AN, et al
    Key variants via the Alzheimer's Disease Sequencing Project whole genome sequence data.
    Alzheimers Dement. 2024 Mar 21. doi: 10.1002/alz.13705.
    >> Share

  74. LARSEN FK, Baksh RA, McGlinchey E, Langballe EM, et al
    Age of Alzheimer's disease diagnosis in people with Down syndrome and associated factors: Results from the Horizon 21 European Down syndrome consortium.
    Alzheimers Dement. 2024 Mar 20. doi: 10.1002/alz.13779.
    >> Share

  75. AMIRI S, Keffeler JI, Crain DR, Denney JT, et al
    Racial, ethnic, and rural disparities in distance to physicians among decedents with Alzheimer's disease and related dementias in Washington State.
    Alzheimers Dement. 2024 Mar 20. doi: 10.1002/alz.13756.
    >> Share

  76. HUANG SY, Zhang YR, Guo Y, Du J, et al
    Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease.
    Alzheimers Dement. 2024 Mar 19. doi: 10.1002/alz.13789.
    >> Share

  77. HOWARD R, Cort E, Rawlinson C, Wiegand M, et al
    Adapted problem adaptation therapy for depression in mild to moderate Alzheimer's disease dementia: A randomized controlled trial.
    Alzheimers Dement. 2024 Mar 13. doi: 10.1002/alz.13766.
    >> Share

  78. GARCIA-AGUDO LF, Shi Z, Smith IF, Kramar EA, et al
    BIN1(K358R) suppresses glial response to plaques in mouse model of Alzheimer's disease.
    Alzheimers Dement. 2024 Mar 9. doi: 10.1002/alz.13767.
    >> Share

  79. MAESTRE G, Hill C, Griffin P, Hall S, et al
    Promoting diverse perspectives: Addressing health disparities related to Alzheimer's and all dementias.
    Alzheimers Dement. 2024 Mar 9. doi: 10.1002/alz.13752.
    >> Share

  80. SEPULVEDA-FALLA D, Velez JI, Acosta-Baena N, Baena A, et al
    Genetic modifiers of cognitive decline in PSEN1 E280A Alzheimer's disease.
    Alzheimers Dement. 2024 Mar 7. doi: 10.1002/alz.13754.
    >> Share

  81. DEMARCO ML, Algeciras-Schimnich A, Budelier MM
    Blood tests for Alzheimer's disease: The impact of disease prevalence on test performance.
    Alzheimers Dement. 2024 Mar 6. doi: 10.1002/alz.13762.
    >> Share

  82. SONI N, Hohsfield LA, Tran KM, Kawauchi S, et al
    Genetic diversity promotes resilience in a mouse model of Alzheimer's disease.
    Alzheimers Dement. 2024 Mar 1. doi: 10.1002/alz.13753.
    >> Share

  83. CHEN K, Ghisays V, Luo J, Chen Y, et al
    Harmonizing florbetapir and PiB PET measurements of cortical Abeta plaque burden using multiple regions-of-interest and machine learning techniques: An alternative to the Centiloid approach.
    Alzheimers Dement. 2024;20:2165-2172.
    >> Share

  84. ALDECOA I, Barroeta I, Carroll SL, Fortea J, et al
    Down Syndrome Biobank Consortium: A perspective.
    Alzheimers Dement. 2024;20:2262-2272.
    >> Share

  85. JACK CR JR, Wiste HJ, Algeciras-Schimnich A, Weigand SD, et al
    Comparison of plasma biomarkers and amyloid PET for predicting memory decline in cognitively unimpaired individuals.
    Alzheimers Dement. 2024;20:2143-2154.
    >> Share

  86. WILKS H, Benzinger TLS, Schindler SE, Cruchaga C, et al
    Predictors and outcomes of fluctuations in the clinical dementia rating scale.
    Alzheimers Dement. 2024;20:2080-2088.
    >> Share

  87. ZHOU L, Nguyen TD, Chiang GC, Wang XH, et al
    Parenchymal CSF fraction is a measure of brain glymphatic clearance and positively associated with amyloid beta deposition on PET.
    Alzheimers Dement. 2024;20:2047-2057.
    >> Share

  88. SEXTON CE, Bitan G, Bowles KR, Brys M, et al
    Novel avenues of tau research.
    Alzheimers Dement. 2024;20:2240-2261.
    >> Share

  89. ROBINSON CG, Lee J, Min PH, Przybelski SA, et al
    Significance of a positive tau PET scan with a negative amyloid PET scan.
    Alzheimers Dement. 2024;20:1923-1932.
    >> Share

  90. SATIZABAL CL, Beiser AS, Fletcher E, Seshadri S, et al
    A novel neuroimaging signature for ADRD risk stratification in the community.
    Alzheimers Dement. 2024;20:1881-1893.
    >> Share

  91. MOONEN JEF, Haan R, Bos I, Teunissen C, et al
    Contributions of amyloid beta and cerebral small vessel disease in clinical decline.
    Alzheimers Dement. 2024;20:1868-1880.
    >> Share

  92. RIVIERE ME, Langbaum JB, Turner RS, Rinne JO, et al
    Effects of the active amyloid beta immunotherapy CAD106 on PET measurements of amyloid plaque deposition in cognitively unimpaired APOE epsilon4 homozygotes.
    Alzheimers Dement. 2024;20:1839-1850.
    >> Share

  93. OLTRA J, Habich A, Schwarz CG, Nedelska Z, et al
    Sex differences in brain atrophy in dementia with Lewy bodies.
    Alzheimers Dement. 2024;20:1815-1826.
    >> Share

  94. CHEN Y, Spina S, Callahan P, Grinberg LT, et al
    Pathology-specific patterns of cerebellar atrophy in neurodegenerative disorders.
    Alzheimers Dement. 2024;20:1771-1783.
    >> Share

  95. SANCHEZ E, Wilkinson T, Coughlan G, Mirza S, et al
    Association of plasma biomarkers with cognition, cognitive decline, and daily function across and within neurodegenerative diseases: Results from the Ontario Neurodegenerative Disease Research Initiative.
    Alzheimers Dement. 2024;20:1753-1770.
    >> Share

  96. SUN X, Eastman G, Shi Y, Saibaba S, et al
    Structural and functional damage to neuronal nuclei caused by extracellular tau oligomers.
    Alzheimers Dement. 2024;20:1656-1670.
    >> Share

  97. KOTAH JM, Kater MSJ, Brosens N, Lesuis SL, et al
    Early-life stress and amyloidosis in mice share pathogenic pathways involving synaptic mitochondria and lipid metabolism.
    Alzheimers Dement. 2024;20:1637-1655.
    >> Share

  98. ROYALL DR, Palmer RF
    Statin use moderates APOE's and CRP's associations with dementia and is associated with lesser dementia severity in epsilon4 carriers.
    Alzheimers Dement. 2024;20:1627-1636.
    >> Share

  99. STITES SD, Largent EA, Schumann R, Harkins K, et al
    How reactions to a brain scan result differ for adults based on self-identified Black and White race.
    Alzheimers Dement. 2024;20:1527-1537.
    >> Share

  100. ROYSE SK, Snitz BE, Hengenius JB, Huppert TJ, et al
    Unhealthy white matter connectivity, cognition, and racialization in older adults.
    Alzheimers Dement. 2024;20:1483-1496.
    >> Share

    February 2024
  101. RUTHIRAKUHAN M, Swardfager W, Xiong L, MacIntosh BJ, et al
    Investigating the impact of hypertension with and without diabetes on Alzheimer's disease risk: A clinico-pathological study.
    Alzheimers Dement. 2024 Feb 29. doi: 10.1002/alz.13717.
    >> Share

  102. NEWTON C, Pope M, Rua C, Henson R, et al
    Entorhinal-based path integration selectively predicts midlife risk of Alzheimer's disease.
    Alzheimers Dement. 2024 Feb 29. doi: 10.1002/alz.13733.
    >> Share

  103. MOHS RC, Beauregard D, Dwyer J, Gaudioso J, et al
    The Bio-Hermes Study: Biomarker database developed to investigate blood-based and digital biomarkers in community-based, diverse populations clinically screened for Alzheimer's disease.
    Alzheimers Dement. 2024 Feb 28. doi: 10.1002/alz.13722.
    >> Share

  104. SHIM KH, Kim D, Kang MJ, Pyun JM, et al
    Subsequent correlated changes in complement component 3 and amyloid beta oligomers in the blood of patients with Alzheimer's disease.
    Alzheimers Dement. 2024 Feb 27. doi: 10.1002/alz.13734.
    >> Share

  105. SASNER M, Onos KD, Territo PR, Sukoff Rizzo SJ, et al
    Meeting report of the fifth annual workshop on Principles and Techniques for Improving Preclinical to Clinical Translation in Alzheimer's Disease Research.
    Alzheimers Dement. 2024 Feb 24. doi: 10.1002/alz.13742.
    >> Share

  106. WANG G, Li Y, Xiong C, Benzinger TLS, et al
    Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease.
    Alzheimers Dement. 2024 Feb 23. doi: 10.1002/alz.13735.
    >> Share

  107. XICOTA L, Cosentino S, Vardarajan B, Mayeux R, et al
    Whole genome-wide sequence analysis of long-lived families (Long-Life Family Study) identifies MTUS2 gene associated with late-onset Alzheimer's disease.
    Alzheimers Dement. 2024 Feb 21. doi: 10.1002/alz.13718.
    >> Share

  108. WOLTERS FJ, Labrecque JA
    Potential impact of unblinding on observed treatment effects in Alzheimer's disease trials.
    Alzheimers Dement. 2024 Feb 21. doi: 10.1002/alz.13690.
    >> Share

  109. FERGUSON CM, Hildebrand S, Godinho BMDC, Buchwald J, et al
    Silencing Apoe with divalent-siRNAs improves amyloid burden and activates immune response pathways in Alzheimer's disease.
    Alzheimers Dement. 2024 Feb 20. doi: 10.1002/alz.13703.
    >> Share

  110. ORTEGA-CRUZ D, Bress KS, Gazula H, Rabano A, et al
    Three-dimensional histology reveals dissociable human hippocampal long-axis gradients of Alzheimer's pathology.
    Alzheimers Dement. 2024 Feb 18. doi: 10.1002/alz.13695.
    >> Share

  111. KUMAR A, Scarpa M, Nordberg A
    Tracing synaptic loss in Alzheimer's brain with SV2A PET-tracer UCB-J.
    Alzheimers Dement. 2024 Feb 16. doi: 10.1002/alz.13720.
    >> Share

  112. PILLAI JA, Bena J, Tousi B, Rothenberg K, et al
    Lewy body pathology modifies risk factors for cerebral amyloid angiopathy when comorbid with Alzheimer's disease pathology.
    Alzheimers Dement. 2024 Feb 14. doi: 10.1002/alz.13704.
    >> Share

  113. PADULA CB, Ball S, Wyman MF, Evans K, et al
    INviting Veterans InTo Enrollment in Alzheimer's Disease Research Centers (INVITE-ADRC): An NIA and VA-sponsored initiative to increase veteran participation in aging and dementia research.
    Alzheimers Dement. 2024 Feb 13. doi: 10.1002/alz.13725.
    >> Share

  114. LI Z, Liang D, Ebelt S, Gearing M, et al
    Differential DNA methylation in the brain as potential mediator of the association between traffic-related PM(2.5) and neuropathology markers of Alzheimer's disease.
    Alzheimers Dement. 2024 Feb 12. doi: 10.1002/alz.13650.
    >> Share

  115. BENZOW K, Karanjeet K, Oblak AL, Carter GW, et al
    Gene replacement-Alzheimer's disease (GR-AD): Modeling the genetics of human dementias in mice.
    Alzheimers Dement. 2024 Feb 11. doi: 10.1002/alz.13730.
    >> Share

  116. DIAZ-GALVAN P, Przybelski SA, Algeciras-Schimnich A, Figdore DJ, et al
    Plasma biomarkers of Alzheimer's disease in the continuum of dementia with Lewy bodies.
    Alzheimers Dement. 2024 Feb 8. doi: 10.1002/alz.13653.
    >> Share

  117. GONZALEZ-ORTIZ F, Karikari TK, Blennow K
    Analytical and clinical validation of Alzheimer's disease blood biomarkers with a focus on plasma p-tau217.
    Alzheimers Dement. 2024 Feb 8. doi: 10.1002/alz.13708.
    >> Share

  118. TAHA HB
    Early detection of subjective cognitive decline and Alzheimer's disease: Analytical validation of a newly developed pT217-tau assay.
    Alzheimers Dement. 2024 Feb 8. doi: 10.1002/alz.13707.
    >> Share

  119. ABADIR P, Oh E, Chellappa R, Choudhry N, et al
    Artificial Intelligence and Technology Collaboratories: Innovating aging research and Alzheimer's care.
    Alzheimers Dement. 2024 Feb 7. doi: 10.1002/alz.13710.
    >> Share

  120. ZHONG H, Zhou X, Uhm H, Jiang Y, et al
    Using blood transcriptome analysis for Alzheimer's disease diagnosis and patient stratification.
    Alzheimers Dement. 2024 Feb 7. doi: 10.1002/alz.13691.
    >> Share

  121. BELLOMO G, Bayoumy S, Megaro A, Toja A, et al
    Fully automated measurement of plasma Abeta42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts.
    Alzheimers Dement. 2024 Feb 7. doi: 10.1002/alz.13687.
    >> Share

  122. BELLOMO G, Toja A, Paolini Paoletti F, Ma Y, et al
    Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay.
    Alzheimers Dement. 2024 Feb 7. doi: 10.1002/alz.13658.
    >> Share

  123. GRIFFIN JM, Kim K, Finnie DM, Lapid MI, et al
    Developing and describing a typology of lucid episodes among people with Alzheimer's disease and related dementias.
    Alzheimers Dement. 2024 Feb 2. doi: 10.1002/alz.13667.
    >> Share

  124. SHAABAN CE, Lin HS, Terry M, Ren D, et al
    COVID-19 pandemic's relationship with enrollment at US Alzheimer's Disease Research Centers.
    Alzheimers Dement. 2024 Feb 1. doi: 10.1002/alz.13706.
    >> Share

  125. ROSSANO SM, Johnson AS, Smith A, Ziaggi G, et al
    Microglia measured by TSPO PET are associated with Alzheimer's disease pathology and mediate key steps in a disease progression model.
    Alzheimers Dement. 2024 Feb 1. doi: 10.1002/alz.13699.
    >> Share


  126. Alzheimer's Association and ASNR announce recipients of imaging grants.
    Alzheimers Dement. 2024;20:1476-1477.
    >> Share

  127. CLARK AL, Thomas KR, Ortega N, Haley AP, et al
    Empirically derived psychosocial-behavioral phenotypes in Black/African American and Hispanic/Latino older adults enrolled in HABS-HD: Associations with AD biomarkers and cognitive outcomes.
    Alzheimers Dement. 2024;20:1360-1373.
    >> Share

  128. EISSMAN JM, Archer DB, Mukherjee S, Lee ML, et al
    Sex-specific genetic architecture of late-life memory performance.
    Alzheimers Dement. 2024;20:1250-1267.
    >> Share

  129. SLEE MG, Rainey-Smith SR, Villemagne VL, Doecke JD, et al
    Physical activity and brain amyloid beta: A longitudinal analysis of cognitively unimpaired older adults.
    Alzheimers Dement. 2024;20:1350-1359.
    >> Share

  130. COGSWELL PM, Lundt ES, Therneau TM, Wiste HJ, et al
    Modeling the temporal evolution of plasma p-tau in relation to amyloid beta and tau PET.
    Alzheimers Dement. 2024;20:1225-1238.
    >> Share

  131. BUTTS B, Huang H, Hu WT, Kehoe PG, et al
    sPDGFRbeta and neuroinflammation are associated with AD biomarkers and differ by race: The ASCEND Study.
    Alzheimers Dement. 2024;20:1175-1189.
    >> Share

  132. CHEN H, Dunk MM, Wang B, Zhao M, et al
    Associations of the Mediterranean-DASH Intervention for Neurodegenerative Delay diet with brain structural markers and their changes.
    Alzheimers Dement. 2024;20:1190-1200.
    >> Share

  133. WOO MS, Tissot C, Lantero-Rodriguez J, Snellman A, et al
    Plasma pTau-217 and N-terminal tau (NTA) enhance sensitivity to identify tau PET positivity in amyloid-beta positive individuals.
    Alzheimers Dement. 2024;20:1166-1174.
    >> Share

  134. ACKLEY SF, Wang J, Chen R, Power MC, et al
    Estimated effects of amyloid reduction on cognitive change: A Bayesian update across a range of priors.
    Alzheimers Dement. 2024;20:1149-1155.
    >> Share

  135. SANFORD SAI, Miller LVC, Vaysburd M, Keeling S, et al
    The type-I interferon response potentiates seeded tau aggregation and exacerbates tau pathology.
    Alzheimers Dement. 2024;20:1013-1025.
    >> Share

  136. GERMAN-CASTELAN L, Shanks HRC, Gros R, Saito T, et al
    Sex-dependent cholinergic effects on amyloid pathology: A translational study.
    Alzheimers Dement. 2024;20:995-1012.
    >> Share

  137. SCHWEITZER N, Li J, Thurston RC, Lopresti B, et al
    Sex-dependent alterations in hippocampal connectivity are linked to cerebrovascular and amyloid pathologies in normal aging.
    Alzheimers Dement. 2024;20:914-924.
    >> Share

  138. AARONSON A, Ashford MT, Jin C, Bride J, et al
    Brain Health Registry Study Partner Portal: Novel infrastructure for digital, dyadic data collection.
    Alzheimers Dement. 2024;20:846-857.
    >> Share

  139. MARINO C, Perez-Corredor P, O'Hare M, Heuer A, et al
    APOE Christchurch-mimetic therapeutic antibody reduces APOE-mediated toxicity and tau phosphorylation.
    Alzheimers Dement. 2024;20:819-836.
    >> Share

  140. TATE AE, Bouteloup V, van Maurik IS, Jean D, et al
    Predicting sojourn times across dementia disease stages, institutionalization, and mortality.
    Alzheimers Dement. 2024;20:809-818.
    >> Share

    January 2024
  141. DAMSGAARD L, Janbek J, Laursen TM, Hogh P, et al
    Mapping morbidity 10 years prior to a diagnosis of young onset Alzheimer's disease.
    Alzheimers Dement. 2024 Jan 31. doi: 10.1002/alz.13681.
    >> Share


  142. Withdrawal: Glycine transporter 1 (GlyT1) is a novel therapeutic target for Alzheimer's disease.
    Alzheimers Dement. 2024 Jan 31. doi: 10.1002/alz.13724.
    >> Share

  143. ALGECIRAS-SCHIMNICH A, Bornhorst JA
    Importance of cerebrospinal fluid (CSF) collection protocol for the accurate diagnosis of Alzheimer's disease when using CSF biomarkers.
    Alzheimers Dement. 2024 Jan 30. doi: 10.1002/alz.13721.
    >> Share

  144. HUBER H, Blennow K, Zetterberg H, Boada M, et al
    Biomarkers of Alzheimer's disease and neurodegeneration in dried blood spots-A new collection method for remote settings.
    Alzheimers Dement. 2024 Jan 29. doi: 10.1002/alz.13697.
    >> Share

  145. GOMEZ-ARBOLEDAS A, Fonseca MI, Kramar E, Chu SH, et al
    C5aR1 signaling promotes region- and age-dependent synaptic pruning in models of Alzheimer's disease.
    Alzheimers Dement. 2024 Jan 26. doi: 10.1002/alz.13682.
    >> Share

  146. RUBINSTEIN T, Brickman AM, Cheng B, Burkett S, et al
    Periodontitis and brain magnetic resonance imaging markers of Alzheimer's disease and cognitive aging.
    Alzheimers Dement. 2024 Jan 26. doi: 10.1002/alz.13683.
    >> Share

  147. DEECKE L, Homann J, Goldecktble D, Ohlei O, et al
    No increase of CD8+ TEMRA cells in the blood of healthy adults at high genetic risk of Alzheimer's disease.
    Alzheimers Dement. 2024 Jan 25. doi: 10.1002/alz.13709.
    >> Share

  148. XU H, Bayless TM, Ostbye T, Dupre ME, et al
    Care sequences leading to the diagnosis of Alzheimer's disease and related dementias: An analysis of electronic health records.
    Alzheimers Dement. 2024 Jan 25. doi: 10.1002/alz.13669.
    >> Share

  149. LANDAU SM, Lee J, Murphy A, Ward TJ, et al
    Individuals with Alzheimer's disease and low tau burden: Characteristics and implications.
    Alzheimers Dement. 2024 Jan 19. doi: 10.1002/alz.13609.
    >> Share

  150. TSOY E, La Joie R, VandeVrede L, Rojas JC, et al
    Scalable plasma and digital cognitive markers for diagnosis and prognosis of Alzheimer's disease and related dementias.
    Alzheimers Dement. 2024 Jan 15. doi: 10.1002/alz.13686.
    >> Share

  151. POMARA N, Imbimbo BP
    Do anti-Abeta monoclonal antibodies lower brain plaques in Alzheimer patients through microglia activation?
    Alzheimers Dement. 2024 Jan 15. doi: 10.1002/alz.13684.
    >> Share

  152. HATA Y, Nakase M, Ichimata S, Yoshida K, et al
    Neuropathology of patients with preclinical or early clinical Alzheimer's disease with pathogenic PSEN1_p. L392V: Comparison of advanced siblings.
    Alzheimers Dement. 2024 Jan 12. doi: 10.1002/alz.13675.
    >> Share

  153. SUCHY-DICEY AM, Longstreth WT Jr, Rhoads K, Umans J, et al
    Plasma biomarkers of Alzheimer's disease and related dementias in American Indians: The Strong Heart Study.
    Alzheimers Dement. 2024 Jan 12. doi: 10.1002/alz.13664.
    >> Share

  154. HO PC, Yu WH, Tee BL, Lee WP, et al
    Asian Cohort for Alzheimer's Disease (ACAD) pilot study on genetic and non-genetic risk factors for Alzheimer's disease among Asian Americans and Canadians.
    Alzheimers Dement. 2024 Jan 12. doi: 10.1002/alz.13611.
    >> Share

  155. OWENS HA, Thorburn LE, Walsby E, Moon OR, et al
    Alzheimer's disease-associated P460L variant of EphA1 dysregulates receptor activity and blood-brain barrier function.
    Alzheimers Dement. 2024 Jan 7. doi: 10.1002/alz.13603.
    >> Share

  156. WANG P, Lynn A, Miskimen K, Song YE, et al
    Genome-wide association studies identify novel loci in rapidly progressive Alzheimer's disease.
    Alzheimers Dement. 2024 Jan 7. doi: 10.1002/alz.13655.
    >> Share

  157. BUTO PT, Wang J, La Joie R, Zimmerman SC, et al
    Genetic risk score for Alzheimer's disease predicts brain volume differences in mid and late life in UK biobank participants.
    Alzheimers Dement. 2024 Jan 6. doi: 10.1002/alz.13610.
    >> Share

  158. GU Y, Honig LS, Kang MS, Bahl A, et al
    Risk of Alzheimer's disease is associated with longitudinal changes in plasma biomarkers in the multi-ethnic Washington Heights-Hamilton Heights-Inwood Columbia Aging Project (WHICAP) cohort.
    Alzheimers Dement. 2024 Jan 6. doi: 10.1002/alz.13652.
    >> Share

  159. JIANG Y, Uhm H, Ip FC, Ouyang L, et al
    A blood-based multi-pathway biomarker assay for early detection and staging of Alzheimer's disease across ethnic groups.
    Alzheimers Dement. 2024 Jan 6. doi: 10.1002/alz.13676.
    >> Share

  160. SRIKRISHNA M, Ashton NJ, Moscoso A, Pereira JB, et al
    CT-based volumetric measures obtained through deep learning: Association with biomarkers of neurodegeneration.
    Alzheimers Dement. 2024;20:629-640.
    >> Share

  161. JAIN L, Khrestian M, Formica S, Tuason ED, et al
    ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium.
    Alzheimers Dement. 2024;20:549-562.
    >> Share

  162. LOPES KP, Yu L, Shen X, Qiu Y, et al
    Associations of cortical SPP1 and ITGAX with cognition and common neuropathologies in older adults.
    Alzheimers Dement. 2024;20:525-537.
    >> Share

  163. MADSEN LS, Kjeldsen PL, Ismail R, Parbo P, et al
    Capillary dysfunction in healthy elderly APOE epsilon4 carriers with raised brain Abeta deposition.
    Alzheimers Dement. 2024;20:459-471.
    >> Share

  164. LIU W, Yu L, Deng Q, Li Y, et al
    Toward digitally screening and profiling AD: A GAMLSS approach of MemTrax in China.
    Alzheimers Dement. 2024;20:399-409.
    >> Share

  165. ZAMMIT MD, Betthauser TJ, McVea AK, Laymon CM, et al
    Characterizing the emergence of amyloid and tau burden in Down syndrome.
    Alzheimers Dement. 2024;20:388-398.
    >> Share

  166. WANG X, Sundermann EE, Buckley RF, Banks SJ, et al
    Sex differences in the association between tau PET and cognitive performance in a non-Hispanic White cohort with preclinical AD.
    Alzheimers Dement. 2024;20:25-33.
    >> Share

  167. SALONER R, VandeVrede L, Asken BM, Paolillo EW, et al
    Plasma phosphorylated tau-217 exhibits sex-specific prognostication of cognitive decline and brain atrophy in cognitively unimpaired adults.
    Alzheimers Dement. 2024;20:376-387.
    >> Share

  168. WALKIEWICZ G, Ronisz A, Van Ginderdeuren R, Lemmens S, et al
    Primary retinal tauopathy: A tauopathy with a distinct molecular pattern.
    Alzheimers Dement. 2024;20:330-340.
    >> Share

  169. PEZZOLI S, Giorgio J, Martersteck A, Dobyns L, et al
    Successful cognitive aging is associated with thicker anterior cingulate cortex and lower tau deposition compared to typical aging.
    Alzheimers Dement. 2024;20:341-355.
    >> Share

  170. GAUTHREAUX K, Kukull WA, Nelson KB, Mock C, et al
    Different cohort, disparate results: Selection bias is a key factor in autopsy cohorts.
    Alzheimers Dement. 2024;20:266-277.
    >> Share

  171. TITCOMB TJ, Richey P, Casanova R, Phillips LS, et al
    Association of type 2 diabetes mellitus with dementia-related and non-dementia-related mortality among postmenopausal women: A secondary competing risks analysis of the women's health initiative.
    Alzheimers Dement. 2024;20:234-242.
    >> Share

  172. BOCCALINI C, Ribaldi F, Hristovska I, Arnone A, et al
    The impact of tau deposition and hypometabolism on cognitive impairment and longitudinal cognitive decline.
    Alzheimers Dement. 2024;20:221-233.
    >> Share

  173. VAN DER HEIDE FCT, Khawaja A, Berendschot TTJM, Littlejohns TJ, et al
    Associations of inner retinal layers with risk of incident dementia: An individual participant data analysis of four prospective cohort studies.
    Alzheimers Dement. 2024;20:211-220.
    >> Share

  174. HARDY CJD, Taylor-Rubin C, Taylor B, Harding E, et al
    Symptom-led staging for semantic and non-fluent/agrammatic variants of primary progressive aphasia.
    Alzheimers Dement. 2024;20:195-210.
    >> Share

  175. WANG X, St George RJ, Bindoff AD, Noyce AJ, et al
    Estimating presymptomatic episodic memory impairment using simple hand movement tests: A cross-sectional study of a large sample of older adults.
    Alzheimers Dement. 2024;20:173-182.
    >> Share

  176. CAMINITI SP, De Francesco S, Tondo G, Galli A, et al
    FDG-PET markers of heterogeneity and different risk of progression in amnestic MCI.
    Alzheimers Dement. 2024;20:159-172.
    >> Share

  177. DENG J, Sun B, Kavcic V, Liu M, et al
    Novel methodology for detection and prediction of mild cognitive impairment using resting-state EEG.
    Alzheimers Dement. 2024;20:145-158.
    >> Share

    December 2023
  178. LU Y, Pike JR, Hoogeveen RC, Walker KA, et al
    Liver integrity and the risk of Alzheimer's disease and related dementias.
    Alzheimers Dement. 2023 Dec 28. doi: 10.1002/alz.13601.
    >> Share

  179. DARRICAU M, Dou C, Kinet R, Zhu T, et al
    Tau seeds from Alzheimer's disease brains trigger tau spread in macaques while oligomeric-Abeta mediates pathology maturation.
    Alzheimers Dement. 2023 Dec 26. doi: 10.1002/alz.13604.
    >> Share

  180. ABIOSE O, Rutledge J, Moran-Losada P, Belloy ME, et al
    Post-translational modifications linked to preclinical Alzheimer's disease-related pathological and cognitive changes.
    Alzheimers Dement. 2023 Dec 25. doi: 10.1002/alz.13576.
    >> Share


  181. Correction to "Strain hypothesis and additional evidence of the GluN3A deficiency? mediated pathogenesis of Alzheimer's disease".
    Alzheimers Dement. 2023 Dec 21. doi: 10.1002/alz.13549.
    >> Share

  182. WANG X, Bakulski KM, Karvonen-Gutierrez CA, Park SK, et al
    Blood-based biomarkers for Alzheimer's disease and cognitive function from mid- to late life.
    Alzheimers Dement. 2023 Dec 21. doi: 10.1002/alz.13583.
    >> Share

  183. ASLANYAN V, Mack WJ, Ortega NE, Nasrallah IM, et al
    Cerebrovascular reactivity in Alzheimer's disease signature regions is associated with mild cognitive impairment in adults with hypertension.
    Alzheimers Dement. 2023 Dec 18. doi: 10.1002/alz.13572.
    >> Share

  184. CRANE PK, Groot C, Ossenkoppele R, Mukherjee S, et al
    Cognitively defined Alzheimer's dementia subgroups have distinct atrophy patterns.
    Alzheimers Dement. 2023 Dec 13. doi: 10.1002/alz.13567.
    >> Share

  185. DOUROS A, Ante Z, Fallone CA, Azoulay L, et al
    Clinically apparent Helicobacter pylori infection and the risk of incident Alzheimer's disease: A population-based nested case-control study.
    Alzheimers Dement. 2023 Dec 13. doi: 10.1002/alz.13561.
    >> Share

  186. VILOR-TEJEDOR N, Genius P, Rodriguez-Fernandez B, Minguillon C, et al
    Genetic characterization of the ALFA study: Uncovering genetic profiles in the Alzheimer's continuum.
    Alzheimers Dement. 2023 Dec 13. doi: 10.1002/alz.13537.
    >> Share

  187. DEVANARAYAN V, Ye Y, Charil A, Andreozzi E, et al
    Predicting clinical progression trajectories of early Alzheimer's disease patients.
    Alzheimers Dement. 2023 Dec 13. doi: 10.1002/alz.13565.
    >> Share

  188. MORGAN DG, Lamb BT
    Transgenic amyloid precursor protein mouse models of amyloidosis. Incomplete models for Alzheimer's disease but effective predictors of anti-amyloid therapies.
    Alzheimers Dement. 2023 Dec 12. doi: 10.1002/alz.13566.
    >> Share

  189. CONNIFF KR, Grill JD, Gillen DL
    Retention of American Indian and Alaska Native participants in the National Alzheimer's Coordinating Center Uniform Data Set.
    Alzheimers Dement. 2023 Dec 5. doi: 10.1002/alz.13573.
    >> Share

  190. AMANO T, Halvorsen CJ, Kim S, Reynolds A, et al
    An outcome-wide analysis of the effects of diagnostic labeling of Alzheimer's disease and related dementias on social relationships.
    Alzheimers Dement. 2023 Dec 5. doi: 10.1002/alz.13574.
    >> Share

  191. LYU X, Duong MT, Xie L, de Flores R, et al
    Tau-neurodegeneration mismatch reveals vulnerability and resilience to comorbidities in Alzheimer's continuum.
    Alzheimers Dement. 2023 Dec 5. doi: 10.1002/alz.13559.
    >> Share

  192. BELLIER JP, Cai Y, Alam SM, Wiederhold T, et al
    Uncovering elevated tau TPP motif phosphorylation in the brain of Alzheimer's disease patients.
    Alzheimers Dement. 2023 Dec 2. doi: 10.1002/alz.13557.
    >> Share

  193. LE BORGNE J, Amouyel P, Andreassen O, Frikke-Schmidt R, et al
    Association of MGMT and BIN1 genes with Alzheimer's disease risk across sex and APOE epsilon4 status.
    Alzheimers Dement. 2023 Dec 2. doi: 10.1002/alz.13550.
    >> Share

  194. REN Y, Li Y, Tian N, Liu R, et al
    Multimorbidity, cognitive phenotypes, and Alzheimer's disease plasma biomarkers in older adults: A population-based study.
    Alzheimers Dement. 2023 Dec 2. doi: 10.1002/alz.13519.
    >> Share

  195. BETTENCOURT C, Skene N, Bandres-Ciga S, Anderson E, et al
    Artificial intelligence for dementia genetics and omics.
    Alzheimers Dement. 2023;19:5905-5921.
    >> Share

  196. BORCHERT RJ, Azevedo T, Badhwar A, Bernal J, et al
    Artificial intelligence for diagnostic and prognostic neuroimaging in dementia: A systematic review.
    Alzheimers Dement. 2023;19:5885-5904.
    >> Share

  197. STERN AM, Van Pelt KL, Liu L, Anderson AK, et al
    Plasma NT1-tau and Abeta(42) correlate with age and cognitive function in two large Down syndrome cohorts.
    Alzheimers Dement. 2023;19:5755-5764.
    >> Share

  198. LEE YG, Jeon S, Kang SW, Ye BS, et al
    Effects of amyloid beta and dopaminergic depletion on perfusion and clinical symptoms.
    Alzheimers Dement. 2023;19:5719-5729.
    >> Share

  199. GRASSET L, Planche V, Bouteloup V, Azouani C, et al
    Physical activity, biomarkers of brain pathologies and dementia risk: Results from the Memento clinical cohort.
    Alzheimers Dement. 2023;19:5700-5718.
    >> Share

  200. GERICKE C, Kirabali T, Flury R, Mallone A, et al
    Early beta-amyloid accumulation in the brain is associated with peripheral T cell alterations.
    Alzheimers Dement. 2023;19:5642-5662.
    >> Share

  201. NGUYEN HO PT, van Arendonk J, Steketee RME, van Rooij FJA, et al
    Predicting amyloid-beta pathology in the general population.
    Alzheimers Dement. 2023;19:5506-5517.
    >> Share

  202. TOSUN D, Thropp P, Southekal S, Spottiswoode B, et al
    Profiling and predicting distinct tau progression patterns: An unsupervised data-driven approach to flortaucipir positron emission tomography.
    Alzheimers Dement. 2023;19:5605-5619.
    >> Share

  203. FRANZEN S, Nuytemans K, Bourdage R, Caramelli P, et al
    Gaps in clinical research in frontotemporal dementia: A call for diversity and disparities-focused research.
    Alzheimers Dement. 2023;19:5817-5836.
    >> Share

  204. JAHREIS K, Bruge A, Borsdorf S, Muller FE, et al
    Amisulpride as a potential disease-modifying drug in the treatment of tauopathies.
    Alzheimers Dement. 2023;19:5482-5497.
    >> Share

  205. KIM KY, Ha J, Lee JY, Kim E, et al
    Weight loss and risk of dementia in individuals with versus without obesity.
    Alzheimers Dement. 2023;19:5471-5481.
    >> Share

  206. STANKEVICIUTE L, Falcon C, Operto G, Garcia M, et al
    Differential effects of sleep on brain structure and metabolism at the preclinical stages of AD.
    Alzheimers Dement. 2023;19:5371-5386.
    >> Share

  207. LANTERO-RODRIGUEZ J, Tissot C, Snellman A, Servaes S, et al
    Plasma and CSF concentrations of N-terminal tau fragments associate with in vivo neurofibrillary tangle burden.
    Alzheimers Dement. 2023;19:5343-5354.
    >> Share

  208. FONTEH AN, Wu X, Astraea N, Elenberger T, et al
    Biomarkers - Part 1.
    Alzheimers Dement. 2023;19 Suppl 14:e079861.
    >> Share

    November 2023
  209. CHUMIN EJ, Burton CP, Silvola R, Miner EW, et al
    Brain metabolic network covariance and aging in a mouse model of Alzheimer's disease.
    Alzheimers Dement. 2023 Nov 30. doi: 10.1002/alz.13538.
    >> Share

  210. FOLEY KE, Winder Z, Sudduth TL, Martin BJ, et al
    Alzheimer's disease and inflammatory biomarkers positively correlate in plasma in the UK-ADRC cohort.
    Alzheimers Dement. 2023 Nov 27. doi: 10.1002/alz.13485.
    >> Share

  211. DALMASSO MC, de Rojas I, Olivar N, Muchnik C, et al
    The first genome-wide association study in the Argentinian and Chilean populations identifies shared genetics with Europeans in Alzheimer's disease.
    Alzheimers Dement. 2023 Nov 20. doi: 10.1002/alz.13522.
    >> Share

  212. HOU Y, Caldwell JZK, Lathia JD, Leverenz JB, et al
    Microglial immunometabolism endophenotypes contribute to sex difference in Alzheimer's disease.
    Alzheimers Dement. 2023 Nov 20. doi: 10.1002/alz.13546.
    >> Share

  213. BRUM WS, Ashton NJ, Simren J, di Molfetta G, et al
    Biological variation estimates of Alzheimer's disease plasma biomarkers in healthy individuals.
    Alzheimers Dement. 2023 Nov 20. doi: 10.1002/alz.13518.
    >> Share

  214. ARCHER DB, Eissman JM, Mukherjee S, Lee ML, et al
    Longitudinal change in memory performance as a strong endophenotype for Alzheimer's disease.
    Alzheimers Dement. 2023 Nov 20. doi: 10.1002/alz.13508.
    >> Share

  215. GONZALEZ-ORTIZ F, Ferreira PCL, Gonzalez-Escalante A, Montoliu-Gaya L, et al
    A novel ultrasensitive assay for plasma p-tau217: Performance in individuals with subjective cognitive decline and early Alzheimer's disease.
    Alzheimers Dement. 2023 Nov 17. doi: 10.1002/alz.13525.
    >> Share

  216. POWELL WR, Vilen L, Zuelsdorff M, Goutman SA, et al
    Association between military service and Alzheimer's disease neuropathology at autopsy.
    Alzheimers Dement. 2023 Nov 15. doi: 10.1002/alz.13520.
    >> Share

  217. RISSMAN RA, Langford O, Raman R, Donohue MC, et al
    Plasma Abeta42/Abeta40 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease.
    Alzheimers Dement. 2023 Nov 6. doi: 10.1002/alz.13542.
    >> Share

  218. ALBER J, Bouwman F, den Haan J, Rissman RA, et al
    Retina pathology as a target for biomarkers for Alzheimer's disease: Current status, ophthalmopathological background, challenges, and future directions.
    Alzheimers Dement. 2023 Nov 2. doi: 10.1002/alz.13529.
    >> Share

  219. CANEPA E, Parodi-Rullan R, Vazquez-Torres R, Gamallo-Lana B, et al
    FDA-approved carbonic anhydrase inhibitors reduce amyloid beta pathology and improve cognition, by ameliorating cerebrovascular health and glial fitness.
    Alzheimers Dement. 2023;19:5048-5073.
    >> Share

  220. HAUSMANN A, Chiabotti PS, Nasuti M, Rouaud O, et al
    Don't forget primary progressive aphasia for anti-amyloid drugs: An estimation of eligible patients from the Lausanne Memory Center registry.
    Alzheimers Dement. 2023;19:5303-5304.
    >> Share

  221. JIANG X, Hu X, Daamen M, Wang X, et al
    Altered limbic functional connectivity in individuals with subjective cognitive decline: Converging and diverging findings across Chinese and German cohorts.
    Alzheimers Dement. 2023;19:4922-4934.
    >> Share

  222. OECKL P, Bluma M, Bucci M, Halbgebauer S, et al
    Blood beta-synuclein is related to amyloid PET positivity in memory clinic patients.
    Alzheimers Dement. 2023;19:4896-4907.
    >> Share

  223. MALEKI BALAJOO S, Eickhoff SB, Masouleh SK, Plachti A, et al
    Hippocampal metabolic subregions and networks: Behavioral, molecular, and pathological aging profiles.
    Alzheimers Dement. 2023;19:4787-4804.
    >> Share

  224. WILCOCK DM
    The longitudinal early-onset Alzheimer's disease study (LEADS): Advancing our understanding of Alzheimer's disease in individuals aged 40-64.
    Alzheimers Dement. 2023;19 Suppl 9:S7.
    >> Share

  225. ORTEGA-CRUZ D, Iglesias JE, Rabano A, Strange BA, et al
    Hippocampal sclerosis of aging at post-mortem is evident on MRI more than a decade prior.
    Alzheimers Dement. 2023;19:5307-5315.
    >> Share

  226. FREEZE WM, Van Veluw SJ, Jansen WJ, Bennett DA, et al
    Locus coeruleus pathology is associated with cerebral microangiopathy at autopsy.
    Alzheimers Dement. 2023;19:5023-5035.
    >> Share

  227. ZHANG M, Ganz AB, Rohde S, Lorenz L, et al
    The correlation between neuropathology levels and cognitive performance in centenarians.
    Alzheimers Dement. 2023;19:5036-5047.
    >> Share

  228. CAI Y, Fan X, Zhao L, Liu W, et al
    Comparing machine learning-derived MRI-based and blood-based neurodegeneration biomarkers in predicting syndromal conversion in early AD.
    Alzheimers Dement. 2023;19:4987-4998.
    >> Share

  229. WEINER MW, Aaronson A, Eichenbaum J, Kwang W, et al
    Brain health registry updates: An online longitudinal neuroscience platform.
    Alzheimers Dement. 2023;19:4935-4951.
    >> Share

  230. SHI H, Koronyo Y, Fuchs DT, Sheyn J, et al
    Retinal arterial Abeta(40) deposition is linked with tight junction loss and cerebral amyloid angiopathy in MCI and AD patients.
    Alzheimers Dement. 2023;19:5185-5197.
    >> Share

    October 2023
  231. MUIR RT, Ismail Z, Black SE, Smith EE, et al
    Comparative methods for quantifying plasma biomarkers in Alzheimer's disease: Implications for the next frontier in cerebral amyloid angiopathy diagnostics.
    Alzheimers Dement. 2023 Oct 31. doi: 10.1002/alz.13510.
    >> Share

  232. KELLY L, Brown C, Michalik D, Hawkes CA, et al
    Clearance of interstitial fluid (ISF) and CSF (CLIC) group-part of Vascular Professional Interest Area (PIA), updates in 2022-2023. Cerebrovascular disease and the failure of elimination of Amyloid-beta from the brain and retina with age and Alzheimer
    Alzheimers Dement. 2023 Oct 28. doi: 10.1002/alz.13512.
    >> Share

  233. PANG M, Gabelle A, Saha-Chaudhuri P, Huijbers W, et al
    Precision medicine analysis of heterogeneity in individual-level treatment response to amyloid beta removal in early Alzheimer's disease.
    Alzheimers Dement. 2023 Oct 26. doi: 10.1002/alz.13431.
    >> Share

  234. FERRETTI MT, Ding H, Au R, Liu C, et al
    Maximizing utility of neuropsychological measures in sex-specific predictive models of incident Alzheimer's disease in the Framingham Heart Study.
    Alzheimers Dement. 2023 Oct 26. doi: 10.1002/alz.13500.
    >> Share

  235. GREENFEST-ALLEN E, Valladares O, Kuksa PP, Gangadharan P, et al
    NIAGADS Alzheimer's GenomicsDB: A resource for exploring Alzheimer's disease genetic and genomic knowledge.
    Alzheimers Dement. 2023 Oct 26. doi: 10.1002/alz.13509.
    >> Share

  236. GONZALEZ-ORTIZ F, Karikari TK, Bentivenga GM, Baiardi S, et al
    Levels of plasma brain-derived tau and p-tau181 in Alzheimer's disease and rapidly progressive dementias.
    Alzheimers Dement. 2023 Oct 19. doi: 10.1002/alz.13516.
    >> Share

  237. XU Y, Sun Z, Jonaitis E, Deming Y, et al
    Apolipoprotein E moderates the association between non-APOE polygenic risk score for Alzheimer's disease and aging on preclinical cognitive function.
    Alzheimers Dement. 2023 Oct 19. doi: 10.1002/alz.13515.
    >> Share

  238. BREEN C, Papale LA, Clark LR, Bergmann PE, et al
    Whole genome methylation sequencing in blood identifies extensive differential DNA methylation in late-onset dementia due to Alzheimer's disease.
    Alzheimers Dement. 2023 Oct 19. doi: 10.1002/alz.13514.
    >> Share

  239. GORIJALA P, Aslam MM, Dang LT, Xicota L, et al
    Alzheimer's polygenic risk scores are associated with cognitive phenotypes in Down syndrome.
    Alzheimers Dement. 2023 Oct 19. doi: 10.1002/alz.13506.
    >> Share

  240. WEI YJ, Winterstein AG, Schmidt S, Fillingim RB, et al
    Pain intensity, physical function, and depressive symptoms associated with discontinuing long-term opioid therapy in older adults with Alzheimer's disease and related dementias.
    Alzheimers Dement. 2023 Oct 19. doi: 10.1002/alz.13489.
    >> Share

  241. TOUROUTOGLOU A, Katsumi Y, Brickhouse M, Zaitsev A, et al
    The Sporadic Early-onset Alzheimer's Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early-onset Alzheimer's Disease Study (LEADS) Cohort.
    Alzheimers Dement. 2023 Oct 18. doi: 10.1002/alz.13466.
    >> Share

  242. LANGELLA S, Lopera F, Baena A, Fox-Fuller JT, et al
    Depressive symptoms and hippocampal volume in autosomal dominant Alzheimer's disease.
    Alzheimers Dement. 2023 Oct 14. doi: 10.1002/alz.13501.
    >> Share

  243. SCOYNI F, Giudice L, Vaananen MA, Downes N, et al
    Alzheimer's disease-induced phagocytic microglia express a specific profile of coding and non-coding RNAs.
    Alzheimers Dement. 2023 Oct 12. doi: 10.1002/alz.13502.
    >> Share

  244. LI P, Gao L, Dashti HS, Hu K, et al
    Authors' response to: A Mendelian randomization study of Alzheimer's disease and daytime napping.
    Alzheimers Dement. 2023 Oct 12. doi: 10.1002/alz.13504.
    >> Share

  245. RAN S, Lin X, Liu B
    A Mendelian randomization study of Alzheimer's disease and daytime napping.
    Alzheimers Dement. 2023 Oct 12. doi: 10.1002/alz.13505.
    >> Share

  246. FERRANTE FJ, Migeot J, Birba A, Amoruso L, et al
    Multivariate word properties in fluency tasks reveal markers of Alzheimer's dementia.
    Alzheimers Dement. 2023 Oct 12. doi: 10.1002/alz.13472.
    >> Share

  247. GAIKWAD S, Senapati S, Haque MA, Kayed R, et al
    Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer's disease: Evidence from clinical and preclinical studies.
    Alzheimers Dement. 2023 Oct 9. doi: 10.1002/alz.13490.
    >> Share

  248. WANG J, Sims KD, Ackley SF, Chen R, et al
    Association of cancer history with structural brain aging markers of Alzheimer's disease and related dementias risk.
    Alzheimers Dement. 2023 Oct 9. doi: 10.1002/alz.13497.
    >> Share

  249. NUDELMAN KNH, Jackson T, Rumbaugh M, Eloyan A, et al
    Pathogenic variants in the Longitudinal Early-onset Alzheimer's Disease Study cohort.
    Alzheimers Dement. 2023 Oct 6. doi: 10.1002/alz.13482.
    >> Share


  250. AAIC 2023: Discoveries propel Alzheimer's diagnosis and clinical care.
    Alzheimers Dement. 2023 Oct 3. doi: 10.1002/alz.13487.
    >> Share

  251. BEYDOUN HA, Beydoun MA, Meirelles O, Erickson LD, et al
    Cardiovascular health, infection burden, and incident dementia in the UK Biobank.
    Alzheimers Dement. 2023;19:4475-4487.
    >> Share

  252. GONZALEZ-ORTIZ F, Dias A, Turton M, Magalhaes R, et al
    Preanalytical stability of plasma/serum brain-derived tau.
    Alzheimers Dement. 2023;19:4764-4770.
    >> Share

  253. KWON HS, Kim JY, Koh SH, Choi SH, et al
    Predicting cognitive stage transition using p-tau181, Centiloid, and other measures.
    Alzheimers Dement. 2023;19:4641-4650.
    >> Share

  254. WANG M, Sajobi TT, Hogan DB, Ganesh A, et al
    Expert elicitation of risk factors for progression to dementia in individuals with mild cognitive impairment.
    Alzheimers Dement. 2023;19:4542-4548.
    >> Share

  255. FERREIRA PCL, Therriault J, Tissot C, Ferrari-Souza JP, et al
    Plasma p-tau231 and p-tau217 inform on tau tangles aggregation in cognitively impaired individuals.
    Alzheimers Dement. 2023;19:4463-4474.
    >> Share

  256. LITKOWSKI EM, Logue MW, Zhang R, Charest BR, et al
    Mendelian randomization study of diabetes and dementia in the Million Veteran Program.
    Alzheimers Dement. 2023;19:4367-4376.
    >> Share

  257. SAMUELSSON J, Marseglia A, Lindberg O, Westman E, et al
    Associations between dietary patterns and dementia-related neuroimaging markers.
    Alzheimers Dement. 2023;19:4629-4640.
    >> Share

  258. ADKINS-JACKSON PB, Kraal AZ, Hill-Jarrett TG, George KM, et al
    Riding the merry-go-round of racial disparities in ADRD research.
    Alzheimers Dement. 2023;19:4735-4742.
    >> Share

    September 2023
  259. WALKER JM, Orr ME, Orr TC, Thorn EL, et al
    Spatial proteomics of hippocampal subfield-specific pathology in Alzheimer's disease and primary age-related tauopathy.
    Alzheimers Dement. 2023 Sep 30. doi: 10.1002/alz.13484.
    >> Share

  260. ERASLAN BOZ H, Kocoglu K, Akkoyun M, Tufekci IY, et al
    Visual search in Alzheimer's disease and amnestic mild cognitive impairment: An eye-tracking study.
    Alzheimers Dement. 2023 Sep 29. doi: 10.1002/alz.13478.
    >> Share

  261. ALBALA B, Appelmans E, Burress R, De Santi S, et al
    The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partners Scientific Board (PPSB).
    Alzheimers Dement. 2023 Sep 29. doi: 10.1002/alz.13483.
    >> Share

  262. HEUER SE, Keezer KJ, Hewes AA, Onos KD, et al
    Control of hippocampal synaptic plasticity by microglia-dendrite interactions depends on genetic context in mouse models of Alzheimer's disease.
    Alzheimers Dement. 2023 Sep 27. doi: 10.1002/alz.13440.
    >> Share

  263. WAGEMANN O, Li Y, Hassenstab J, Aschenbrenner AJ, et al
    Investigation of sex differences in mutation carriers of the Dominantly Inherited Alzheimer Network.
    Alzheimers Dement. 2023 Sep 23. doi: 10.1002/alz.13460.
    >> Share

  264. MORRISON C, Dadar M, Collins DL
    Sex differences in risk factors, burden, and outcomes of cerebrovascular disease in Alzheimer's disease populations.
    Alzheimers Dement. 2023 Sep 21. doi: 10.1002/alz.13452.
    >> Share

  265. BONOMI S, Gupta MR, Schindler SE
    Inadequate reimbursement for lumbar puncture is a potential barrier to accessing new Alzheimer's disease treatments.
    Alzheimers Dement. 2023 Sep 18. doi: 10.1002/alz.13473.
    >> Share

  266. VEITCH DP, Weiner MW, Miller M, Aisen PS, et al
    The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022.
    Alzheimers Dement. 2023 Sep 12. doi: 10.1002/alz.13449.
    >> Share

  267. GAUGLER JE, Borson S, Epps F, Shih RA, et al
    The intersection of social determinants of health and family care of people living with Alzheimer's disease and related dementias: A public health opportunity.
    Alzheimers Dement. 2023 Sep 12. doi: 10.1002/alz.13437.
    >> Share

  268. CHEN K, Gupta R, Martin-Avila A, Cui M, et al
    Anesthesia-induced hippocampal-cortical hyperactivity and tau hyperphosphorylation impair remote memory retrieval in Alzheimer's disease.
    Alzheimers Dement. 2023 Sep 11. doi: 10.1002/alz.13464.
    >> Share

  269. BLENNOW K, Galasko D, Perneczky R, Quevenco FC, et al
    The potential clinical value of plasma biomarkers in Alzheimer's disease.
    Alzheimers Dement. 2023 Sep 11. doi: 10.1002/alz.13455.
    >> Share

  270. CHO H, Mundada NS, Apostolova LG, Carrillo MC, et al
    Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS).
    Alzheimers Dement. 2023 Sep 10. doi: 10.1002/alz.13453.
    >> Share

  271. PELKMANS W, Shekari M, Brugulat-Serrat A, Sanchez-Benavides G, et al
    Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer's disease progression.
    Alzheimers Dement. 2023 Sep 10. doi: 10.1002/alz.13450.
    >> Share

  272. ASKEN BM, Wang WE, McFarland K, Arias F, et al
    Plasma Alzheimer's biomarkers and brain amyloid in Hispanic and non-Hispanic older adults.
    Alzheimers Dement. 2023 Sep 6. doi: 10.1002/alz.13456.
    >> Share

  273. TOSUN D, Yardibi O, Benzinger TLS, Kukull WA, et al
    Identifying individuals with non-Alzheimer's disease co-pathologies: A precision medicine approach to clinical trials in sporadic Alzheimer's disease.
    Alzheimers Dement. 2023 Sep 4. doi: 10.1002/alz.13447.
    >> Share

  274. WOOD KA, Han F, Ko YA, Wharton WW, et al
    Is the association between cognitive disease progression and atrial fibrillation modified by sex?
    Alzheimers Dement. 2023;19:4163-4173.
    >> Share

  275. LU J, Liang F, Bai P, Liu C, et al
    Blood tau-PT217 contributes to the anesthesia/surgery-induced delirium-like behavior in aged mice.
    Alzheimers Dement. 2023;19:4110-4126.
    >> Share

  276. WEAVER DF
    Amyloid-beta is a cytokine.
    Alzheimers Dement. 2023;19:4237-4247.
    >> Share

  277. ROBINSON T, Klinger H, Buckley R, Deters KD, et al
    Subjective cognitive decline across ethnoracial groups in the A4 study.
    Alzheimers Dement. 2023;19:4084-4093.
    >> Share

  278. QIANG YX, Deng YT, Zhang YR, Wang HF, et al
    Associations of blood cell indices and anemia with risk of incident dementia: A prospective cohort study of 313,448 participants.
    Alzheimers Dement. 2023;19:3965-3976.
    >> Share

  279. MATTKE S, Batie D, Chodosh J, Felten K, et al
    Expanding the use of brief cognitive assessments to detect suspected early-stage cognitive impairment in primary care.
    Alzheimers Dement. 2023;19:4252-4259.
    >> Share

  280. OH H, White EM, Muench U, Santostefano C, et al
    Advanced practice clinician care and end-of-life outcomes for community- and nursing home-dwelling Medicare beneficiaries with dementia.
    Alzheimers Dement. 2023;19:3946-3964.
    >> Share

  281. BURGDORF JG, Mroz TM, Reckrey JM, Barron Y, et al
    Prevalence and predictors of incident ADRD diagnosis following a Medicare home health episode.
    Alzheimers Dement. 2023;19:3936-3945.
    >> Share

  282. NASSAN M, Daghlas I, Piras IS, Rogalski E, et al
    Evaluating the association between genetically proxied ACE inhibition and dementias.
    Alzheimers Dement. 2023;19:3894-3901.
    >> Share

  283. JUTKOWITZ E, Pizzi LT, Shewmaker P, Alarid-Escudero F, et al
    Cost effectiveness of non-drug interventions that reduce nursing home admissions for people living with dementia.
    Alzheimers Dement. 2023;19:3867-3893.
    >> Share

  284. SINGH NA, Martin PR, Graff-Radford J, Machulda MM, et al
    APOE epsilon4 influences within and between network functional connectivity in posterior cortical atrophy and logopenic progressive aphasia.
    Alzheimers Dement. 2023;19:3858-3866.
    >> Share

  285. COCHRAN JN, Acosta-Uribe J, Esposito BT, Madrigal L, et al
    Genetic associations with age at dementia onset in the PSEN1 E280A Colombian kindred.
    Alzheimers Dement. 2023;19:3835-3847.
    >> Share

  286. BELLAVER B, Puig-Pijoan A, Ferrari-Souza JP, Leffa DT, et al
    Blood-brain barrier integrity impacts the use of plasma amyloid-beta as a proxy of brain amyloid-beta pathology.
    Alzheimers Dement. 2023;19:3815-3825.
    >> Share

  287. BAXTER LC, Limback-Stokin M, Patten KJ, Arreola AC, et al
    Hippocampal connectivity and memory decline in cognitively intact APOE epsilon4 carriers.
    Alzheimers Dement. 2023;19:3806-3814.
    >> Share

    August 2023
  288. WINCHESTER LM, Harshfield EL, Shi L, Badhwar A, et al
    Artificial intelligence for biomarker discovery in Alzheimer's disease and dementia.
    Alzheimers Dement. 2023 Aug 31. doi: 10.1002/alz.13390.
    >> Share

  289. BUSHNELL J, Hammers DB, Aisen P, Dage JL, et al
    Influence of amyloid and diagnostic syndrome on non-traditional memory scores in early-onset Alzheimer's disease.
    Alzheimers Dement. 2023 Aug 31. doi: 10.1002/alz.13434.
    >> Share

  290. HARTLEY SL, Handen B, Tudorascu D, Lee L, et al
    AT(N) biomarker profiles and Alzheimer's disease symptomology in Down syndrome.
    Alzheimers Dement. 2023 Aug 28. doi: 10.1002/alz.13446.
    >> Share

  291. GILLESPIE NA, Elman JA, McKenzie RE, Tu XM, et al
    The heritability of blood-based biomarkers related to risk of Alzheimer's disease in a population-based sample of early old-age men.
    Alzheimers Dement. 2023 Aug 25. doi: 10.1002/alz.13407.
    >> Share

  292. PULVER RL, Kronberg E, Medenblik LM, Kheyfets VO, et al
    Mapping sleep's oscillatory events as a biomarker of Alzheimer's disease.
    Alzheimers Dement. 2023 Aug 23. doi: 10.1002/alz.13420.
    >> Share

  293. ECHEVARRIA-COOPER SL, Ho EH, Gershon RC, Weintraub S, et al
    Evaluation of the NIH Toolbox Odor Identification Test across normal cognition, amnestic mild cognitive impairment, and dementia due to Alzheimer's disease.
    Alzheimers Dement. 2023 Aug 21. doi: 10.1002/alz.13426.
    >> Share

  294. MIRANDA A, Rubovits E, Mudar R, Leung V, et al
    Where are caregivers in the clinical trial? Evaluation of caregiver responsibilities in Alzheimer's disease and related dementias clinical trials.
    Alzheimers Dement. 2023 Aug 18. doi: 10.1002/alz.13418.
    >> Share

  295. TEJEDA M, Farrell J, Zhu C, Wetzler L, et al
    DNA from multiple viral species is associated with Alzheimer's disease risk.
    Alzheimers Dement. 2023 Aug 14. doi: 10.1002/alz.13414.
    >> Share

  296. STRAIN JF, Phuah CL, Adeyemo B, Cheng K, et al
    White matter hyperintensity longitudinal morphometric analysis in association with Alzheimer disease.
    Alzheimers Dement. 2023 Aug 10. doi: 10.1002/alz.13377.
    >> Share

  297. PYUN JM, Park YH, Wang J, Bennett DA, et al
    Transcriptional risk scores in Alzheimer's disease: From pathology to cognition.
    Alzheimers Dement. 2023 Aug 10. doi: 10.1002/alz.13406.
    >> Share

  298. TIAN Q, Bilgel M, Walker KA, Moghekar AR, et al
    Skeletal muscle mitochondrial function predicts cognitive impairment and is associated with biomarkers of Alzheimer's disease and neurodegeneration.
    Alzheimers Dement. 2023 Aug 2. doi: 10.1002/alz.13388.
    >> Share

  299. PILOTTO A, Bongianni M, Tirloni C, Galli A, et al
    CSF alpha-synuclein aggregates by seed amplification and clinical presentation of AD.
    Alzheimers Dement. 2023;19:3754-3759.
    >> Share

  300. KOPEC RE, Chasman DI, Okereke OI, Sesso HD, et al
    Re-remembering the influence of randomized beta-carotene on cognitive decline.
    Alzheimers Dement. 2023;19:3718-3721.
    >> Share

  301. LOIZOS M, Zhu CW, Akrivos J, Sewell M, et al
    Evaluating memory testing to distinguish dementia severity among White, Black, and Spanish-speaking individuals in the Uniform Data Set (UDS).
    Alzheimers Dement. 2023;19:3625-3634.
    >> Share

  302. ESTEPP TG, Charnigo RJ, Abner EL, Jicha GA, et al
    Associations of potential ADRD plasma biomarkers in cognitively normal volunteers.
    Alzheimers Dement. 2023;19:3593-3601.
    >> Share

  303. BABULAL GM, Zhu Y, Trani JF
    Racial and ethnic differences in neuropsychiatric symptoms and progression to incident cognitive impairment among community-dwelling participants.
    Alzheimers Dement. 2023;19:3635-3643.
    >> Share

  304. WOLZAK K, Vermunt L, Campo MD, Jorge-Oliva M, et al
    Protein disulfide isomerases as CSF biomarkers for the neuronal response to tau pathology.
    Alzheimers Dement. 2023;19:3563-3574.
    >> Share

  305. NISENBAUM L, Martone R, Chen T, Rajagovindan R, et al
    CSF biomarker concordance with amyloid PET in Phase 3 studies of aducanumab.
    Alzheimers Dement. 2023;19:3379-3388.
    >> Share

  306. SNYDER A, Grant H, Chou A, Lindbergh CA, et al
    Immune cell counts in cerebrospinal fluid predict cognitive function in aging and neurodegenerative disease.
    Alzheimers Dement. 2023;19:3339-3349.
    >> Share

    July 2023
  307. WANG ZB, Tan L, Gao PY, Ma YH, et al
    Associations of the A/T/N profiles in PET, CSF, and plasma biomarkers with Alzheimer's disease neuropathology at autopsy.
    Alzheimers Dement. 2023 Jul 28. doi: 10.1002/alz.13413.
    >> Share

  308. VAN DER SCHAAR J, Visser LNC, Ket JCF, Groot C, et al
    Impact of sharing Alzheimer's disease biomarkers with individuals without dementia: A systematic review and meta-analysis of empirical data.
    Alzheimers Dement. 2023 Jul 26. doi: 10.1002/alz.13410.
    >> Share

  309. NEMES S, Logan PE, Manchella MK, Mundada NS, et al
    Sex and APOE epsilon4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's disease.
    Alzheimers Dement. 2023 Jul 26. doi: 10.1002/alz.13403.
    >> Share

  310. LIAO Y, Wang Y, Tao QQ, Yang C, et al
    CALHM2 V136G polymorphism reduces astrocytic ATP release and is associated with depressive symptoms and Alzheimer's disease risk.
    Alzheimers Dement. 2023 Jul 26. doi: 10.1002/alz.13366.
    >> Share

  311. BROOKE B, Lidan Z, Scherazad K, Jane AK, et al
    Sex and gender differences in risk scores for dementia and Alzheimer's disease among cisgender, transgender, and non-binary adults.
    Alzheimers Dement. 2023 Jul 26. doi: 10.1002/alz.13317.
    >> Share

  312. DAGE JL, Eloyan A, Thangarajah M, Hammers DB, et al
    Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease Study.
    Alzheimers Dement. 2023 Jul 25. doi: 10.1002/alz.13399.
    >> Share

  313. ELOYAN A, Thangarajah M, An N, Borowski BJ, et al
    White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS).
    Alzheimers Dement. 2023 Jul 25. doi: 10.1002/alz.13402.
    >> Share

  314. SINTINI I, Graff-Radford J, Schwarz CG, Machulda MM, et al
    Longitudinal rates of atrophy and tau accumulation differ between the visual and language variants of atypical Alzheimer's disease.
    Alzheimers Dement. 2023 Jul 23. doi: 10.1002/alz.13396.
    >> Share

  315. YU SP, Jiang M, Berglund K, Wei L, et al
    Strain hypothesis and additional evidence of the GluN3A deficiency-mediated pathogenesis of Alzheimer's disease.
    Alzheimers Dement. 2023 Jul 23. doi: 10.1002/alz.13374.
    >> Share

  316. GOLLAN TH, Garcia DL, Stasenko A, Murillo M, et al
    The MINT Sprint 2.0: A picture naming test for detection of naming impairments in Alzheimer's disease and in preclinical AD.
    Alzheimers Dement. 2023 Jul 19. doi: 10.1002/alz.13381.
    >> Share

  317. DAS S, Li Z, Wachter A, Alla S, et al
    Distinct transcriptomic responses to Abeta plaques, neurofibrillary tangles, and APOE in Alzheimer's disease.
    Alzheimers Dement. 2023 Jul 17. doi: 10.1002/alz.13387.
    >> Share

  318. DHANA K, Beck T, Desai P, Wilson RS, et al
    Prevalence of Alzheimer's disease dementia in the 50 US states and 3142 counties: A population estimate using the 2020 bridged-race postcensal from the National Center for Health Statistics.
    Alzheimers Dement. 2023 Jul 17. doi: 10.1002/alz.13081.
    >> Share

  319. RAHMAN-FILIPIAK A, Bolton C, Grill JD, Rostamzadeh A, et al
    Biomarker disclosure protocols in prodromal Alzheimer's disease clinical trials.
    Alzheimers Dement. 2023 Jul 14. doi: 10.1002/alz.13380.
    >> Share

  320. SLEIMAN PM, Qu HQ, Connolly JJ, Mentch F, et al
    Trans-ethnic genomic informed risk assessment for Alzheimer's disease: An International Hundred K+ Cohorts Consortium study.
    Alzheimers Dement. 2023 Jul 14. doi: 10.1002/alz.13378.
    >> Share

  321. GARNIER-CRUSSARD A, Chetelat G
    White matter hyperintensities in Alzheimer's disease: Beyond (but not instead of) the vascular contribution.
    Alzheimers Dement. 2023 Jul 12. doi: 10.1002/alz.13372.
    >> Share

  322. BRICKMAN AM, Rizvi B
    White matter hyperintensities and Alzheimer's disease: An alternative view of an alternative hypothesis.
    Alzheimers Dement. 2023 Jul 12. doi: 10.1002/alz.13371.
    >> Share

  323. KRISHNAMURTHY S, Rollin FG
    We must be clear that the root cause of racial disparities in Alzheimer's disease is racism.
    Alzheimers Dement. 2023 Jul 12. doi: 10.1002/alz.13389.
    >> Share

  324. VINZE S, Chodosh J, Lee M, Wright J, et al
    The national public health response to Alzheimer's disease and related dementias: Origins, evolution, and recommendations to improve early detection.
    Alzheimers Dement. 2023 Jul 12. doi: 10.1002/alz.13376.
    >> Share

  325. CHOUDHURY P, Zhang N, Adler CH, Chen K, et al
    Longitudinal motor decline in dementia with Lewy bodies, Parkinson disease dementia, and Alzheimer's dementia in a community autopsy cohort.
    Alzheimers Dement. 2023 Jul 8. doi: 10.1002/alz.13357.
    >> Share

  326. BAE J, Logan PE, Acri DJ, Bharthur A, et al
    A simulative deep learning model of SNP interactions on chromosome 19 for predicting Alzheimer's disease risk and rates of disease progression.
    Alzheimers Dement. 2023 Jul 6. doi: 10.1002/alz.13319.
    >> Share

  327. WANG K, Tang W, Hao X, Zhao J, et al
    Ultra-processed food consumption and risk of dementia and Alzheimer's disease: Long-term results from the Framingham Offspring Study.
    Alzheimers Dement. 2023 Jul 3. doi: 10.1002/alz.13351.
    >> Share

  328. DONAGHY PC, Carrarini C, Ferreira D, Habich A, et al
    Research diagnostic criteria for mild cognitive impairment with Lewy bodies: A systematic review and meta-analysis.
    Alzheimers Dement. 2023;19:3186-3202.
    >> Share

  329. WALKER JM, Goette W, Farrell K, Iida MA, et al
    The relationship between hippocampal amyloid beta burden and spatial distribution of neurofibrillary degeneration.
    Alzheimers Dement. 2023;19:3158-3170.
    >> Share

  330. VASILJEVIC E, Koscik RL, Jonaitis E, Betthauser T, et al
    Cognitive trajectories diverge by genetic risk in a preclinical longitudinal cohort.
    Alzheimers Dement. 2023;19:3108-3118.
    >> Share

  331. ORTEGA-CRUZ D, Uceda-Heras A, Iglesias JE, Zea-Sevilla MA, et al
    A novel histological staging of hippocampal sclerosis that is evident in gray matter loss in vivo.
    Alzheimers Dement. 2023;19:3028-3040.
    >> Share

  332. LAUKKA EJ, Ekstrom I, Larsson M, Grande G, et al
    Markers of olfactory dysfunction and progression to dementia: A 12-year population-based study.
    Alzheimers Dement. 2023;19:3019-3027.
    >> Share

  333. PHONGPREECHA T, Cholerton B, Bukhari S, Chang AL, et al
    Prediction of neuropathologic lesions from clinical data.
    Alzheimers Dement. 2023;19:3005-3018.
    >> Share

  334. LEUZY A, Mattsson-Carlgren N, Cullen NC, Stomrud E, et al
    Robustness of CSF Abeta42/40 and Abeta42/P-tau181 measured using fully automated immunoassays to detect AD-related outcomes.
    Alzheimers Dement. 2023;19:2994-3004.
    >> Share

  335. SALVADO G, Larsson V, Cody KA, Cullen NC, et al
    Optimal combinations of CSF biomarkers for predicting cognitive decline and clinical conversion in cognitively unimpaired participants and mild cognitive impairment patients: A multi-cohort study.
    Alzheimers Dement. 2023;19:2943-2955.
    >> Share

  336. PILLAI JA, Bena J, Maly EF, Leverenz JB, et al
    Initial non-amnestic symptoms relate to faster rate of functional and cognitive decline compared to amnestic symptoms in neuropathologically confirmed dementias.
    Alzheimers Dement. 2023;19:2956-2965.
    >> Share

  337. DUBBELMAN MA, Sikkes SAM, Ebenau JL, van Leeuwenstijn MSSA, et al
    Changes in self- and study partner-perceived cognitive functioning in relation to amyloid status and future clinical progression: Findings from the SCIENCe project.
    Alzheimers Dement. 2023;19:2933-2942.
    >> Share

  338. PERNA L, Mons U, Stocker H, Beyer L, et al
    High cholesterol levels change the association of biomarkers of neurodegenerative diseases with dementia risk: Findings from a population-based cohort.
    Alzheimers Dement. 2023;19:2913-2922.
    >> Share

  339. RAJBANSHI B, Guruacharya A, Mandell JW, Bloom GS, et al
    Localization, induction, and cellular effects of tau phosphorylated at threonine 217.
    Alzheimers Dement. 2023;19:2874-2887.
    >> Share

  340. ZHANG M, Ganz AB, Rohde S, Rozemuller AJM, et al
    Resilience and resistance to the accumulation of amyloid plaques and neurofibrillary tangles in centenarians: An age-continuous perspective.
    Alzheimers Dement. 2023;19:2831-2841.
    >> Share

  341. GOMEZ-TORTOSA E, Baradaran-Heravi Y, Dillen L, Choudhury NR, et al
    TRIM25 mutation (p.C168*), coding for an E3 ubiquitin ligase, is a cause of early-onset autosomal dominant dementia with amyloid load and parkinsonism.
    Alzheimers Dement. 2023;19:2805-2815.
    >> Share

  342. WANG S, Wang J, Dove A, Guo J, et al
    Association of impaired kidney function with dementia and brain pathologies: A community-based cohort study.
    Alzheimers Dement. 2023;19:2765-2773.
    >> Share

    June 2023
  343. RAY NR, Ayodele T, Jean-Francois M, Baez P, et al
    The Early-Onset Alzheimer's Disease Whole-Genome Sequencing Project: Study design and methodology.
    Alzheimers Dement. 2023 Jun 30. doi: 10.1002/alz.13370.
    >> Share

  344. GRIFFIN P, Apostolova L, Dickerson BC, Rabinovici G, et al
    Developments in understanding early onset Alzheimer's disease.
    Alzheimers Dement. 2023 Jun 30. doi: 10.1002/alz.13353.
    >> Share

  345. MARQUINE MJ, Parks A, Perales-Puchalt J, Gonzalez DA, et al
    Demographically-adjusted normative data among Latinos for the version 3 of the Alzheimer's Disease Centers' Neuropsychological Test Battery in the Uniform Data Set.
    Alzheimers Dement. 2023 Jun 25. doi: 10.1002/alz.13313.
    >> Share

  346. BOLLACK A, Pemberton HG, Collij LE, Markiewicz P, et al
    Longitudinal amyloid and tau PET imaging in Alzheimer's disease: A systematic review of methodologies and factors affecting quantification.
    Alzheimers Dement. 2023 Jun 12. doi: 10.1002/alz.13158.
    >> Share

  347. YAKOUB Y, Ashton NJ, Strikwerda-Brown C, Montoliu-Gaya L, et al
    Longitudinal blood biomarker trajectories in preclinical Alzheimer's disease.
    Alzheimers Dement. 2023 Jun 9. doi: 10.1002/alz.13318.
    >> Share

  348. POLSINELLI AJ, Wonderlin RJ, Hammers DB, Garcia AP, et al
    Baseline neuropsychiatric symptoms and psychotropic medication use midway through data collection of the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort.
    Alzheimers Dement. 2023 Jun 9. doi: 10.1002/alz.13344.
    >> Share

  349. LATHE R, Schultek NM, Balin BJ, Ehrlich GD, et al
    Establishment of a consensus protocol to explore the brain pathobiome in patients with mild cognitive impairment and Alzheimer's disease: Research outline and call for collaboration: Research outline and call for collaboration.
    Alzheimers Dement. 2023 Jun 7. doi: 10.1002/alz.13076.
    >> Share

  350. VILA-CASTELAR C, Chen Y, Langella S, Lopera F, et al
    Sex differences in blood biomarkers and cognitive performance in individuals with autosomal dominant Alzheimer's disease.
    Alzheimers Dement. 2023 Jun 6. doi: 10.1002/alz.13314.
    >> Share

  351. MATTKE S, Loh WK, Yuen KH, Yoong J, et al
    Preparedness of China's health care system to provide access to a disease-modifying Alzheimer's treatment.
    Alzheimers Dement. 2023 Jun 6. doi: 10.1002/alz.13348.
    >> Share

  352. KNAPSKOG AB, Aksnes M, Edwin TH, Ueland PM, et al
    Higher concentrations of kynurenic acid in CSF are associated with the slower clinical progression of Alzheimer's disease.
    Alzheimers Dement. 2023 Jun 2. doi: 10.1002/alz.13162.
    >> Share

  353. KRONIMUS Y, Albus A, Hasenberg M, Walkenfort B, et al
    Fc N-glycosylation of autoreactive Abeta antibodies as a blood-based biomarker for Alzheimer's disease.
    Alzheimers Dement. 2023 Jun 1. doi: 10.1002/alz.13124.
    >> Share

  354. LI D, Farrell JJ, Mez J, Martin ER, et al
    Novel loci for Alzheimer's disease identified by a genome-wide association study in Ashkenazi Jews.
    Alzheimers Dement. 2023 Jun 1. doi: 10.1002/alz.13117.
    >> Share

  355. COLEMAN ME, Roessler MEH, Peng S, Roth AR, et al
    Social enrichment on the job: Complex work with people improves episodic memory, promotes brain reserve, and reduces the risk of dementia.
    Alzheimers Dement. 2023;19:2655-2665.
    >> Share

  356. KLOSKE CM, Barnum CJ, Batista AF, Bradshaw EM, et al
    APOE and immunity: Research highlights.
    Alzheimers Dement. 2023;19:2677-2696.
    >> Share

  357. THANAPORNSANGSUTH P, Booncharoen K, Luechaipanit W, Supharatpariyakorn T, et al
    Prospective evaluation of plasma phosphorylated tau in a real-life memory clinic in Thailand.
    Alzheimers Dement. 2023;19:2745-2749.
    >> Share

  358. HRAST B, Khachatryan E, Suput D, Van Hulle MM, et al
    Effects of risk factors on longitudinal changes in brain structure and function in the progression of AD.
    Alzheimers Dement. 2023;19:2666-2676.
    >> Share

  359. LEHMANN S, Schraen-Maschke S, Vidal JS, Allinquant B, et al
    Plasma Abeta42/Abeta40 ratio is independent of renal function.
    Alzheimers Dement. 2023;19:2737-2739.
    >> Share

  360. PETERSEN RC, Aisen PS, Andrews JS, Atri A, et al
    Expectations and clinical meaningfulness of randomized controlled trials.
    Alzheimers Dement. 2023;19:2730-2736.
    >> Share

  361. KING D, Holt K, Toombs J, He X, et al
    Synaptic resilience is associated with maintained cognition during ageing.
    Alzheimers Dement. 2023;19:2560-2574.
    >> Share

  362. THORWALD MA, Silva J, Head E, Finch CE, et al
    Amyloid futures in the expanding pathology of brain aging and dementia.
    Alzheimers Dement. 2023;19:2605-2617.
    >> Share

  363. SMITH R, Cullen NC, Pichet Binette A, Leuzy A, et al
    Tau-PET is superior to phospho-tau when predicting cognitive decline in symptomatic AD patients.
    Alzheimers Dement. 2023;19:2497-2507.
    >> Share

  364. NICHOLS E, Brickman AM, Casaletto KB, Dams-O'Connor K, et al
    AD and non-AD mediators of the pathway between the APOE genotype and cognition.
    Alzheimers Dement. 2023;19:2508-2519.
    >> Share

  365. ADHIKARI UK, Khan R, Mikhael M, Balez R, et al
    Therapeutic anti-amyloid beta antibodies cause neuronal disturbances.
    Alzheimers Dement. 2023;19:2479-2496.
    >> Share

  366. LAN G, Li A, Liu Z, Ma S, et al
    Presynaptic membrane protein dysfunction occurs prior to neurodegeneration and predicts faster cognitive decline.
    Alzheimers Dement. 2023;19:2408-2419.
    >> Share

  367. COLLIJ LE, Salvado G, de Wilde A, Altomare D, et al
    Quantification of [(18) F]florbetaben amyloid-PET imaging in a mixed memory clinic population: The ABIDE project.
    Alzheimers Dement. 2023;19:2397-2407.
    >> Share

  368. LUSK JB, Ford C, Clark AG, Greiner MA, et al
    Racial/ethnic disparities in dementia incidence, outcomes, and health-care utilization.
    Alzheimers Dement. 2023;19:2376-2388.
    >> Share

  369. GONCALVES RA, Sudo FK, Lourenco MV, Drummond C, et al
    Cerebrospinal fluid irisin and lipoxin A4 are reduced in elderly Brazilian individuals with depression: Insight into shared mechanisms between depression and dementia.
    Alzheimers Dement. 2023;19:2595-2604.
    >> Share

  370. SADAGHIANI S, Trotman W, Lim SA, Chung E, et al
    Associations of phosphorylated tau pathology with whole-hemisphere ex vivo morphometry in 7 tesla MRI.
    Alzheimers Dement. 2023;19:2355-2364.
    >> Share

  371. LESPINASSE J, Chene G, Mangin JF, Dubois B, et al
    Associations among hypertension, dementia biomarkers, and cognition: The MEMENTO cohort.
    Alzheimers Dement. 2023;19:2332-2342.
    >> Share

  372. SUCHY-DICEY A, Su Y, Buchwald DS, Manson SM, et al
    Volume atrophy in medial temporal cortex and verbal memory scores in American Indians: Data from the Strong Heart Study.
    Alzheimers Dement. 2023;19:2298-2306.
    >> Share

    May 2023
  373. HAMMERS DB, Eloyan A, Taurone A, Thangarajah M, et al
    Profiling baseline performance on the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collection.
    Alzheimers Dement. 2023 May 31. doi: 10.1002/alz.13160.
    >> Share

  374. LUTZ MW, Chiba-Falek O
    Bioinformatics pipeline to guide post-GWAS studies in Alzheimer's: A new catalogue of disease candidate short structural variants.
    Alzheimers Dement. 2023 May 30. doi: 10.1002/alz.13168.
    >> Share

  375. HAMMERS DB, Nemes S, Diedrich T, Eloyan A, et al
    Learning slopes in early-onset Alzheimer's disease.
    Alzheimers Dement. 2023 May 27. doi: 10.1002/alz.13159.
    >> Share

  376. HUBER H, Ashton NJ, Schieren A, Montoliu-Gaya L, et al
    Levels of Alzheimer's disease blood biomarkers are altered after food intake-A pilot intervention study in healthy adults.
    Alzheimers Dement. 2023 May 27. doi: 10.1002/alz.13163.
    >> Share

  377. SAITO Y, Kamagata K, Uchida W, Takabayashi K, et al
    The partial volume effect of choroid plexus in pathogenesis of Alzheimer's disease.
    Alzheimers Dement. 2023 May 26. doi: 10.1002/alz.13123.
    >> Share

  378. STERN AM
    Anti-dementia bias and Medicare regulation of Alzheimer's disease care.
    Alzheimers Dement. 2023 May 24. doi: 10.1002/alz.13166.
    >> Share

  379. WIESE LAK, Gibson A, Guest MA, Nelson AR, et al
    Global rural health disparities in Alzheimer's disease and related dementias: State of the science.
    Alzheimers Dement. 2023 May 23. doi: 10.1002/alz.13104.
    >> Share

  380. WANG J, Chen M, Masters CL, Wang YJ, et al
    Translating blood biomarkers into clinical practice for Alzheimer's disease: Challenges and perspectives.
    Alzheimers Dement. 2023 May 23. doi: 10.1002/alz.13116.
    >> Share

  381. PANYARD DJ, McKetney J, Deming YK, Morrow AR, et al
    Large-scale proteome and metabolome analysis of CSF implicates altered glucose and carbon metabolism and succinylcarnitine in Alzheimer's disease.
    Alzheimers Dement. 2023 May 22. doi: 10.1002/alz.13130.
    >> Share

  382. BILGEL M, An Y, Walker KA, Moghekar AR, et al
    Longitudinal changes in Alzheimer's-related plasma biomarkers and brain amyloid.
    Alzheimers Dement. 2023 May 22. doi: 10.1002/alz.13157.
    >> Share

  383. BYFIELD G, Starks TD, Luther R, Edwards CL, et al
    Leveraging African American family connectors for Alzheimer's disease genomic studies.
    Alzheimers Dement. 2023 May 22. doi: 10.1002/alz.13106.
    >> Share

  384. BODART-SANTOS V, Pinheiro LS, da Silva-Junior AJ, Froza RL, et al
    Alzheimer's disease brain-derived extracellular vesicles reveal altered synapse-related proteome and induce cognitive impairment in mice.
    Alzheimers Dement. 2023 May 19. doi: 10.1002/alz.13134.
    >> Share

  385. PEROVNIK M, Tang CC, Namias M, Eidelberg D, et al
    Longitudinal changes in metabolic network activity in early Alzheimer's disease.
    Alzheimers Dement. 2023 May 19. doi: 10.1002/alz.13137.
    >> Share

  386. LI M, Li Y, Schindler SE, Yen D, et al
    Design and feasibility of an Alzheimer's disease blood test study in a diverse community-based population.
    Alzheimers Dement. 2023 May 19. doi: 10.1002/alz.13125.
    >> Share

  387. KARMARKAR AM, Roy I, Rivera-Hernandez M, Shaibi S, et al
    Examining the role of race and quality of home health agencies in delayed initiation of home health services for individuals with Alzheimer's disease and related dementias (ADRD).
    Alzheimers Dement. 2023 May 19. doi: 10.1002/alz.13139.
    >> Share

  388. EVANS CD, Sparks J, Andersen SW, Brooks DA, et al
    APOE epsilon4's impact on response to amyloid therapies in early symptomatic Alzheimer's disease: Analyses from multiple clinical trials.
    Alzheimers Dement. 2023 May 19. doi: 10.1002/alz.13128.
    >> Share

  389. LANGBAUM JB, Maloney E, Hennessy M, Harkins K, et al
    How intention to join an Alzheimer's participant recruitment registry differs by race, ethnicity, sex, and family history: Results from a national survey of US adults.
    Alzheimers Dement. 2023 May 19. doi: 10.1002/alz.13126.
    >> Share

  390. TUMURBAATAR B, Fracassi A, Scaduto P, Guptarak J, et al
    Preserved autophagy in cognitively intact non-demented individuals with Alzheimer's neuropathology.
    Alzheimers Dement. 2023 May 16. doi: 10.1002/alz.13074.
    >> Share

  391. CHUNG J, Sahelijo N, Maruyama T, Hu J, et al
    Alzheimer's disease heterogeneity explained by polygenic risk scores derived from brain transcriptomic profiles.
    Alzheimers Dement. 2023 May 11. doi: 10.1002/alz.13069.
    >> Share

  392. SHULMAN D, Dubnov S, Zorbaz T, Madrer N, et al
    Sex-specific declines in cholinergic-targeting tRNA fragments in the nucleus accumbens in Alzheimer's disease.
    Alzheimers Dement. 2023 May 9. doi: 10.1002/alz.13095.
    >> Share

  393. D'ALESSANDRO A, Lukens JR, Zimring JC
    The role of PIMT in Alzheimer's disease pathogenesis: A novel hypothesis.
    Alzheimers Dement. 2023 May 8. doi: 10.1002/alz.13115.
    >> Share

  394. QUINNEY SK, Murugesh K, Oblak A, Onos KD, et al
    STOP-AD portal: Selecting the optimal pharmaceutical for preclinical drug testing in Alzheimer's disease.
    Alzheimers Dement. 2023 May 8. doi: 10.1002/alz.13108.
    >> Share

  395. MILLER MR, Lee YF, Kastanenka KV
    Calcium sensor Yellow Cameleon 3.6 as a tool to support the calcium hypothesis of Alzheimer's disease.
    Alzheimers Dement. 2023 May 8. doi: 10.1002/alz.13111.
    >> Share

  396. WEBBER EK, Fivaz M, Stutzmann GE, Griffioen G, et al
    Cytosolic calcium: Judge, jury and executioner of neurodegeneration in Alzheimer's disease and beyond.
    Alzheimers Dement. 2023 May 3. doi: 10.1002/alz.13065.
    >> Share

  397. REAS ET, Shadrin A, Frei O, Motazedi E, et al
    Improved multimodal prediction of progression from MCI to Alzheimer's disease combining genetics with quantitative brain MRI and cognitive measures.
    Alzheimers Dement. 2023 May 2. doi: 10.1002/alz.13112.
    >> Share

  398. VASUNILASHORN SM, Lunardi N, Newman JC, Crosby G, et al
    Preclinical and translational models for delirium: Recommendations for future research from the NIDUS delirium network.
    Alzheimers Dement. 2023;19:2150-2174.
    >> Share

  399. DALY T
    Amyloid PET-assisted diagnosis and improved outcomes: Biomarkering or biomarketing?
    Alzheimers Dement. 2023;19:2211.
    >> Share

  400. POLSINELLI AJ, Lane KA, Manchella MK, Logan PE, et al
    APOE epsilon4 is associated with earlier symptom onset in LOAD but later symptom onset in EOAD.
    Alzheimers Dement. 2023;19:2212-2217.
    >> Share

  401. WOLFF JL, DesRoches CM, Amjad H, Burgdorf JG, et al
    Catalyzing dementia care through the learning health system and consumer health information technology.
    Alzheimers Dement. 2023;19:2197-2207.
    >> Share

  402. JONSDOTTIR MK, Harrison J, Hannesdottir KI
    The ambivalence toward neuropsychology in dementia research, diagnosis, and drug development: Myths and misconceptions.
    Alzheimers Dement. 2023;19:2175-2181.
    >> Share

  403. KISBY GE, Oakes H, Beckett D, Spencer PS, et al
    MGMT, a risk factor for both genetic and environmental forms of dementia.
    Alzheimers Dement. 2023;19:2208-2210.
    >> Share

  404. VAN MAURIK IS, Broulikova HM, Mank A, Bakker ED, et al
    A more precise diagnosis by means of amyloid PET contributes to delayed institutionalization, lower mortality, and reduced care costs in a tertiary memory clinic setting.
    Alzheimers Dement. 2023;19:2006-2013.
    >> Share

  405. POLSTERL S, Wachinger C
    Identification of causal effects of neuroanatomy on cognitive decline requires modeling unobserved confounders.
    Alzheimers Dement. 2023;19:1994-2005.
    >> Share

  406. ASHTON NJ, Puig-Pijoan A, Mila-Aloma M, Fernandez-Lebrero A, et al
    Plasma and CSF biomarkers in a memory clinic: Head-to-head comparison of phosphorylated tau immunoassays.
    Alzheimers Dement. 2023;19:1913-1924.
    >> Share

  407. WORTHA SM, Frenzel S, Bahls M, Habes M, et al
    Association of spermidine plasma levels with brain aging in a population-based study.
    Alzheimers Dement. 2023;19:1832-1840.
    >> Share

  408. SWADDIWUDHIPONG N, Whiteside DJ, Hezemans FH, Street D, et al
    Pre-diagnostic cognitive and functional impairment in multiple sporadic neurodegenerative diseases.
    Alzheimers Dement. 2023;19:1752-1763.
    >> Share

  409. KLEINEIDAM L, Wagner M, Guski J, Wolfsgruber S, et al
    Disentangling the relationship of subjective cognitive decline and depressive symptoms in the development of cognitive decline and dementia.
    Alzheimers Dement. 2023;19:2056-2068.
    >> Share

    April 2023
  410. DINESH D, Shao Q, Palnati M, McDannold S, et al
    The epidemiology of mild cognitive impairment, Alzheimer's disease and related dementia in U.S. veterans.
    Alzheimers Dement. 2023 Apr 28. doi: 10.1002/alz.13071.
    >> Share

  411. MGAIETH F, Baksh RA, Startin CM, Hamburg S, et al
    Exploring semantic verbal fluency patterns and their relationship to age and Alzheimer's disease in adults with Down syndrome.
    Alzheimers Dement. 2023 Apr 28. doi: 10.1002/alz.13097.
    >> Share

  412. XIAO C, Pappas I, Aksman LM, O'Bryant SE, et al
    Comparison of genetic and health risk factors for mild cognitive impairment and Alzheimer's disease between Hispanic and non-Hispanic white participants.
    Alzheimers Dement. 2023 Apr 27. doi: 10.1002/alz.13110.
    >> Share

  413. ADHIKARI S, Qiao Y, Singer M, Sagare A, et al
    Retinotopic degeneration of the retina and optic tracts in autosomal dominant Alzheimer's disease.
    Alzheimers Dement. 2023 Apr 27. doi: 10.1002/alz.13100.
    >> Share

  414. OECKL P, Janelidze S, Halbgebauer S, Stomrud E, et al
    Higher plasma beta-synuclein indicates early synaptic degeneration in Alzheimer's disease.
    Alzheimers Dement. 2023 Apr 27. doi: 10.1002/alz.13103.
    >> Share

  415. XU Y, Aung HL, Bateman RJ, Brooks WS, et al
    Higher systolic blood pressure in early-mid adulthood is associated with poorer cognitive performance in those with a dominantly inherited Alzheimer's disease mutation but not in non-carriers. Results from the DIAN study.
    Alzheimers Dement. 2023 Apr 23. doi: 10.1002/alz.13082.
    >> Share

  416. IMBIMBO BP, Watling M, Imbimbo C, Nistico R, et al
    Plasma ATN(I) classification and precision pharmacology in Alzheimer's disease.
    Alzheimers Dement. 2023 Apr 20. doi: 10.1002/alz.13084.
    >> Share

  417. THERRIAULT J, Servaes S, Tissot C, Rahmouni N, et al
    Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's disease.
    Alzheimers Dement. 2023 Apr 20. doi: 10.1002/alz.13026.
    >> Share

  418. ADKINS-JACKSON PB, George KM, Besser LM, Hyun J, et al
    The structural and social determinants of Alzheimer's disease related dementias.
    Alzheimers Dement. 2023 Apr 19. doi: 10.1002/alz.13027.
    >> Share

  419. KUMAR A, Su Y, Sharma M, Singh S, et al
    MicroRNA expression in extracellular vesicles as a novel blood-based biomarker for Alzheimer's disease.
    Alzheimers Dement. 2023 Apr 18. doi: 10.1002/alz.13055.
    >> Share

  420. SASNER M, Territo PR, Sukoff Rizzo SJ
    Meeting report of the annual workshop on Principles and Techniques for Improving Preclinical to Clinical Translation in Alzheimer's Disease research.
    Alzheimers Dement. 2023 Apr 18. doi: 10.1002/alz.13093.
    >> Share

  421. SAMUELS JD, Moore KA, Ennerfelt HE, Johnson AM, et al
    The Alzheimer's disease risk factor INPP5D restricts neuroprotective microglial responses in amyloid beta-mediated pathology.
    Alzheimers Dement. 2023 Apr 15. doi: 10.1002/alz.13089.
    >> Share

  422. MORENO M, Kline CR, Lanigan K, Kallmyer B, et al
    Personal meaningfulness of potential FDA-approved treatments: Perspectives of individuals living with Alzheimer's disease.
    Alzheimers Dement. 2023 Apr 14. doi: 10.1002/alz.13079.
    >> Share

  423. BAI H, Naj AC, Benchek P, Dumitrescu L, et al
    A haptoglobin (HP) structural variant alters the effect of APOE alleles on Alzheimer's disease.
    Alzheimers Dement. 2023 Apr 12. doi: 10.1002/alz.13050.
    >> Share

  424. ZHOU RZ, Vetrano DL, Grande G, Duell F, et al
    A glycan epitope correlates with tau in serum and predicts progression to Alzheimer's disease in combination with APOE4 allele status.
    Alzheimers Dement. 2023 Apr 12. doi: 10.1002/alz.13024.
    >> Share

  425. VIDELA L, Benejam B, Carmona-Iragui M, Barroeta I, et al
    Cross-sectional versus longitudinal cognitive assessments for the diagnosis of symptomatic Alzheimer's disease in adults with Down syndrome.
    Alzheimers Dement. 2023 Apr 11. doi: 10.1002/alz.13073.
    >> Share

  426. CELIS K, Moreno MDMM, Rajabli F, Whitehead P, et al
    Ancestry-related differences in chromatin accessibility and gene expression of APOE epsilon4 are associated with Alzheimer's disease risk.
    Alzheimers Dement. 2023 Apr 10. doi: 10.1002/alz.13075.
    >> Share

  427. HUANG CW, Rust NC, Wu HF, Yin A, et al
    Low glucose induced Alzheimer's disease-like biochemical changes in human induced pluripotent stem cell-derived neurons is due to dysregulated O-GlcNAcylation.
    Alzheimers Dement. 2023 Apr 10. doi: 10.1002/alz.13058.
    >> Share

  428. GARNIER-CRUSSARD A, Cotton F, Krolak-Salmon P, Chetelat G, et al
    White matter hyperintensities in Alzheimer's disease: Beyond vascular contribution.
    Alzheimers Dement. 2023 Apr 7. doi: 10.1002/alz.13057.
    >> Share

  429. CHATTERJEE M, Ozdemir S, Kunadt M, Koel-Simmelink M, et al
    C1q is increased in cerebrospinal fluid-derived extracellular vesicles in Alzheimer's disease: A multi-cohort proteomics and immuno-assay validation study.
    Alzheimers Dement. 2023 Apr 6. doi: 10.1002/alz.13066.
    >> Share

  430. ROZALEM ARANHA M, Iulita MF, Montal V, Pegueroles J, et al
    Basal forebrain atrophy along the Alzheimer's disease continuum in adults with Down syndrome.
    Alzheimers Dement. 2023 Apr 6. doi: 10.1002/alz.12999.
    >> Share

  431. DILMORE AH, Martino C, Neth BJ, West KA, et al
    Effects of a ketogenic and low-fat diet on the human metabolome, microbiome, and foodome in adults at risk for Alzheimer's disease.
    Alzheimers Dement. 2023 Apr 5. doi: 10.1002/alz.13007.
    >> Share

  432. KUO K, Zhang YR, Chen SD, He XY, et al
    Associations of grip strength, walking pace, and the risk of incident dementia: A prospective cohort study of 340212 participants.
    Alzheimers Dement. 2023;19:1415-1427.
    >> Share

  433. GIBSON LL, Grinberg LT, Ffytche D, Leite REP, et al
    Neuropathological correlates of neuropsychiatric symptoms in dementia.
    Alzheimers Dement. 2023;19:1372-1382.
    >> Share

  434. RABE C, Bittner T, Jethwa A, Suridjan I, et al
    Clinical performance and robustness evaluation of plasma amyloid-beta(42/40) prescreening.
    Alzheimers Dement. 2023;19:1393-1402.
    >> Share

  435. OECKL P, Anderl-Straub S, Danek A, Diehl-Schmid J, et al
    Relationship of serum beta-synuclein with blood biomarkers and brain atrophy.
    Alzheimers Dement. 2023;19:1358-1371.
    >> Share

  436. OTTOY J, Ozzoude M, Zukotynski K, Adamo S, et al
    Vascular burden and cognition: Mediating roles of neurodegeneration and amyloid PET.
    Alzheimers Dement. 2023;19:1503-1517.
    >> Share

  437. PANG M, Zhu L, Gabelle A, Gafson AR, et al
    Effect of reduction in brain amyloid levels on change in cognitive and functional decline in randomized clinical trials: An instrumental variable meta-analysis.
    Alzheimers Dement. 2023;19:1292-1299.
    >> Share

  438. GROTHE MJ, Moscoso A, Silva-Rodriguez J, Lange C, et al
    Differential diagnosis of amnestic dementia patients based on an FDG-PET signature of autopsy-confirmed LATE-NC.
    Alzheimers Dement. 2023;19:1234-1244.
    >> Share

  439. PALMA-GUDIEL H, Yu L, Huo Z, Yang J, et al
    Fine-mapping and replication of EWAS loci harboring putative epigenetic alterations associated with AD neuropathology in a large collection of human brain tissue samples.
    Alzheimers Dement. 2023;19:1216-1226.
    >> Share

  440. PACYNA RR, Han SD, Wroblewski KE, McClintock MK, et al
    Rapid olfactory decline during aging predicts dementia and GMV loss in AD brain regions.
    Alzheimers Dement. 2023;19:1479-1490.
    >> Share

    March 2023
  441. CHEN XL, Fortes JM, Hu YT, van Iersel J, et al
    Sexually dimorphic age-related molecular differences in the entorhinal cortex of cognitively intact elderly: Relation to early Alzheimer's changes.
    Alzheimers Dement. 2023 Mar 24. doi: 10.1002/alz.13037.
    >> Share

  442. WEINER S, Sauer M, Brinkmalm G, Constantinescu J, et al
    SCRN1: A cerebrospinal fluid biomarker correlating with tau in Alzheimer's disease.
    Alzheimers Dement. 2023 Mar 22. doi: 10.1002/alz.13042.
    >> Share

  443. HOLDRIDGE KC, Yaari R, Hoban DB, Andersen S, et al
    Targeting amyloid beta in Alzheimer's disease: Meta-analysis of low-dose solanezumab in Alzheimer's disease with mild dementia studies.
    Alzheimers Dement. 2023 Mar 22. doi: 10.1002/alz.13031.
    >> Share

  444. CHENG Y, Zamrini E, Faselis C, Redd D, et al
    Cardiorespiratory fitness and risk of Alzheimer's disease and related dementias among American veterans.
    Alzheimers Dement. 2023 Mar 22. doi: 10.1002/alz.12998.
    >> Share

  445. CHAPPELLE SD, Gigliotti C, Leger GC, Peavy GM, et al
    Comparison of the telephone-Montreal Cognitive Assessment (T-MoCA) and Telephone Interview for Cognitive Status (TICS) as screening tests for early Alzheimer's disease.
    Alzheimers Dement. 2023 Mar 20. doi: 10.1002/alz.13039.
    >> Share

  446. KUSTERS CDJ, Paul KC, Romero T, Sinsheimer JS, et al
    Among men, androgens are associated with a decrease in Alzheimer's disease risk.
    Alzheimers Dement. 2023 Mar 20. doi: 10.1002/alz.13013.
    >> Share

  447. URAS I, Karayel-Basar M, Sahin B, Baykal AT, et al
    Detection of early proteomic alterations in 5xFAD Alzheimer's disease neonatal mouse model via MALDI-MSI.
    Alzheimers Dement. 2023 Mar 18. doi: 10.1002/alz.13008.
    >> Share

  448. WESTON PSJ, Coath W, Harris MJ, Malone IB, et al
    Cortical tau is associated with microstructural imaging biomarkers of neurite density and dendritic complexity in Alzheimer's disease.
    Alzheimers Dement. 2023 Mar 18. doi: 10.1002/alz.13011.
    >> Share

  449. SCHUMACHER J, Ray NJ, Hamilton CA, Bergamino M, et al
    Free water imaging of the cholinergic system in dementia with Lewy bodies and Alzheimer's disease.
    Alzheimers Dement. 2023 Mar 15. doi: 10.1002/alz.13034.
    >> Share


  450. 2023 Alzheimer's disease facts and figures.
    Alzheimers Dement. 2023 Mar 14. doi: 10.1002/alz.13016.
    >> Share

  451. MOURTZI N, Charisis S, Tsapanou A, Ntanasi E, et al
    Genetic propensity for cerebral amyloidosis and risk of mild cognitive impairment and Alzheimer's disease within a cognitive reserve framework.
    Alzheimers Dement. 2023 Mar 9. doi: 10.1002/alz.12980.
    >> Share

  452. FERREIRA PCL, Zhang Y, Snitz B, Chang CH, et al
    Plasma biomarkers identify older adults at risk of Alzheimer's disease and related dementias in a real-world population-based cohort.
    Alzheimers Dement. 2023 Mar 6. doi: 10.1002/alz.12986.
    >> Share

  453. MEYERS EA, Sexton C, Snyder HM, Carrillo MC, et al
    Impact of Alzheimer's association support and engagement in the AD/ADRD research community through the COVID-19 pandemic and beyond.
    Alzheimers Dement. 2023 Mar 5. doi: 10.1002/alz.13015.
    >> Share

    February 2023
  454. LIN PJ, Levine A, Rucker J, Chambers JD, et al
    Variation in Medicaid and commercial payer coverage of aducanumab for Alzheimer's disease.
    Alzheimers Dement. 2023 Feb 28. doi: 10.1002/alz.12965.
    >> Share

  455. LLIBRE-GUERRA JJ, Heavener A, Brucki SMD, Marante JPD, et al
    A call for clinical trial globalization in Alzheimer's disease and related dementia.
    Alzheimers Dement. 2023 Feb 25. doi: 10.1002/alz.12995.
    >> Share

  456. WANG ZB, Tan L, Wang HF, Chen SD, et al
    Differences between ante mortem Alzheimer's disease biomarkers in predicting neuropathology at autopsy.
    Alzheimers Dement. 2023 Feb 25. doi: 10.1002/alz.12997.
    >> Share

  457. ZHANG W, Wang HF, Kuo K, Wang L, et al
    Contribution of Alzheimer's disease pathology to biological and clinical progression: A longitudinal study across two cohorts.
    Alzheimers Dement. 2023 Feb 25. doi: 10.1002/alz.12992.
    >> Share

  458. YU L, Wang T, Wilson RS, Guo W, et al
    Predicting age at Alzheimer's dementia onset with the cognitive clock.
    Alzheimers Dement. 2023 Feb 24. doi: 10.1002/alz.13004.
    >> Share

  459. CARNA M, Onyango IG, Katina S, Holub D, et al
    Pathogenesis of Alzheimer's disease: Involvement of the choroid plexus.
    Alzheimers Dement. 2023 Feb 24. doi: 10.1002/alz.12970.
    >> Share

  460. LI M, Larsen PA
    Single-cell sequencing of entorhinal cortex reveals widespread disruption of neuropeptide networks in Alzheimer's disease.
    Alzheimers Dement. 2023 Feb 24. doi: 10.1002/alz.12979.
    >> Share

  461. LI Q, Yang X, Xu J, Guo Y, et al
    Early prediction of Alzheimer's disease and related dementias using real-world electronic health records.
    Alzheimers Dement. 2023 Feb 23. doi: 10.1002/alz.12967.
    >> Share

  462. WANG E, Wang M, Guo L, Fullard JF, et al
    Genome-wide methylomic regulation of multiscale gene networks in Alzheimer's disease.
    Alzheimers Dement. 2023 Feb 22. doi: 10.1002/alz.12969.
    >> Share

  463. CHARISIS S, Lin H, Ray R, Joehanes R, et al
    Obesity impacts the expression of Alzheimer's disease-related genes: The Framingham Heart Study.
    Alzheimers Dement. 2023 Feb 22. doi: 10.1002/alz.12954.
    >> Share

  464. SALONER R, Paolillo EW, Wojta KJ, Fonseca C, et al
    Sex-specific effects of SNAP-25 genotype on verbal memory and Alzheimer's disease biomarkers in clinically normal older adults.
    Alzheimers Dement. 2023 Feb 18. doi: 10.1002/alz.12989.
    >> Share

  465. PURI S, Hu J, Sun Z, Lin M, et al
    Identification of circRNAs linked to Alzheimer's disease and related dementias.
    Alzheimers Dement. 2023 Feb 16. doi: 10.1002/alz.12960.
    >> Share

  466. DEMING Y, Vasiljevic E, Morrow A, Miao J, et al
    Neuropathology-based APOE genetic risk score better quantifies Alzheimer's risk.
    Alzheimers Dement. 2023 Feb 16. doi: 10.1002/alz.12990.
    >> Share

  467. ULEMAN JF, Melis RJF, Ntanasi E, Scarmeas N, et al
    Simulating the multicausality of Alzheimer's disease with system dynamics.
    Alzheimers Dement. 2023 Feb 16. doi: 10.1002/alz.12923.
    >> Share

  468. SHI L, Xu J, Green R, Wretlind A, et al
    Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's disease.
    Alzheimers Dement. 2023 Feb 15. doi: 10.1002/alz.12961.
    >> Share

  469. ZOU X, Liao Y, Jiang C, Yuan Y, et al
    Brain perfusion, cognition, and plasma Alzheimer's biomarkers in moyamoya disease.
    Alzheimers Dement. 2023 Feb 10. doi: 10.1002/alz.12958.
    >> Share

  470. SOLFRIZZI V, Scafato E, Custodero C, Piazzolla G, et al
    Biopsychosocial frailty and mild cognitive impairment subtypes: Findings from the Italian project on the epidemiology of Alzheimer's disease (IPREA).
    Alzheimers Dement. 2023 Feb 9. doi: 10.1002/alz.12944.
    >> Share

  471. FALGAS N, Walsh CM, Yack L, Simon AJ, et al
    Alzheimer's disease phenotypes show different sleep architecture.
    Alzheimers Dement. 2023 Feb 7. doi: 10.1002/alz.12963.
    >> Share

  472. PLANCHE V, Mansencal B, Manjon JV, Tourdias T, et al
    Anatomical MRI staging of frontotemporal dementia variants: For the Frontotemporal Lobar Degeneration Neuroimaging Initiative and the National Alzheimer's Coordinating Center cohort: For the Frontotemporal Lobar Degeneration Neuroimaging Initiative an
    Alzheimers Dement. 2023 Feb 7. doi: 10.1002/alz.12975.
    >> Share

  473. ELLISON TS, Cappa SF, Garrett D, Georges J, et al
    Outcome measures for Alzheimer's disease: A global inter-societal Delphi consensus.
    Alzheimers Dement. 2023 Feb 7. doi: 10.1002/alz.12945.
    >> Share

  474. LI YJ, Nuytemans K, La JO, Jiang R, et al
    Identification of novel genes for age-at-onset of Alzheimer's disease by combining quantitative and survival trait analyses.
    Alzheimers Dement. 2023 Feb 4. doi: 10.1002/alz.12927.
    >> Share


  475. Apply now to the Alzheimer's Association Interdisciplinary Summer Research Institute.
    Alzheimers Dement. 2023 Feb 1. doi: 10.1002/alz.12973.
    >> Share

  476. DEVANAND DP, Masurkar AV, Wisniewski T
    Vigorous, regular physical exercise may slow disease progression in Alzheimer's disease.
    Alzheimers Dement. 2023 Feb 1. doi: 10.1002/alz.12946.
    >> Share

  477. DONG Y, Li Y, Liu K, Han X, et al
    Anosmia, mild cognitive impairment, and biomarkers of brain aging in older adults.
    Alzheimers Dement. 2023;19:589-601.
    >> Share

  478. LLIBRE-GUERRA JJ, Li J, Qian Y, Llibre-Rodriguez JJ, et al
    Apolipoprotein E (APOE) genotype, dementia, and memory performance among Caribbean Hispanic versus US populations.
    Alzheimers Dement. 2023;19:602-610.
    >> Share

  479. RAMOS J, Caywood LJ, Prough MB, Clouse JE, et al
    Genetic variants in the SHISA6 gene are associated with delayed cognitive impairment in two family datasets.
    Alzheimers Dement. 2023;19:611-620.
    >> Share

  480. WEIJS RWJ, Shkredova DA, Brekelmans ACM, Thijssen DHJ, et al
    Longitudinal changes in cerebral blood flow and their relation with cognitive decline in patients with dementia: Current knowledge and future directions.
    Alzheimers Dement. 2023;19:532-548.
    >> Share

  481. SEMMENS EO, Leary CS, Fitzpatrick AL, Ilango SD, et al
    Air pollution and dementia in older adults in the Ginkgo Evaluation of Memory Study.
    Alzheimers Dement. 2023;19:549-559.
    >> Share

  482. LANDAU SM, Ward TJ, Murphy A, Iaccarino L, et al
    Quantification of amyloid beta and tau PET without a structural MRI.
    Alzheimers Dement. 2023;19:444-455.
    >> Share

  483. WANG L, Davis PB, Kaelber DC, Xu R, et al
    COVID-19 breakthrough infections and hospitalizations among vaccinated patients with dementia in the United States between December 2020 and August 2021.
    Alzheimers Dement. 2023;19:421-432.
    >> Share

    January 2023
  484. WANG X, Broce I, Qiu Y, Deters KD, et al
    A simple genetic stratification method for lower cost, more expedient clinical trials in early Alzheimer's disease: A preliminary study of tau PET and cognitive outcomes.
    Alzheimers Dement. 2023 Jan 26. doi: 10.1002/alz.12952.
    >> Share

  485. GRAHAM NSN, Cole JH, Bourke NJ, Schott JM, et al
    Distinct patterns of neurodegeneration after TBI and in Alzheimer's disease.
    Alzheimers Dement. 2023 Jan 25. doi: 10.1002/alz.12934.
    >> Share

  486. LIU H, Barthelemy NR, Ovod V, Bollinger JG, et al
    Acute sleep loss decreases CSF-to-blood clearance of Alzheimer's disease biomarkers.
    Alzheimers Dement. 2023 Jan 25. doi: 10.1002/alz.12930.
    >> Share

  487. ZAWAR I, Kapur J
    Does Alzheimer's disease with mesial temporal lobe epilepsy represent a distinct disease subtype?
    Alzheimers Dement. 2023 Jan 17. doi: 10.1002/alz.12943.
    >> Share

  488. EHRENBERG AJ, Kelberman MA, Liu KY, Dahl MJ, et al
    Priorities for research on neuromodulatory subcortical systems in Alzheimer's disease: Position paper from the NSS PIA of ISTAART.
    Alzheimers Dement. 2023 Jan 15. doi: 10.1002/alz.12937.
    >> Share

  489. XIONG C, McCue LM, Buckles V, Grant E, et al
    Cross-sectional and longitudinal comparisons of biomarkers and cognition among asymptomatic middle-aged individuals with a parental history of either autosomal dominant or late-onset Alzheimer's disease.
    Alzheimers Dement. 2023 Jan 14. doi: 10.1002/alz.12912.
    >> Share

  490. KRUSE C, Maier F, Spottke A, Bach JP, et al
    Apathy in patients with Alzheimer's disease is a cost-driving factor.
    Alzheimers Dement. 2023 Jan 2. doi: 10.1002/alz.12915.
    >> Share

  491. TOLEDO JB, Abdelnour C, Weil RS, Ferreira D, et al
    Dementia with Lewy bodies: Impact of co-pathologies and implications for clinical trial design.
    Alzheimers Dement. 2023;19:318-332.
    >> Share

  492. ROSEBOROUGH AD, Saad L, Goodman M, Cipriano LE, et al
    White matter hyperintensities and longitudinal cognitive decline in cognitively normal populations and across diagnostic categories: A meta-analysis, systematic review, and recommendations for future study harmonization.
    Alzheimers Dement. 2023;19:194-207.
    >> Share

    December 2022
  493. DAUAR MT, Labonte A, Picard C, Miron J, et al
    Characterization of the contactin 5 protein and its risk-associated polymorphic variant throughout the Alzheimer's disease spectrum.
    Alzheimers Dement. 2022 Dec 30. doi: 10.1002/alz.12868.
    >> Share

  494. VELIOGLU HA, Ayyildiz B, Ayyildiz S, Sutcubasi B, et al
    A structural and resting-state functional connectivity investigation of the pulvinar in elderly individuals and Alzheimer's disease patients.
    Alzheimers Dement. 2022 Dec 28. doi: 10.1002/alz.12850.
    >> Share

  495. CHATTERJEE P, Vermunt L, Gordon BA, Pedrini S, et al
    Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Abeta-PET, neurodegeneration, and cognition.
    Alzheimers Dement. 2022 Dec 28. doi: 10.1002/alz.12879.
    >> Share

  496. AGUILLON D, Langella S, Chen Y, Sanchez JS, et al
    Plasma p-tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's disease.
    Alzheimers Dement. 2022 Dec 26. doi: 10.1002/alz.12906.
    >> Share

  497. STRICKER NH, Twohy EL, Albertson SM, Karstens AJ, et al
    Mayo-PACC: A parsimonious preclinical Alzheimer's disease cognitive composite comprised of public-domain measures to facilitate clinical translation.
    Alzheimers Dement. 2022 Dec 24. doi: 10.1002/alz.12895.
    >> Share

  498. LOGUE MW, Miller MW, Sherva R, Zhang R, et al
    Alzheimer's disease and related dementias among aging veterans: Examining gene-by-environment interactions with post-traumatic stress disorder and traumatic brain injury.
    Alzheimers Dement. 2022 Dec 22. doi: 10.1002/alz.12870.
    >> Share

  499. HUSEBY CJ, Delvaux E, Brokaw DL, Coleman PD, et al
    Blood RNA transcripts reveal similar and differential alterations in fundamental cellular processes in Alzheimer's disease and other neurodegenerative diseases.
    Alzheimers Dement. 2022 Dec 21. doi: 10.1002/alz.12880.
    >> Share

  500. RAJABLI F, Tosto G, Hamilton-Nelson KL, Kunkle BW, et al
    Admixture mapping identifies novel Alzheimer's disease risk regions in African Americans.
    Alzheimers Dement. 2022 Dec 20. doi: 10.1002/alz.12865.
    >> Share

  501. LIN PB, Tsai AP, Soni D, Lee-Gosselin A, et al
    INPP5D deficiency attenuates amyloid pathology in a mouse model of Alzheimer's disease.
    Alzheimers Dement. 2022 Dec 16. doi: 10.1002/alz.12849.
    >> Share


  502. Alzheimer's Association names Dr. Joanne Pike its next chief executive officer.
    Alzheimers Dement. 2022 Dec 9. doi: 10.1002/alz.12911.
    >> Share

  503. YASSINE HN, Self W, Kerman BE, Santoni G, et al
    Nutritional metabolism and cerebral bioenergetics in Alzheimer's disease and related dementias.
    Alzheimers Dement. 2022 Dec 8. doi: 10.1002/alz.12845.
    >> Share

  504. BALL DE, Mattke S, Frank L, Murray JF, et al
    A framework for addressing Alzheimer's disease: Without a frame, the work has no aim.
    Alzheimers Dement. 2022 Dec 8. doi: 10.1002/alz.12869.
    >> Share

  505. YU H, Wang M, Yang Q, Xu X, et al
    The electrophysiological and neuropathological profiles of cerebellum in APP(swe) /PS1(DeltaE9) mice: A hypothesis on the role of cerebellum in Alzheimer's disease.
    Alzheimers Dement. 2022 Dec 5. doi: 10.1002/alz.12853.
    >> Share

  506. KUCUKALI F, Neumann A, Van Dongen J, De Pooter T, et al
    Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits.
    Alzheimers Dement. 2022 Dec 4. doi: 10.1002/alz.12842.
    >> Share

  507. CARLOS AF, Tosakulwong N, Weigand SD, Senjem ML, et al
    TDP-43 pathology effect on volume and flortaucipir uptake in Alzheimer's disease.
    Alzheimers Dement. 2022 Dec 4. doi: 10.1002/alz.12878.
    >> Share

  508. MAZER NA, Hofmann C, Lott D, Gieschke R, et al
    Development of a quantitative semi-mechanistic model of Alzheimer's disease based on the amyloid/tau/neurodegeneration framework (the Q-ATN model).
    Alzheimers Dement. 2022 Dec 1. doi: 10.1002/alz.12877.
    >> Share

  509. SUSHKO VV, Sushko VV
    Use Acetazolamide in the Complex Therapy of Alzheimer's Disease.
    Alzheimers Dement. 2022;18 Suppl 9:e059982.
    >> Share

  510. HENDRIX SB, Nicodemus-Johnson J, Hogan NJ, Knowlton N, et al
    Not sexy enough: the uphill battle faced by non-traditional treatments in the U.S. despite having the most compelling AD results to date.
    Alzheimers Dement. 2022;18 Suppl 9:e068373.
    >> Share

  511. COSE DS
    An Innovative Approach to Empowering Care Partners Living with A Loved One Diagnosed with Younger-Onset Alzheimer's.
    Alzheimers Dement. 2022;18 Suppl 9:e061257.
    >> Share

  512. FIELDS BE, Boutilier JJ, Jolliff A, Elliott C, et al
    Does Caregiver Education Level Influence Confidence in Care Budgeting and Planning for Persons Living with Alzheimer's Disease or Related Dementias?
    Alzheimers Dement. 2022;18 Suppl 9:e068923.
    >> Share

  513. MACKOWICZ M, Yee J, Clark LR, Wanninger E, et al
    Dysphagia Evaluation in a Multidisciplinary VA Cognitive Care Clinic.
    Alzheimers Dement. 2022;18 Suppl 9:e063955.
    >> Share

  514. DIAZ-SANTOS M, Yanez JJ, Suarez PA
    Alzheimer's Disease in Bilingual Latinos: Clinical Decisions for Diagnosis and Treatment Planning.
    Alzheimers Dement. 2022;18 Suppl 9:e064253.
    >> Share

  515. BLEKOU P, Sakka P, Leonti AA, Megagianni S, et al
    The Greek Dementia Helpline: experience and impact.
    Alzheimers Dement. 2022;18 Suppl 9:e061186.
    >> Share

  516. VAN PHAN T, Praet J, Guarnieri R, Lowenthal E, et al
    An Educational Platform about Current and Future Paradigms of Neuroimaging in the Management of Alzheimer's Disease.
    Alzheimers Dement. 2022;18 Suppl 9:e065989.
    >> Share

  517. MCGURIN NE, McCarthy L, Arsenault L, Showalter E, et al
    Dementia Care Coordination: Evaluating a Program to Support Caregivers through Collaboration with the Alzheimer's Association and Health Care Partners.
    Alzheimers Dement. 2022;18 Suppl 9:e059900.
    >> Share

  518. REUBEN D, Panlilio M
    Effects of an Alzheimer's and Dementia Care Co-management Program on Quality, Clinical Outcomes, and Utilization.
    Alzheimers Dement. 2022;18 Suppl 9:e063939.
    >> Share

  519. JOYCE JL, Caes D, Chapman S, Gottesman RT, et al
    Screening for Memory Concerns at the Well-Woman Visit.
    Alzheimers Dement. 2022;18 Suppl 9:e067894.
    >> Share

  520. COSE DS
    Supporting Youth With A Parent Who Is Living Younger-Onset Alzheimer's: A Crucial Component In Integrated Care.
    Alzheimers Dement. 2022;18 Suppl 9:e062968.
    >> Share

  521. BLEKOU P, Sakka P, Zoi P, Kalligeros N, et al
    Tablet training at home for people with dementia and their caregivers during pandemic.
    Alzheimers Dement. 2022;18 Suppl 9:e065713.
    >> Share

  522. BORMANS K, Zwakhalen S
    Using children's drawings as implicit measurements in future Alzheimer's research for the detection and alteration of negative stereotyping.
    Alzheimers Dement. 2022;18 Suppl 9:e067593.
    >> Share

  523. SPENSLEY SB
    Identifying priorities and supporting ADRD researchers through Alzheimer's Disease Research Center Research Education Components.
    Alzheimers Dement. 2022;18 Suppl 9:e062410.
    >> Share

  524. SUPER N
    Scaling Comprehensive Dementia Care.
    Alzheimers Dement. 2022;18 Suppl 9:e063942.
    >> Share

  525. MIRABNAHRAZAM G, Ma D, Beaulac C, Lee S, et al
    Predicting Alzheimer's disease progression in healthy and MCI subjects using multi-modal deep learning approach.
    Alzheimers Dement. 2022;18 Suppl 2:e060949.
    >> Share

  526. HILSABECK RC, Keller JN, Henry ML, Toprac P, et al
    Multidisciplinary collaboration to develop a digital health solution for early detection of cognitive decline in primary care.
    Alzheimers Dement. 2022;18 Suppl 2:e067832.
    >> Share

  527. KOLANKO MA, Soreq E, Lai H, Barnaghi P, et al
    Clinically relevant monitoring of long-term night-time behaviour and physiology from the homes of people living with dementia.
    Alzheimers Dement. 2022;18 Suppl 2:e068241.
    >> Share

  528. WATERMEYER TJ, Butler J, Matterson E, Harper EG, et al
    A digital biomarker for remote self-assessment of Alzheimer's Diseases: development and validation.
    Alzheimers Dement. 2022;18 Suppl 2:e066066.
    >> Share

  529. BEATTIE ZT, Gothard S, Barnes LL, Calloway S, et al
    The Collaboration and Harmonization of Digital Biomarkers for Alzheimer's Research.
    Alzheimers Dement. 2022;18 Suppl 2:e067984.
    >> Share

  530. OHMAN F, Berron D, Skoog J, Bodin TH, et al
    Smartphone-based long-term delayed memory performance is associated with the Preclinical Alzheimer's Cognitive Composite and CSF levels of beta-amyloid.
    Alzheimers Dement. 2022;18 Suppl 2:e068015.
    >> Share

  531. SCHUSSLER S, Zuschnegg J, Paletta L, Russegger S, et al
    Experiences of people with Alzheimer's disease, relatives, and dementia trainers on the usability of a tablet-based dementia training.
    Alzheimers Dement. 2022;18 Suppl 2:e062097.
    >> Share

  532. MEYER T, Moro-Velazquez L, Motley S, Butala A, et al
    Automatic Extraction of Oculographic Signals as Digital Biomarkers for Alzheimer's Disease.
    Alzheimers Dement. 2022;18 Suppl 2:e066018.
    >> Share

  533. BABATOPE EY, Rodriguez ML, Garcia-Vazquez MS, Alvaro Ramirez-Acosta A, et al
    Recognizing human functional patterns in IADLs through hand detection and artificial intelligence.
    Alzheimers Dement. 2022;18 Suppl 2:e064212.
    >> Share

  534. FAVARO A, Motley S, Samus QM, Butala A, et al
    Artificial Intelligence Tools to Evaluate Language and Speech Patterns in Alzheimer's Disease.
    Alzheimers Dement. 2022;18 Suppl 2:e064913.
    >> Share

  535. RANSON JM, Khleifat AA, Lyall DM, Newby D, et al
    The Deep Dementia Phenotyping (DEMON) Network: A global platform for innovation using data science and artificial intelligence.
    Alzheimers Dement. 2022;18 Suppl 2:e067308.
    >> Share

  536. PARSAPOOR M
    Towards Fair ML-based Language Assessment Methods for Detecting Alzheimer's Disease.
    Alzheimers Dement. 2022;18 Suppl 2:e063426.
    >> Share

  537. ROSSINI PM, Miraglia F, Vecchio F
    Early dementia diagnosis, MCI-to-dementia risk prediction, and the role of machine learning methods for feature extraction from integrated biomarkers, in particular for EEG signal analysis.
    Alzheimers Dement. 2022;18:2699-2706.
    >> Share

  538. FOCKLER J, Ashford MT, Eichenbaum J, Howell T, et al
    Remote blood collection from older adults in the Brain Health Registry for plasma biomarker and genetic analysis.
    Alzheimers Dement. 2022;18:2627-2636.
    >> Share

  539. MOSCOSO A, Karikari TK, Grothe MJ, Ashton NJ, et al
    CSF biomarkers and plasma p-tau181 as predictors of longitudinal tau accumulation: Implications for clinical trial design.
    Alzheimers Dement. 2022;18:2614-2626.
    >> Share

  540. ZHU CW, Neugroschl J, Barnes LL, Sano M, et al
    Racial/ethnic disparities in initiation and persistent use of anti-dementia medications.
    Alzheimers Dement. 2022;18:2582-2592.
    >> Share

  541. HANON O, Vidal JS, Lehmann S, Bombois S, et al
    Plasma amyloid beta predicts conversion to dementia in subjects with mild cognitive impairment: The BALTAZAR study.
    Alzheimers Dement. 2022;18:2537-2550.
    >> Share

  542. WANG J, Dove A, Song R, Qi X, et al
    Poor pulmonary function is associated with mild cognitive impairment, its progression to dementia, and brain pathologies: A community-based cohort study.
    Alzheimers Dement. 2022;18:2551-2559.
    >> Share

  543. GODRICH D, Martin ER, Schellenberg G, Pericak-Vance MA, et al
    Neuropathological lesions and their contribution to dementia and cognitive impairment in a heterogeneous clinical population.
    Alzheimers Dement. 2022;18:2403-2412.
    >> Share

  544. SHAH J, Gao F, Li B, Ghisays V, et al
    Deep residual inception encoder-decoder network for amyloid PET harmonization.
    Alzheimers Dement. 2022;18:2448-2457.
    >> Share

  545. BHARTHUR SANJAY A, Patania A, Yan X, Svaldi D, et al
    Characterization of gene expression patterns in mild cognitive impairment using a transcriptomics approach and neuroimaging endophenotypes.
    Alzheimers Dement. 2022;18:2493-2508.
    >> Share

    November 2022
  546. GUEORGUIEVA I, Chua L, Willis BA, Sims JR, et al
    Disease progression model using the integrated Alzheimer's Disease Rating Scale.
    Alzheimers Dement. 2022 Nov 30. doi: 10.1002/alz.12876.
    >> Share

  547. CASTRANIO EL, Hasel P, Haure-Mirande JV, Ramirez Jimenez AV, et al
    Microglial INPP5D limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer's disease.
    Alzheimers Dement. 2022 Nov 30. doi: 10.1002/alz.12821.
    >> Share

  548. FERRELL PB, Fillit H, Neumann PJ, Wall JK, et al
    Toward comprehensive value assessment for Alzheimer's disease innovations.
    Alzheimers Dement. 2022 Nov 25. doi: 10.1002/alz.12874.
    >> Share

  549. STEWARD A, Biel D, Brendel M, Dewenter A, et al
    Functional network segregation is associated with attenuated tau spreading in Alzheimer's disease.
    Alzheimers Dement. 2022 Nov 25. doi: 10.1002/alz.12867.
    >> Share

  550. DOHERTY JM, Murphy SA, Bayat S, Wisch JK, et al
    Adverse driving behaviors increase over time as a function of preclinical Alzheimer's disease biomarkers.
    Alzheimers Dement. 2022 Nov 23. doi: 10.1002/alz.12852.
    >> Share

  551. CAREY A, Fossati S
    Hypertension and hyperhomocysteinemia as modifiable risk factors for Alzheimer's disease and dementia: New evidence, potential therapeutic strategies, and biomarkers.
    Alzheimers Dement. 2022 Nov 19. doi: 10.1002/alz.12871.
    >> Share

  552. KARPOUZIAN-ROGERS T, Ho E, Novack M, Chinkers M, et al
    Baseline characterization of the ARMADA (Assessing Reliable Measurement in Alzheimer's Disease) study cohorts.
    Alzheimers Dement. 2022 Nov 17. doi: 10.1002/alz.12816.
    >> Share

  553. GOLDHARDT O, Freiberger R, Dreyer T, Wilner L, et al
    Herpes simplex virus alters Alzheimer's disease biomarkers - A hypothesis paper.
    Alzheimers Dement. 2022 Nov 17. doi: 10.1002/alz.12834.
    >> Share

  554. HUANG J, Stein TD, Wang Y, Ang TFA, et al
    Blood levels of MCP-1 modulate the genetic risks of Alzheimer's disease mediated by HLA-DRB1 and APOE for Alzheimer's disease.
    Alzheimers Dement. 2022 Nov 17. doi: 10.1002/alz.12851.
    >> Share

  555. POLSINELLI AJ, Logan PE, Lane KA, Manchella MK, et al
    APOE epsilon4 carrier status and sex differentiate rates of cognitive decline in early- and late-onset Alzheimer's disease.
    Alzheimers Dement. 2022 Nov 17. doi: 10.1002/alz.12831.
    >> Share

  556. PANG M, Zhu L, Gabelle A, Gafson AR, et al
    Toward the end of a controversy on the effect of reduction in brain amyloid levels on change in cognitive and functional decline in Alzheimer's disease-Reply to a letter.
    Alzheimers Dement. 2022 Nov 16. doi: 10.1002/alz.12864.
    >> Share

  557. REIMAN EM, Pruzin JJ, Rios-Romenets S, Brown C, et al
    A public resource of baseline data from the Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial.
    Alzheimers Dement. 2022 Nov 14. doi: 10.1002/alz.12843.
    >> Share

  558. MINDT MR, Okonkwo O, Weiner MW, Veitch DP, et al
    Improving generalizability and study design of Alzheimer's disease cohort studies in the United States by including under-represented populations.
    Alzheimers Dement. 2022 Nov 13. doi: 10.1002/alz.12823.
    >> Share

  559. CHEN XQ, Zuo X, Becker A, Head E, et al
    Reduced synaptic proteins and SNARE complexes in Down syndrome with Alzheimer's disease and the Dp16 mouse Down syndrome model: Impact of APP gene dose.
    Alzheimers Dement. 2022 Nov 12. doi: 10.1002/alz.12835.
    >> Share

  560. HSHIEH TT, Gou RY, Jones RN, Leslie DL, et al
    One-year Medicare costs associated with delirium in older hospitalized patients with and without Alzheimer's disease dementia and related disorders.
    Alzheimers Dement. 2022 Nov 10. doi: 10.1002/alz.12826.
    >> Share

  561. HUANG X, Li Y, Fowler C, Doecke JD, et al
    Leukocyte surface biomarkers implicate deficits of innate immunity in sporadic Alzheimer's disease.
    Alzheimers Dement. 2022 Nov 9. doi: 10.1002/alz.12813.
    >> Share

  562. WU R, Tripathy S, Menon V, Yu L, et al
    Fragmentation of rest periods, astrocyte activation, and cognitive decline in older adults with and without Alzheimer's disease.
    Alzheimers Dement. 2022 Nov 6. doi: 10.1002/alz.12817.
    >> Share

  563. ZHANG P, Hou Y, Tu W, Campbell N, et al
    Population-based discovery and Mendelian randomization analysis identify telmisartan as a candidate medicine for Alzheimer's disease in African Americans.
    Alzheimers Dement. 2022 Nov 4. doi: 10.1002/alz.12819.
    >> Share


  564. Alzheimer's Association takes on leadership role in landmark Alzheimer's biomarker study.
    Alzheimers Dement. 2022 Nov 4. doi: 10.1002/alz.12873.
    >> Share

  565. KYLE S, Youran T, Thomas W, Liuhua S, et al
    The effect of race and co-morbidities on Alzheimer's disease based on Medicare data.
    Alzheimers Dement. 2022 Nov 3. doi: 10.1002/alz.12838.
    >> Share

  566. GILLIS C, Montenigro P, Nejati M, Maserejian N, et al
    Estimating prevalence of early Alzheimer's disease in the United States, accounting for racial and ethnic diversity.
    Alzheimers Dement. 2022 Nov 2. doi: 10.1002/alz.12822.
    >> Share


  567. Improving community health-care systems' early detection of cognitive decline and dementia.
    Alzheimers Dement. 2022;18:2375-2381.
    >> Share

  568. TEMP AGM, Ly A, van Doorn J, Wagenmakers EJ, et al
    A Bayesian perspective on Biogen's aducanumab trial.
    Alzheimers Dement. 2022;18:2341-2351.
    >> Share

  569. LECCA D, Jung YJ, Scerba MT, Hwang I, et al
    Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis.
    Alzheimers Dement. 2022;18:2327-2340.
    >> Share

  570. HEGAZY SH, Thomassen JQ, Rasmussen IJ, Nordestgaard BG, et al
    C-reactive protein levels and risk of dementia-Observational and genetic studies of 111,242 individuals from the general population.
    Alzheimers Dement. 2022;18:2262-2271.
    >> Share

  571. BHASIN H, Agrawal RK
    Triploid genetic algorithm for convolutional neural network-based diagnosis of mild cognitive impairment.
    Alzheimers Dement. 2022;18:2283-2291.
    >> Share

  572. KULLER LH, Snitz BE, Hughes TM, Chang Y, et al
    Low untreated systolic blood pressure over 18 years is associated with survival free of dementia age 90.
    Alzheimers Dement. 2022;18:2176-2187.
    >> Share

  573. PADOVANI A, Canale A, Schiavon L, Masciocchi S, et al
    Is amyloid involved in acute neuroinflammation? A CSF analysis in encephalitis.
    Alzheimers Dement. 2022;18:2167-2175.
    >> Share

  574. BELLEVILLE S, Cloutier S, Mellah S, Willis S, et al
    Is more always better? Dose effect in a multidomain intervention in older adults at risk of dementia.
    Alzheimers Dement. 2022;18:2140-2150.
    >> Share

    October 2022
  575. HANDELS RLH, Green C, Gustavsson A, Herring WL, et al
    Cost-effectiveness models for Alzheimer's disease and related dementias: IPECAD modeling workshop cross-comparison challenge.
    Alzheimers Dement. 2022 Oct 25. doi: 10.1002/alz.12811.
    >> Share

  576. NOVOTNY BC, Fernandez MV, Wang C, Budde JP, et al
    Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer's disease brains.
    Alzheimers Dement. 2022 Oct 17. doi: 10.1002/alz.12800.
    >> Share

  577. NILSSON J, Cousins KAQ, Gobom J, Portelius E, et al
    Cerebrospinal fluid biomarker panel of synaptic dysfunction in Alzheimer's disease and other neurodegenerative disorders.
    Alzheimers Dement. 2022 Oct 14. doi: 10.1002/alz.12809.
    >> Share


  578. AAIC((R)) 2022: The promise of Alzheimer's research.
    Alzheimers Dement. 2022 Oct 12. doi: 10.1002/alz.12829.
    >> Share

  579. HARERIMANA NV, Paliwali D, Romero-Molina C, Bennett DA, et al
    The role of mitochondrial genome abundance in Alzheimer's disease.
    Alzheimers Dement. 2022 Oct 12. doi: 10.1002/alz.12812.
    >> Share

  580. LIEBERMAN OJ, Lee S, Zabinski J
    Donepezil treatment is associated with improved outcomes in critically ill dementia patients via a reduction in delirium.
    Alzheimers Dement. 2022 Oct 11. doi: 10.1002/alz.12807.
    >> Share

  581. WEINER MW, Veitch DP, Miller MJ, Aisen PS, et al
    Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community-engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4.
    Alzheimers Dement. 2022 Oct 9. doi: 10.1002/alz.12797.
    >> Share

  582. STEPHAN BCM, Gaughan DM, Edland S, Gudnason V, et al
    Mid- and later-life risk factors for predicting neuropathological brain changes associated with Alzheimer's and vascular dementia: The Honolulu Asia Aging Study and the Age, Gene/Environment Susceptibility-Reykjavik Study.
    Alzheimers Dement. 2022 Oct 4. doi: 10.1002/alz.12762.
    >> Share

  583. NUYTEMANS K, Lipkin Vasquez M, Wang L, Van Booven D, et al
    Identifying differential regulatory control of APOE varepsilon4 on African versus European haplotypes as potential therapeutic targets.
    Alzheimers Dement. 2022;18:1930-1942.
    >> Share

  584. CORNELL PY, Zhang W, Smith L, Rahman M, et al
    Memory care reduces nursing home admissions among assisted-living residents with dementia.
    Alzheimers Dement. 2022;18:1880-1888.
    >> Share

  585. MARRIOTT RJ, Murray K, Flicker L, Hankey GJ, et al
    Lower serum testosterone concentrations are associated with a higher incidence of dementia in men: The UK Biobank prospective cohort study.
    Alzheimers Dement. 2022;18:1907-1918.
    >> Share

  586. PINK A, Krell-Roesch J, Syrjanen JA, Vassilaki M, et al
    A longitudinal investigation of Abeta, anxiety, depression, and mild cognitive impairment.
    Alzheimers Dement. 2022;18:1824-1831.
    >> Share

  587. JANSSEN O, Jansen WJ, Vos SJB, Boada M, et al
    Characteristics of subjective cognitive decline associated with amyloid positivity.
    Alzheimers Dement. 2022;18:1832-1845.
    >> Share

  588. SCHLIEP KC, Ju S, Foster NL, Smith KR, et al
    How good are medical and death records for identifying dementia?
    Alzheimers Dement. 2022;18:1812-1823.
    >> Share

  589. GAO Y, Felsky D, Reyes-Dumeyer D, Sariya S, et al
    Integration of GWAS and brain transcriptomic analyses in a multiethnic sample of 35,245 older adults identifies DCDC2 gene as predictor of episodic memory maintenance.
    Alzheimers Dement. 2022;18:1797-1811.
    >> Share

    September 2022
  590. HARTZ SM, Mozersky J, Schindler SE, Linnenbringer E, et al
    A flexible modeling approach for biomarker-based computation of absolute risk of Alzheimer's disease dementia.
    Alzheimers Dement. 2022 Sep 30. doi: 10.1002/alz.12781.
    >> Share

  591. SCHAEVERBEKE J, Tome SO, Ronisz A, Ospitalieri S, et al
    Neuronal loss of the nucleus basalis of Meynert in primary progressive aphasia is associated with Alzheimer's disease neuropathological changes.
    Alzheimers Dement. 2022 Sep 28. doi: 10.1002/alz.12794.
    >> Share

  592. KATABATHULA S, Davis PB, Xu R
    Comorbidity-driven multi-modal subtype analysis in mild cognitive impairment of Alzheimer's disease.
    Alzheimers Dement. 2022 Sep 27. doi: 10.1002/alz.12792.
    >> Share

  593. WEAVER DF
    Alzheimer's disease as an innate autoimmune disease (AD(2) ): A new molecular paradigm.
    Alzheimers Dement. 2022 Sep 27. doi: 10.1002/alz.12789.
    >> Share

  594. LIU KY, Thambisetty M, Howard R
    How can secondary dementia prevention trials of Alzheimer's disease be clinically meaningful?
    Alzheimers Dement. 2022 Sep 26. doi: 10.1002/alz.12788.
    >> Share

  595. PICHET BINETTE A, Janelidze S, Cullen N, Dage JL, et al
    Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance.
    Alzheimers Dement. 2022 Sep 24. doi: 10.1002/alz.12787.
    >> Share

  596. VETELEANU A, Pape S, Davies K, Kodosaki E, et al
    Complement dysregulation and Alzheimer's disease in Down syndrome.
    Alzheimers Dement. 2022 Sep 23. doi: 10.1002/alz.12799.
    >> Share

  597. YIN L, Zhou J, Li T, Wang X, et al
    Inhibition of the dopamine transporter promotes lysosome biogenesis and ameliorates Alzheimer's disease-like symptoms in mice.
    Alzheimers Dement. 2022 Sep 21. doi: 10.1002/alz.12776.
    >> Share

  598. DEPYPERE H, Vergallo A, Lemercier P, Lista S, et al
    Menopause hormone therapy significantly alters pathophysiological biomarkers of Alzheimer's disease.
    Alzheimers Dement. 2022 Sep 15. doi: 10.1002/alz.12759.
    >> Share


  599. Alzheimer's Association launches ALZ-NET: A long-term data collection and sharing network for new treatments.
    Alzheimers Dement. 2022 Sep 12. doi: 10.1002/alz.12782.
    >> Share

  600. JUTTEN RJ, Papp KV, Hendrix S, Ellison N, et al
    Why a clinical trial is as good as its outcome measure: A framework for the selection and use of cognitive outcome measures for clinical trials of Alzheimer's disease.
    Alzheimers Dement. 2022 Sep 10. doi: 10.1002/alz.12773.
    >> Share

  601. DALY T
    The conundrum of the AD continuum.
    Alzheimers Dement. 2022 Sep 8. doi: 10.1002/alz.12783.
    >> Share

  602. MATTKE S, Correa Dos Santos Filho O, Hanson M, Mateus EF, et al
    Preparedness of the Brazilian health-care system to provide access to a disease-modifying Alzheimer's disease treatment.
    Alzheimers Dement. 2022 Sep 5. doi: 10.1002/alz.12778.
    >> Share

  603. SKILLBACK T, Blennow K, Zetterberg H, Skoog J, et al
    Slowing gait speed precedes cognitive decline by several years.
    Alzheimers Dement. 2022;18:1667-1676.
    >> Share

    August 2022
  604. JIANG L, Li JC, Tang BS, Guo JF, et al
    Lack of bidirectional association between age-related macular degeneration and Alzheimer's disease: A Mendelian randomization study.
    Alzheimers Dement. 2022 Aug 25. doi: 10.1002/alz.12775.
    >> Share

  605. LUTZ MW, Khachaturian AS, Zetterberg H, Blennow K, et al
    Biomarkers of Alzheimer syndrome and related dementias: A&D author's guide.
    Alzheimers Dement. 2022 Aug 25. doi: 10.1002/alz.12772.
    >> Share

  606. FRIKKE-SCHMIDT R, Hegazy SH, Rasmussen IJ, Nordestgaard BG, et al
    Observational and genetic studies of C-reactive protein levels and risk of Alzheimer's disease.
    Alzheimers Dement. 2022 Aug 21. doi: 10.1002/alz.12742.
    >> Share

  607. RAFII MS, Sperling RA, Donohue MC, Zhou J, et al
    The AHEAD 3-45 Study: Design of a prevention trial for Alzheimer's disease.
    Alzheimers Dement. 2022 Aug 15. doi: 10.1002/alz.12748.
    >> Share

  608. PALMQVIST S, Stomrud E, Cullen N, Janelidze S, et al
    An accurate fully automated panel of plasma biomarkers for Alzheimer's disease.
    Alzheimers Dement. 2022 Aug 11. doi: 10.1002/alz.12751.
    >> Share

  609. LANGBAUM JB, Zissimopoulos J, Au R, Bose N, et al
    Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials.
    Alzheimers Dement. 2022 Aug 10. doi: 10.1002/alz.12737.
    >> Share

  610. OLCHANSKI N, Daly AT, Zhu Y, Breslau R, et al
    Alzheimer's disease medication use and adherence patterns by race and ethnicity.
    Alzheimers Dement. 2022 Aug 8. doi: 10.1002/alz.12753.
    >> Share

  611. SCHINDLER SE, Li Y, Li M, Despotis A, et al
    Using Alzheimer's disease blood tests to accelerate clinical trial enrollment.
    Alzheimers Dement. 2022 Aug 7. doi: 10.1002/alz.12754.
    >> Share

  612. WANG J, Guo C, Meng Z, Zwan MD, et al
    Testing the link between isoaspartate and Alzheimer's disease etiology.
    Alzheimers Dement. 2022 Aug 4. doi: 10.1002/alz.12735.
    >> Share

  613. MOLONEY CM, Labuzan SA, Crook JE, Siddiqui H, et al
    Phosphorylated tau sites that are elevated in Alzheimer's disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brain.
    Alzheimers Dement. 2022 Aug 3. doi: 10.1002/alz.12749.
    >> Share

  614. PETERSEN RC, Graf A, Carrillo MC, Weber CJ, et al
    Current understanding of AD pathophysiology and impact of amyloid beta-targeted treatments on biomarkers and clinical endpoints.
    Alzheimers Dement. 2022;18:1586.
    >> Share

  615. HACHINSKI V
    The comprehensive, customized, cost-effective approach (CCCAP) to prevention of dementia.
    Alzheimers Dement. 2022;18:1565-1568.
    >> Share

  616. LENNON JC, Aita SL, Bene VAD, Rhoads T, et al
    Black and White individuals differ in dementia prevalence, risk factors, and symptomatic presentation.
    Alzheimers Dement. 2022;18:1461-1471.
    >> Share

  617. PERLUIGI M, Picca A, Montanari E, Calvani R, et al
    Aberrant crosstalk between insulin signaling and mTOR in young Down syndrome individuals revealed by neuronal-derived extracellular vesicles.
    Alzheimers Dement. 2022;18:1498-1510.
    >> Share

  618. PAJEWSKI NM, Elahi FM, Tamura MK, Hinman JD, et al
    Plasma amyloid beta, neurofilament light chain, and total tau in the Systolic Blood Pressure Intervention Trial (SPRINT).
    Alzheimers Dement. 2022;18:1472-1483.
    >> Share

    July 2022
  619. HANSSON O, Edelmayer RM, Boxer AL, Carrillo MC, et al
    The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease.
    Alzheimers Dement. 2022 Jul 31. doi: 10.1002/alz.12756.
    >> Share

  620. NOTARIANNI E
    Risk association between midlife lipid and glucose levels and future Alzheimer's disease.
    Alzheimers Dement. 2022 Jul 28. doi: 10.1002/alz.12738.
    >> Share

  621. LOZUPONE M, Imbimbo BP, Balducci C, Lo Vecchio F, et al
    Does the imbalance in the apolipoprotein E isoforms underlie the pathophysiological process of sporadic Alzheimer's disease?
    Alzheimers Dement. 2022 Jul 28. doi: 10.1002/alz.12728.
    >> Share

  622. MAHAPATRA G, Gao Z, Bateman JR 3rd, Lockhart SN, et al
    Blood-based bioenergetic profiling reveals differences in mitochondrial function associated with cognitive performance and Alzheimer's disease.
    Alzheimers Dement. 2022 Jul 23. doi: 10.1002/alz.12731.
    >> Share

  623. CHATTERJEE P, Pedrini S, Doecke JD, Thota R, et al
    Plasma Abeta42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort.
    Alzheimers Dement. 2022 Jul 21. doi: 10.1002/alz.12724.
    >> Share

  624. BEYER L, Stocker H, Rujescu D, Holleczek B, et al
    Amyloid-beta misfolding and GFAP predict risk of clinical Alzheimer's disease diagnosis within 17 years.
    Alzheimers Dement. 2022 Jul 19. doi: 10.1002/alz.12745.
    >> Share

  625. LIU H, Xie Y, Wang X, Abboud MI, et al
    Exploring links between 2-oxoglutarate-dependent oxygenases and Alzheimer's disease.
    Alzheimers Dement. 2022 Jul 19. doi: 10.1002/alz.12733.
    >> Share

  626. BATRA R, Arnold M, Worheide MA, Allen M, et al
    The landscape of metabolic brain alterations in Alzheimer's disease.
    Alzheimers Dement. 2022 Jul 13. doi: 10.1002/alz.12714.
    >> Share

  627. WANG JT, Xu G, Ren RJ, Wang Y, et al
    The impacts of health insurance and resource on the burden of Alzheimer's disease and related dementias in the world population.
    Alzheimers Dement. 2022 Jul 12. doi: 10.1002/alz.12730.
    >> Share

  628. LIN Z, Lim C, Jiang D, Soldan A, et al
    Longitudinal changes in brain oxygen extraction fraction (OEF) in older adults: Relationship to markers of vascular and Alzheimer's pathology.
    Alzheimers Dement. 2022 Jul 6. doi: 10.1002/alz.12727.
    >> Share

  629. TIAN C, Stewart T, Hong Z, Guo Z, et al
    Blood extracellular vesicles carrying synaptic function- and brain-related proteins as potential biomarkers for Alzheimer's disease.
    Alzheimers Dement. 2022 Jul 2. doi: 10.1002/alz.12723.
    >> Share

  630. SALVADO G, Ferreira D, Operto G, Cumplido-Mayoral I, et al
    The protective gene dose effect of the APOE epsilon2 allele on gray matter volume in cognitively unimpaired individuals.
    Alzheimers Dement. 2022;18:1383-1395.
    >> Share

  631. KATSEL P, Fam P, Tan W, Khan S, et al
    Engagement of vascular early response genes typifies mild cognitive impairment.
    Alzheimers Dement. 2022;18:1357-1369.
    >> Share

    June 2022
  632. CHUNG J, Das A, Sun X, Sobreira DR, et al
    Genome-wide association and multi-omics studies identify MGMT as a novel risk gene for Alzheimer's disease among women.
    Alzheimers Dement. 2022 Jun 30. doi: 10.1002/alz.12719.
    >> Share

  633. WEINER MW, Harvey D, Landau SM, Veitch DP, et al
    Traumatic brain injury and post-traumatic stress disorder are not associated with Alzheimer's disease pathology measured with biomarkers.
    Alzheimers Dement. 2022 Jun 29. doi: 10.1002/alz.12712.
    >> Share

  634. ABDULRAHMAN H, van Dalen JW, den Brok M, Latimer CS, et al
    Hypertension and Alzheimer's disease pathology at autopsy: A systematic review.
    Alzheimers Dement. 2022 Jun 27. doi: 10.1002/alz.12707.
    >> Share

  635. GILMORE-BYKOVSKYI A, Griffin JM, Mueller KD, Parnia S, et al
    Toward harmonization of strategies for investigating lucidity in AD/ADRD: A preliminary research framework.
    Alzheimers Dement. 2022;19:343-52.
    >> Share

  636. WINGO TS, Gerasimov ES, Canon SM, Lah JJ, et al
    Alzheimer's disease genetic burden is associated with mid-life depression among persons with normal cognition.
    Alzheimers Dement. 2022 Jun 21. doi: 10.1002/alz.12716.
    >> Share

  637. CULLEN NC, Janelidze S, Mattsson-Carlgren N, Palmqvist S, et al
    Test-retest variability of plasma biomarkers in Alzheimer's disease and its effects on clinical prediction models.
    Alzheimers Dement. 2022 Jun 14. doi: 10.1002/alz.12706.
    >> Share

  638. DELVENNE A, Gobom J, Tijms B, Bos I, et al
    Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiology.
    Alzheimers Dement. 2022 Jun 14. doi: 10.1002/alz.12713.
    >> Share

  639. SINGH NA, Tosakulwong N, Graff-Radford J, Machulda MM, et al
    APOE epsilon4 influences medial temporal atrophy and tau deposition in atypical Alzheimer's disease.
    Alzheimers Dement. 2022 Jun 12. doi: 10.1002/alz.12711.
    >> Share

  640. RISCHEL EB, Gejl M, Brock B, Rungby J, et al
    In Alzheimer's disease, amyloid beta accumulation is a protective mechanism that ultimately fails.
    Alzheimers Dement. 2022 Jun 8. doi: 10.1002/alz.12701.
    >> Share

  641. GAO F, Lv X, Dai L, Wang Q, et al
    A combination model of AD biomarkers revealed by machine learning precisely predicts Alzheimer's dementia: China Aging and Neurodegenerative Initiative (CANDI) study.
    Alzheimers Dement. 2022 Jun 6. doi: 10.1002/alz.12700.
    >> Share

  642. GUSTAVSSON A, Norton N, Fast T, Frolich L, et al
    Global estimates on the number of persons across the Alzheimer's disease continuum.
    Alzheimers Dement. 2022 Jun 2. doi: 10.1002/alz.12694.
    >> Share

  643. SAWA M, Overk C, Becker A, Derse D, et al
    Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model.
    Alzheimers Dement. 2022;18:1203-1234.
    >> Share

  644. SYRJANEN JA, Campbell MR, Algeciras-Schimnich A, Vemuri P, et al
    Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities.
    Alzheimers Dement. 2022;18:1128-1140.
    >> Share

  645. LIU L, Kwak H, Lawton TL, Jin SX, et al
    An ultra-sensitive immunoassay detects and quantifies soluble Abeta oligomers in human plasma.
    Alzheimers Dement. 2022;18:1186-1202.
    >> Share

  646. SANZ-BLASCO R, Ruiz-Sanchez de Leon JM, Avila-Villanueva M, Valenti-Soler M, et al
    Transition from mild cognitive impairment to normal cognition: Determining the predictors of reversion with multi-state Markov models.
    Alzheimers Dement. 2022;18:1177-1185.
    >> Share

    May 2022
  647. VOGLEIN J, Franzmeier N, Morris JC, Dieterich M, et al
    Patterns and implications of neurological examination findings in autosomal dominant Alzheimer disease.
    Alzheimers Dement. 2022 May 24. doi: 10.1002/alz.12684.
    >> Share

  648. HU Y, Zhang Y, Zhang H, Gao S, et al
    Mendelian randomization highlights causal association between genetically increased C-reactive protein levels and reduced Alzheimer's disease risk.
    Alzheimers Dement. 2022 May 22. doi: 10.1002/alz.12687.
    >> Share

  649. LUO J, Thomassen JQ, Hegazy SH, Rasmussen IJ, et al
    Reply to "Mendelian randomization highlights causal association between genetically increased C-reactive protein levels and reduced Alzheimer's disease risk".
    Alzheimers Dement. 2022 May 22. doi: 10.1002/alz.12688.
    >> Share

  650. ASHLEIGH T, Swerdlow RH, Beal MF
    The role of mitochondrial dysfunction in Alzheimer's disease pathogenesis.
    Alzheimers Dement. 2022 May 6. doi: 10.1002/alz.12683.
    >> Share

  651. SEXTON C, Snyder H, Beher D, Boxer AL, et al
    Current directions in tau research: Highlights from Tau 2020.
    Alzheimers Dement. 2022;18:988-1007.
    >> Share

  652. IMBIMBO BP, Ippati S, Watling M, Balducci C, et al
    A critical appraisal of tau-targeting therapies for primary and secondary tauopathies.
    Alzheimers Dement. 2022;18:1008-1037.
    >> Share

  653. PERRY BL, McConnell WR, Coleman ME, Roth AR, et al
    Why the cognitive "fountain of youth" may be upstream: Pathways to dementia risk and resilience through social connectedness.
    Alzheimers Dement. 2022;18:934-941.
    >> Share

    April 2022
  654. CHANG R, Trushina E, Zhu K, Zaidi SSA, et al
    Predictive metabolic networks reveal sex- and APOE genotype-specific metabolic signatures and drivers for precision medicine in Alzheimer's disease.
    Alzheimers Dement. 2022 Apr 28. doi: 10.1002/alz.12675.
    >> Share

  655. PARK SY, Setiawan VW, White LR, Wu AH, et al
    Modifying effects of race and ethnicity and APOE on the association of physical activity with risk of Alzheimer's disease and related dementias.
    Alzheimers Dement. 2022 Apr 27. doi: 10.1002/alz.12677.
    >> Share

  656. JESSEN F, Wolfsgruber S, Kleineindam L, Spottke A, et al
    Subjective cognitive decline and stage 2 of Alzheimer disease in patients from memory centers.
    Alzheimers Dement. 2022 Apr 22. doi: 10.1002/alz.12674.
    >> Share

  657. QUAN L, Moreno-Gonzalez I, Xie Z, Gamez N, et al
    A near-infrared probe for detecting and interposing amyloid beta oligomerization in early Alzheimer's disease.
    Alzheimers Dement. 2022 Apr 18. doi: 10.1002/alz.12673.
    >> Share

  658. TJANDRA D, Migrino RQ, Giordani B, Wiens J, et al
    Use of blood pressure measurements extracted from the electronic health record in predicting Alzheimer's disease: A retrospective cohort study at two medical centers.
    Alzheimers Dement. 2022 Apr 16. doi: 10.1002/alz.12676.
    >> Share

  659. TA PARK VM, Meyer OL, Tsoh JY, Kanaya AM, et al
    The Collaborative Approach for Asian Americans and Pacific Islanders Research and Education (CARE): A recruitment registry for Alzheimer's disease and related dementias, aging, and caregiver-related research.
    Alzheimers Dement. 2022 Apr 14. doi: 10.1002/alz.12667.
    >> Share

  660. MARTINEZ AE, Weissberger G, Kuklenyik Z, He X, et al
    The small HDL particle hypothesis of Alzheimer's disease.
    Alzheimers Dement. 2022 Apr 13. doi: 10.1002/alz.12649.
    >> Share

  661. MIELKE MM, Aggarwal NT, Vila-Castelar C, Agarwal P, et al
    Consideration of sex and gender in Alzheimer's disease and related disorders from a global perspective.
    Alzheimers Dement. 2022 Apr 8. doi: 10.1002/alz.12662.
    >> Share

  662. WANG Y, Li M, Kazis LE, Xia W, et al
    Clinical outcomes of COVID-19 infection among patients with Alzheimer's disease or mild cognitive impairment.
    Alzheimers Dement. 2022 Apr 4. doi: 10.1002/alz.12665.
    >> Share

  663. FRUIJTIER AD, van der Schaar J, van Maurik IS, Zwan MD, et al
    Identifying best practices for disclosure of amyloid imaging results: A randomized controlled trial.
    Alzheimers Dement. 2022 Apr 2. doi: 10.1002/alz.12630.
    >> Share

  664. LUCKETT PH, Chen C, Gordon BA, Wisch J, et al
    Biomarker clustering in autosomal dominant Alzheimer's disease.
    Alzheimers Dement. 2022 Apr 1. doi: 10.1002/alz.12661.
    >> Share

  665. NEUPANE A, Lenny B, Budde JP, Wang F, et al
    Replication study of AD-associated rare variants.
    Alzheimers Dement. 2022;18:858-862.
    >> Share

  666. AKINYEMI RO, Yaria J, Ojagbemi A, Guerchet M, et al
    Dementia in Africa: Current evidence, knowledge gaps, and future directions.
    Alzheimers Dement. 2022;18:790-809.
    >> Share

  667. MURA T, Coley N, Amieva H, Berr C, et al
    Cognitive decline as an outcome and marker of progression toward dementia, in early preventive trials.
    Alzheimers Dement. 2022;18:676-687.
    >> Share

  668. LINDBOHM JV, Mars N, Walker KA, Singh-Manoux A, et al
    Plasma proteins, cognitive decline, and 20-year risk of dementia in the Whitehall II and Atherosclerosis Risk in Communities studies.
    Alzheimers Dement. 2022;18:612-624.
    >> Share

  669. POURHADI N, Morch LS, Holm EA, Torp-Pedersen CT, et al
    Vaginal estrogen and association with dementia: A nationwide population-based study.
    Alzheimers Dement. 2022;18:625-634.
    >> Share

  670. MIELKE MM, Aakre JA, Algeciras-Schimnich A, Proctor NK, et al
    Comparison of CSF phosphorylated tau 181 and 217 for cognitive decline.
    Alzheimers Dement. 2022;18:602-611.
    >> Share

  671. CASANOVA R, Hsu FC, Barnard RT, Anderson AM, et al
    Comparing data-driven and hypothesis-driven MRI-based predictors of cognitive impairment in individuals from the Atherosclerosis Risk in Communities (ARIC) study.
    Alzheimers Dement. 2022;18:561-571.
    >> Share

  672. YANG HS, Zhang C, Carlyle BC, Zhen SY, et al
    Plasma IL-12/IFN-gamma axis predicts cognitive trajectories in cognitively unimpaired older adults.
    Alzheimers Dement. 2022;18:645-653.
    >> Share

    March 2022
  673. BRODY M, Agronin M, Herskowitz BJ, Bookheimer SY, et al
    Results and insights from a phase I clinical trial of Lomecel-B for Alzheimer's disease.
    Alzheimers Dement. 2022 Mar 31. doi: 10.1002/alz.12651.
    >> Share

  674. SUNDERLAND KM, Beaton D, Arnott SR, Kleinstiver P, et al
    Characteristics of the Ontario Neurodegenerative Disease Research Initiative cohort.
    Alzheimers Dement. 2022 Mar 30. doi: 10.1002/alz.12632.
    >> Share

  675. ZHANG X, Tong T, Chang A, Ang TFA, et al
    Midlife lipid and glucose levels are associated with Alzheimer's disease.
    Alzheimers Dement. 2022 Mar 23. doi: 10.1002/alz.12641.
    >> Share

  676. JACOBS HIL, Becker JA, Kwong K, Munera D, et al
    Waning locus coeruleus integrity precedes cortical tau accrual in preclinical autosomal dominant Alzheimer's disease.
    Alzheimers Dement. 2022 Mar 17. doi: 10.1002/alz.12656.
    >> Share

  677. LI P, Gao L, Yu L, Zheng X, et al
    Daytime napping and Alzheimer's dementia: A potential bidirectional relationship.
    Alzheimers Dement. 2022 Mar 17. doi: 10.1002/alz.12636.
    >> Share

  678. COE NB, White L, Oney M, Basu A, et al
    Public spending on acute and long-term care for Alzheimer's disease and related dementias.
    Alzheimers Dement. 2022 Mar 16. doi: 10.1002/alz.12657.
    >> Share

  679. NITCHINGHAM A, Pereira JV, Wegner EA, Oxenham V, et al
    Regional cerebral hypometabolism on 18F-FDG PET/CT scan in delirium is independent of acute illness and dementia.
    Alzheimers Dement. 2022 Mar 15. doi: 10.1002/alz.12604.
    >> Share


  680. 2022 Alzheimer's disease facts and figures.
    Alzheimers Dement. 2022 Mar 14. doi: 10.1002/alz.12638.
    >> Share

  681. LIU L, Lauro BM, He A, Lee H, et al
    Identification of the Abeta37/42 peptide ratio in CSF as an improved Abeta biomarker for Alzheimer's disease.
    Alzheimers Dement. 2022 Mar 12. doi: 10.1002/alz.12646.
    >> Share

  682. WINDER Z, Sudduth TL, Anderson S, Patel E, et al
    Examining the association between blood-based biomarkers and human post mortem neuropathology in the University of Kentucky Alzheimer's Disease Research Center autopsy cohort.
    Alzheimers Dement. 2022 Mar 10. doi: 10.1002/alz.12639.
    >> Share

  683. GATZ M, Mack WJ, Chui HC, Law EM, et al
    Prevalence of dementia and mild cognitive impairment in indigenous Bolivian forager-horticulturalists.
    Alzheimers Dement. 2022;19:44-55.
    >> Share

  684. BREITNER JCS, Dodge HH, Khachaturian ZS, Khachaturian AS, et al
    "Exceptions that prove the rule"-Why have clinical trials failed to show efficacy of risk factor interventions suggested by observational studies of the dementia-Alzheimer's disease syndrome?
    Alzheimers Dement. 2022 Mar 4. doi: 10.1002/alz.12633.
    >> Share


  685. Alzheimer's Association welcomes new Medical and Scientific Advisory Group members.
    Alzheimers Dement. 2022 Mar 4. doi: 10.1002/alz.12621.
    >> Share

  686. O'BRYANT SE, Petersen M, Hall J, Johnson LA, et al
    Medical comorbidities and ethnicity impact plasma Alzheimer's disease biomarkers: Important considerations for clinical trials and practice.
    Alzheimers Dement. 2022 Mar 2. doi: 10.1002/alz.12647.
    >> Share

  687. CONNOLLY K, Lehoux M, O'Rourke R, Assetta B, et al
    Potential role of chitinase-3-like protein 1 (CHI3L1/YKL-40) in neurodegeneration and Alzheimer's disease.
    Alzheimers Dement. 2022 Mar 2. doi: 10.1002/alz.12612.
    >> Share

  688. STOCKER H, Beyer L, Perna L, Rujescu D, et al
    Association of plasma biomarkers, p-tau181, glial fibrillary acidic protein, and neurofilament light, with intermediate and long-term clinical Alzheimer's disease risk: Results from a prospective cohort followed over 17 years.
    Alzheimers Dement. 2022 Mar 2. doi: 10.1002/alz.12614.
    >> Share

  689. CUMMINGS J, Salloway S
    Aducanumab: Appropriate use recommendations.
    Alzheimers Dement. 2022;18:531-533.
    >> Share

  690. PETERSON A, Clapp J, Largent EA, Harkins K, et al
    What is paradoxical lucidity? The answer begins with its definition.
    Alzheimers Dement. 2022;18:513-521.
    >> Share

  691. BARIL AA, Beiser AS, Sanchez E, Mysliwiec V, et al
    Insomnia symptom severity and cognitive performance: Moderating role of APOE genotype.
    Alzheimers Dement. 2022;18:408-421.
    >> Share

    February 2022
  692. GIETL AF, Frisoni GB
    Early termination of pivotal trials in Alzheimer's disease-Preserving optimal value for participants and science.
    Alzheimers Dement. 2022 Feb 27. doi: 10.1002/alz.12605.
    >> Share

  693. KETCHUM FB, Chin NA, Grill J, Gleason CE, et al
    Moving beyond disclosure: Stages of care in preclinical Alzheimer's disease biomarker testing.
    Alzheimers Dement. 2022 Feb 25. doi: 10.1002/alz.12620.
    >> Share

  694. ASHFORD MT, Raman R, Miller G, Donohue MC, et al
    Screening and enrollment of underrepresented ethnocultural and educational populations in the Alzheimer's Disease Neuroimaging Initiative (ADNI).
    Alzheimers Dement. 2022 Feb 25. doi: 10.1002/alz.12640.
    >> Share

  695. ZETTERBERG H
    Biofluid-based biomarkers for Alzheimer's disease-related pathologies: An update and synthesis of the literature.
    Alzheimers Dement. 2022 Feb 25. doi: 10.1002/alz.12618.
    >> Share

  696. XIONG C, Luo J, Schindler SE, Fagan AM, et al
    Racial differences in longitudinal Alzheimer's disease biomarkers among cognitively normal adults.
    Alzheimers Dement. 2022 Feb 25. doi: 10.1002/alz.12608.
    >> Share

  697. MONI F, Petersen ME, Zhang F, Lao PJ, et al
    Probing the proteome to explore potential correlates of increased Alzheimer's-related cerebrovascular disease in adults with Down syndrome.
    Alzheimers Dement. 2022 Feb 24. doi: 10.1002/alz.12627.
    >> Share

  698. LEVIN J, Voglein J, Quiroz YT, Bateman RJ, et al
    Testing the amyloid cascade hypothesis: Prevention trials in autosomal dominant Alzheimer disease.
    Alzheimers Dement. 2022 Feb 24. doi: 10.1002/alz.12624.
    >> Share

  699. QUIROZ YT, Solis M, Aranda MP, Arbaje AI, et al
    Addressing the disparities in dementia risk, early detection and care in Latino populations: Highlights from the second Latinos & Alzheimer's Symposium.
    Alzheimers Dement. 2022 Feb 24. doi: 10.1002/alz.12589.
    >> Share

  700. SEXTON C, Solis M, Aharon-Peretz J, Alexopoulos P, et al
    Alzheimer's disease research progress in the Mediterranean region: The Alzheimer's Association International Conference Satellite Symposium.
    Alzheimers Dement. 2022 Feb 20. doi: 10.1002/alz.12588.
    >> Share

  701. MECCA AP, O'Dell RS, Sharp ES, Banks ER, et al
    Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [(11) C]UCB-J.
    Alzheimers Dement. 2022 Feb 17. doi: 10.1002/alz.12582.
    >> Share

  702. SUCHY-DICEY A, Howard B, Longstreth WT Jr, Reiman EM, et al
    APOE genotype, hippocampus, and cognitive markers of Alzheimer's disease in American Indians: Data from the Strong Heart Study.
    Alzheimers Dement. 2022 Feb 10. doi: 10.1002/alz.12573.
    >> Share

  703. KRELL-ROESCH J, Rakusa M, Syrjanen JA, van Harten AC, et al
    Association between CSF biomarkers of Alzheimer's disease and neuropsychiatric symptoms: Mayo Clinic Study of Aging.
    Alzheimers Dement. 2022 Feb 9. doi: 10.1002/alz.12557.
    >> Share

  704. CLAES C, England WE, Danhash EP, Kiani Shabestari S, et al
    The P522R protective variant of PLCG2 promotes the expression of antigen presentation genes by human microglia in an Alzheimer's disease mouse model.
    Alzheimers Dement. 2022 Feb 9. doi: 10.1002/alz.12577.
    >> Share

  705. HU WT
    Reporting and social construction of race in Alzheimer's disease clinical trials.
    Alzheimers Dement. 2022 Feb 9. doi: 10.1002/alz.12609.
    >> Share

  706. ASTILLERO-LOPEZ V, Gonzalez-Rodriguez M, Villar-Conde S, Flores-Cuadrado A, et al
    Neurodegeneration and astrogliosis in the entorhinal cortex in Alzheimer's disease: Stereological layer-specific assessment and proteomic analysis.
    Alzheimers Dement. 2022 Feb 9. doi: 10.1002/alz.12580.
    >> Share

  707. FLACH M, Leu C, Martinisi A, Skachokova Z, et al
    Trans-seeding of Alzheimer-related tau protein by a yeast prion.
    Alzheimers Dement. 2022 Feb 9. doi: 10.1002/alz.12581.
    >> Share

  708. PRADOS MJ, Liu Y, Jun H, Lam J, et al
    Projecting the long-term societal value of a disease-modifying treatment for Alzheimer's disease in the United States.
    Alzheimers Dement. 2022 Feb 9. doi: 10.1002/alz.12578.
    >> Share

  709. BABULAL GM, Franzen S, Abner EL, Smith JE, et al
    Diversity in Alzheimer's disease drug trials: Reflections on reporting and social construction of race.
    Alzheimers Dement. 2022 Feb 9. doi: 10.1002/alz.12611.
    >> Share

  710. JUN GR, You Y, Zhu C, Meng G, et al
    Protein phosphatase 2A and complement component 4 are linked to the protective effect of APOE varepsilon2 for Alzheimer's disease.
    Alzheimers Dement. 2022 Feb 9. doi: 10.1002/alz.12607.
    >> Share

  711. VARDARAJAN BN, Reyes-Dumeyer D, Piriz AL, Lantigua RA, et al
    Progranulin mutations in clinical and neuropathological Alzheimer's disease.
    Alzheimers Dement. 2022 Feb 9. doi: 10.1002/alz.12567.
    >> Share

  712. REIKEN S, Sittenfeld L, Dridi H, Liu Y, et al
    Alzheimer's-like signaling in brains of COVID-19 patients.
    Alzheimers Dement. 2022 Feb 3. doi: 10.1002/alz.12558.
    >> Share

  713. RUTHIRAKUHAN M, Ismail Z, Herrmann N, Gallagher D, et al
    Mild behavioral impairment is associated with progression to Alzheimer's disease: A clinicopathological study.
    Alzheimers Dement. 2022 Feb 1. doi: 10.1002/alz.12519.
    >> Share

  714. REIMAN EM, Mattke S, Kordower JH, Khachaturian ZS, et al
    Developing a pathway to support the appropriate, affordable, and widespread use of effective Alzheimer's prevention drugs.
    Alzheimers Dement. 2022 Feb 1. doi: 10.1002/alz.12533.
    >> Share


  715. Applications being accepted for the Alzheimer's Association Interdisciplinary Summer Research Institute.
    Alzheimers Dement. 2022 Feb 1. doi: 10.1002/alz.12585.
    >> Share

  716. VILA-CASTELAR C, Tariot PN, Sink KM, Clayton D, et al
    Sex differences in cognitive resilience in preclinical autosomal-dominant Alzheimer's disease carriers and non-carriers: Baseline findings from the API ADAD Colombia Trial.
    Alzheimers Dement. 2022 Feb 1. doi: 10.1002/alz.12552.
    >> Share

  717. WAGNER M, Wilson RS, Leurgans SE, Boyle PA, et al
    Quantifying longitudinal cognitive resilience to Alzheimer's disease and other neuropathologies.
    Alzheimers Dement. 2022 Feb 1. doi: 10.1002/alz.12576.
    >> Share

  718. ERATNE D, Loi SM, Li QX, Stehmann C, et al
    Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer's disease and frontotemporal disorders in clinical settings.
    Alzheimers Dement. 2022 Feb 1. doi: 10.1002/alz.12549.
    >> Share

  719. O'BRYANT S, Petersen M, Hall J, Johnson L, et al
    Characterizing plasma NfL in a community-dwelling multi-ethnic cohort: Results from the HABLE study.
    Alzheimers Dement. 2022;18:240-250.
    >> Share

  720. NAUEN DW, Troncoso JC
    Amyloid-beta is present in human lymph nodes and greatly enriched in those of the cervical region.
    Alzheimers Dement. 2022;18:205-210.
    >> Share

  721. KREISL WC, Lao PJ, Johnson A, Tomljanovic Z, et al
    Patterns of tau pathology identified with (18) F-MK-6240 PET imaging.
    Alzheimers Dement. 2022;18:272-282.
    >> Share

  722. SCHMUTTE T, Olfson M, Maust DT, Xie M, et al
    Suicide risk in first year after dementia diagnosis in older adults.
    Alzheimers Dement. 2022;18:262-271.
    >> Share

    January 2022
  723. CALDWELL AB, Liu Q, Zhang C, Schroth GP, et al
    Endotype reversal as a novel strategy for screening drugs targeting familial Alzheimer's disease.
    Alzheimers Dement. 2022 Jan 27. doi: 10.1002/alz.12553.
    >> Share

  724. WANG T, Huynh K, Giles C, Mellett NA, et al
    APOE epsilon2 resilience for Alzheimer's disease is mediated by plasma lipid species: Analysis of three independent cohort studies.
    Alzheimers Dement. 2022 Jan 25. doi: 10.1002/alz.12538.
    >> Share

  725. JORDA-SIQUIER T, Petrel M, Kouskoff V, Smailovic U, et al
    APP accumulates with presynaptic proteins around amyloid plaques: A role for presynaptic mechanisms in Alzheimer's disease?
    Alzheimers Dement. 2022 Jan 25. doi: 10.1002/alz.12546.
    >> Share

  726. FRONTERA JA, Boutajangout A, Masurkar AV, Betensky RA, et al
    Comparison of serum neurodegenerative biomarkers among hospitalized COVID-19 patients versus non-COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer's dementia.
    Alzheimers Dement. 2022 Jan 13. doi: 10.1002/alz.12556.
    >> Share

  727. YAO J, Liu Y, Sun B, Zhan X, et al
    Increased RyR2 open probability induces neuronal hyperactivity and memory loss with or without Alzheimer's disease-causing gene mutations.
    Alzheimers Dement. 2022 Jan 5. doi: 10.1002/alz.12543.
    >> Share

  728. NAZARIAN A, Loika Y, He L, Culminskaya I, et al
    Genome-wide analysis identified abundant genetic modulators of contributions of the apolipoprotein E alleles to Alzheimer's disease risk.
    Alzheimers Dement. 2022 Jan 3. doi: 10.1002/alz.12540.
    >> Share

  729. REYES-DUMEYER D, Faber K, Vardarajan B, Goate A, et al
    The National Institute on Aging Late-Onset Alzheimer's Disease Family Based Study: A resource for genetic discovery.
    Alzheimers Dement. 2022 Jan 3. doi: 10.1002/alz.12514.
    >> Share

  730. QIU S, Hu Y, Cheng L
    BIN1 rs744373 located in enhancers of brain tissues upregulates BIN1 mRNA expression, thereby leading to Alzheimer's disease.
    Alzheimers Dement. 2022 Jan 3. doi: 10.1002/alz.12548.
    >> Share

  731. ZAMOLODCHIKOV D, Duffield M, Macdonald LE, Alessandri-Haber N, et al
    Accumulation of high molecular weight kininogen in the brains of Alzheimer's disease patients may affect microglial function by altering phagocytosis and lysosomal cathepsin activity.
    Alzheimers Dement. 2022 Jan 3. doi: 10.1002/alz.12531.
    >> Share


  732. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring announces new editor-in-chief for open access, peer reviewed journal.
    Alzheimers Dement. 2022 Jan 3. doi: 10.1002/alz.12517.
    >> Share

  733. KETCHUM FB
    Solomon Carter Fuller: Alzheimer's contemporary and American pioneer.
    Alzheimers Dement. 2022 Jan 3. doi: 10.1002/alz.12551.
    >> Share

  734. JAKEL L, De Kort AM, Klijn CJM, Schreuder FHBM, et al
    Prevalence of cerebral amyloid angiopathy: A systematic review and meta-analysis.
    Alzheimers Dement. 2022;18:10-28.
    >> Share

  735. ZHAO Y, Kuca K, Wu W, Wang X, et al
    Hypothesis: JNK signaling is a therapeutic target of neurodegenerative diseases.
    Alzheimers Dement. 2022;18:152-158.
    >> Share

  736. BUTT OH, Meeker KL, Wisch JK, Schindler SE, et al
    Network dysfunction in cognitively normal APOE epsilon4 carriers is related to subclinical tau.
    Alzheimers Dement. 2022;18:116-126.
    >> Share

  737. VOGT NM, Hunt JFV, Adluru N, Ma Y, et al
    Interaction of amyloid and tau on cortical microstructure in cognitively unimpaired adults.
    Alzheimers Dement. 2022;18:65-76.
    >> Share

    December 2021
  738. DELABY C, Teunissen CE, Blennow K, Alcolea D, et al
    Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview.
    Alzheimers Dement. 2021 Dec 22. doi: 10.1002/alz.12545.
    >> Share

  739. MING C, Wang M, Wang Q, Neff R, et al
    Whole genome sequencing-based copy number variations reveal novel pathways and targets in Alzheimer's disease.
    Alzheimers Dement. 2021 Dec 17. doi: 10.1002/alz.12507.
    >> Share

  740. HAWKINSON TR, Clarke HA, Young LEA, Conroy LR, et al
    In situ spatial glycomic imaging of mouse and human Alzheimer's disease brains.
    Alzheimers Dement. 2021 Dec 15. doi: 10.1002/alz.12523.
    >> Share

  741. LIM U, Wang S, Park SY, Bogumil D, et al
    Risk of Alzheimer's disease and related dementia by sex and race/ethnicity: The Multiethnic Cohort Study.
    Alzheimers Dement. 2021 Dec 9. doi: 10.1002/alz.12528.
    >> Share

  742. GORDON MN, Heneka MT, Le Page LM, Limberger C, et al
    Impact of COVID-19 on the Onset and Progression of Alzheimer's Disease and Related Dementias: A Roadmap for Future Research.
    Alzheimers Dement. 2021 Dec 7. doi: 10.1002/alz.12488.
    >> Share

  743. DE KORT AM, Kuiperij HB, Kersten I, Versleijen AAM, et al
    Normal cerebrospinal fluid concentrations of PDGFRbeta in patients with cerebral amyloid angiopathy and Alzheimer's disease.
    Alzheimers Dement. 2021 Dec 7. doi: 10.1002/alz.12506.
    >> Share

  744. SILVERMAN W, Krinsky-McHale SJ, Zigman WB, Schupf N, et al
    Adults with Down syndrome in randomized clinical trials targeting prevention of Alzheimer's disease.
    Alzheimers Dement. 2021 Dec 7. doi: 10.1002/alz.12520.
    >> Share

  745. SAROJA SR, Sharma A, Hof PR, Pereira AC, et al
    Differential expression of tau species and the association with cognitive decline and synaptic loss in Alzheimer's disease.
    Alzheimers Dement. 2021 Dec 7. doi: 10.1002/alz.12518.
    >> Share

  746. GLEASON CE, Zuelsdorff M, Gooding DC, Kind AJH, et al
    Alzheimer's disease biomarkers in Black and non-Hispanic White cohorts: A contextualized review of the evidence.
    Alzheimers Dement. 2021 Dec 6. doi: 10.1002/alz.12511.
    >> Share

  747. HAEGER A, Bottlaender M, Lagarde J, Porciuncula Baptista R, et al
    What can 7T sodium MRI tell us about cellular energy depletion and neurotransmission in Alzheimer's disease?
    Alzheimers Dement. 2021 Dec 2. doi: 10.1002/alz.12501.
    >> Share


  748. AAIC 2021: The promise of Alzheimer's research.
    Alzheimers Dement. 2021 Dec 2. doi: 10.1002/alz.12500.
    >> Share

  749. FRANK B, Ally M, Brekke B, Zetterberg H, et al
    Plasma p-tau181 shows stronger network association to Alzheimer's disease dementia than neurofilament light and total tau.
    Alzheimers Dement. 2021 Dec 2. doi: 10.1002/alz.12508.
    >> Share

  750. STATHAS S, Alvarez VE, Xia W, Nicks R, et al
    Tau phosphorylation sites serine202 and serine396 are differently altered in chronic traumatic encephalopathy and Alzheimer's disease.
    Alzheimers Dement. 2021 Dec 2. doi: 10.1002/alz.12502.
    >> Share

  751. BUCKLES VD, Xiong C, Bateman RJ, Hassenstab J, et al
    Different rates of cognitive decline in autosomal dominant and late-onset Alzheimer disease.
    Alzheimers Dement. 2021 Dec 2. doi: 10.1002/alz.12505.
    >> Share

  752. STRINGER C, Smithroat N, Samus QM, Johnston D, et al
    From research to realization: How a Texas health plan implemented an academic model of care for Alzheimer's disease.
    Alzheimers Dement. 2021;17 Suppl 8:e054058.
    >> Share

  753. MENENGIC KN, Yeldan I, Cinar N, Sahiner TA, et al
    Effectiveness of home-based telerehabilitation in mild to moderate Alzheimer's disease: A randomised controlled study.
    Alzheimers Dement. 2021;17 Suppl 8:e053406.
    >> Share

  754. ASCHETTINO LA, Labyak CA, Sealey-Potts C
    Nutritional treatments for Alzheimer's disease: A narrative review.
    Alzheimers Dement. 2021;17 Suppl 8:e053172.
    >> Share

  755. LEE JH, Kim DY, Kim MG, Kang H, et al
    Preventing cognitive decline in older adults with mild cognitive impairment using integrated Korean and Western treatments: Initial results.
    Alzheimers Dement. 2021;17 Suppl 8:e052545.
    >> Share

  756. GELDMACHER DS, Christopher R, Anderson M, Bero AW, et al
    Development of a site readiness framework to improve health system preparedness for potential new Alzheimer's disease therapies.
    Alzheimers Dement. 2021;17 Suppl 8:e057672.
    >> Share

  757. KEELY AJ
    The first female engineer at General Motor's descent into Alzheimer's with sundowners: A daughter's scholarly research and case study as caregiver.
    Alzheimers Dement. 2021;17 Suppl 8:e050143.
    >> Share

  758. FLATT JD, Pollock K, Lee R, Song Y, et al
    Feasibility of the Savvy Caregiver program for care providers of LGBTQ adults living with Alzheimer's disease and related dementias.
    Alzheimers Dement. 2021;17 Suppl 8:e055633.
    >> Share

  759. MILLER DR, Jasuja G, Davila HW, Palnati M, et al
    Care processes related to clinical detection of Alzheimer's disease in the U.S. Veterans Affairs Health Care System.
    Alzheimers Dement. 2021;17 Suppl 8:e054149.
    >> Share

  760. MAKSIMOVICH IV
    Stimulation of cerebral angiogenesis and neurogenesis with transcatheter intracerebral laser photobiomodulation therapy during dementia in patients with Alzheimer's and Binswanger's disease.
    Alzheimers Dement. 2021;17 Suppl 8:e054945.
    >> Share

  761. GONZALEZ A, Camila C, Maccioni RB
    Alzheimer's disease: A potential diabetes type 3.
    Alzheimers Dement. 2021;17 Suppl 2:e058533.
    >> Share

  762. MOYLAN C, Cao TV, Huynh QS, Pratap A, et al
    Exercise-Induced Alterations in TrkB expression in the 5XFAD Mouse Model of Alzheimer's Disease.
    Alzheimers Dement. 2021;17 Suppl 2:e058733.
    >> Share

  763. GAITAN JM, Dubal DB, Okonkwo OC
    Circulating klotho is elevated in cerebrospinal fluid, but not serum, among KLOTHO KL-VS allele carriers at risk for Alzheimer's disease.
    Alzheimers Dement. 2021;17 Suppl 2:e058612.
    >> Share

  764. COULON A, Mendes T, Kilinc D, Dumont J, et al
    High-content screening of Alzheimer's disease genetic risk factors based on synaptic density analysis.
    Alzheimers Dement. 2021;17 Suppl 2:e058660.
    >> Share

  765. TSAI AP, Lin PB, Dong C, Moutinho M, et al
    Impact of PLCG2 expression on Microglial Biology and Disease Pathogenesis in Alzheimer's Disease.
    Alzheimers Dement. 2021;17 Suppl 2:e058740.
    >> Share

  766. HUANG CW, Hart GW
    Decreased O-GlcNAcylation and mitochondrial dysfunction are involving in low glucose induced Alzheimer's disease-like phenotype in induced pluripotent stem cell-derived neurons.
    Alzheimers Dement. 2021;17 Suppl 2:e058620.
    >> Share

  767. BRACH TL, Gaitan JM, Okonkwo OC
    Effect of Aerobic Exercise Training on Mood and Cognition in Adults at Risk for Alzheimer's Disease.
    Alzheimers Dement. 2021;17 Suppl 2:e058523.
    >> Share

  768. LIN PB, Tsai AP, Nho K, Lamb BT, et al
    INPP5D regulates the amyloid pathology in Alzheimer's disease.
    Alzheimers Dement. 2021;17 Suppl 2:e058724.
    >> Share

  769. KUMAR A, Doran E, Martini AC, Head E, et al
    CAA and related co-morbidities in Down syndrome and Alzheimer disease.
    Alzheimers Dement. 2021;17 Suppl 2:e058726.
    >> Share

  770. TEMITOPE SR
    The role of lycopene on the hippocampus of rat model of lipopolysaccharide-induced Alzheimer's disease.
    Alzheimers Dement. 2021;17 Suppl 2:e058528.
    >> Share

  771. YEATES C, Sarkar A, Deshpande P, Kango-Singh M, et al
    A Two-Clone approach to study signaling interactions among neuronal cells in a pre-clinical Alzheimer's Disease model.
    Alzheimers Dement. 2021;17 Suppl 2:e058690.
    >> Share

  772. GOMEZ J JR, Villegas-Lanau CA, Mesa A Sr
    Colocalization of the beta amyloid peptide with bacteria in postmortem brain tissue of patients with familial Alzheimer's disease.
    Alzheimers Dement. 2021;17 Suppl 2:e058692.
    >> Share

  773. SUNG K, Yang F, Noble W, Jimenez-Sanchez M, et al
    Investigating the non-cell autonomous role of glial chaperones in Alzheimer's disease.
    Alzheimers Dement. 2021;17 Suppl 2:e058572.
    >> Share

  774. GOMEZ J JR, Villegas-Lanau CA, Mesa A Sr
    Human Herpesvirus detection and identification in postmortem brain tissue of patients with Alzheimer's disease.
    Alzheimers Dement. 2021;17 Suppl 2:e058693.
    >> Share

  775. SCHRAUBEN M, Smith AR, Washer S, Dempster E, et al
    Investigating epigenetic loci implicated in Alzheimer's disease via the CRISPR-Cas9 system.
    Alzheimers Dement. 2021;17 Suppl 2:e058573.
    >> Share

  776. TALIYAN R, Kakoty V, Kc S, Kumari S, et al
    Fibroblast Growth Factor 21 and Autophagy Modulation Ameliorates Amyloid beta-Induced Alzheimer Disease Pathology in Rats.
    Alzheimers Dement. 2021;17 Suppl 2:e058695.
    >> Share

  777. YANG F, Sung K, Sanchez MJ
    Investigating the secretion of small heat shock proteins in reactive astrocytes in Alzheimer's disease.
    Alzheimers Dement. 2021;17 Suppl 2:e058498.
    >> Share

  778. ROSENE MJ, Hsu S, Martinez R, Norton J, et al
    Defining the role of PLD3 in Alzheimer's disease pathology.
    Alzheimers Dement. 2021;17 Suppl 2:e058730.
    >> Share

  779. TREMBLAY JP, Tremblay G, Guyon A, Joel R, et al
    Insertion of the Icelandic mutation (A673T) in the APP gene using the CRISPR/Cas9 base editing and Prime editing technologies, a preventive treatment for Alzheimer?
    Alzheimers Dement. 2021;17 Suppl 2:e058710.
    >> Share

  780. CHEN J, Samoylova NG, Cummings MG
    TOMM40, a risk gene for Alzheimer's disease, is upregulated during proinflammatory response.
    Alzheimers Dement. 2021;17 Suppl 2:e058711.
    >> Share

  781. MCARDLE CJ, Niere F, Uneri A, Raab-Graham KF, et al
    Alterations in dendritic GABAB receptor expression in an Alzheimer's disease mouse model.
    Alzheimers Dement. 2021;17 Suppl 2:e058557.
    >> Share

  782. DESHPANDE P, Chen CY, Yeates C, Chen CH, et al
    miR-277 targets hid to ameliorate Abeta42-mediated neurodegeneration in Drosophila eye model of Alzheimer's Disease.
    Alzheimers Dement. 2021;17 Suppl 2:e058678.
    >> Share

  783. ZHAO P, Mangleburg CG, Al-Ramahi I, Botas J, et al
    Systems genetic dissection of Alzheimer's disease brain gene expression networks.
    Alzheimers Dement. 2021;17 Suppl 2:e058716.
    >> Share

  784. MUMFORD P, Noy S, Tybulewicz VL, Fisher E, et al
    Preclinical modelling in the mouse of altered neuroinflammation in Alzheimer's disease - Down syndrome.
    Alzheimers Dement. 2021;17 Suppl 2:e058441.
    >> Share

  785. TIPTON AE, George J, Ratner M, Farb D, et al
    Data from single nuclei RNA-sequencing reveals a prodromal gene network response in excitatory neurons of a humanized rat Alzheimer's disease model.
    Alzheimers Dement. 2021;17 Suppl 2:e058589.
    >> Share

  786. TAYLOR AL, Davis DE Jr, Codreanu SG, Harrison FE, et al
    Targeted and untargeted mass spectrometry reveals impact of high fat diet on peripheral amino acid regulation in a mouse model of Alzheimer's disease.
    Alzheimers Dement. 2021;17 Suppl 2:e058428.
    >> Share

  787. ROSOLEN SA
    Exercise-induced metabolic changes in astrocytes in the 5xFAD mouse model of Alzheimer's Disease.
    Alzheimers Dement. 2021;17 Suppl 2:e058627.
    >> Share

  788. SRIVASTAV A, Mohideen SS
    Intestinal microbial dysbiosis induced tau accumulation establishes a gut-brain correlation for pathology Alzheimer's disease in Drosophila melanogaster.
    Alzheimers Dement. 2021;17 Suppl 2:e058708.
    >> Share

  789. HERSH SW, You Y, Aslebagh R, Shaffer SA, et al
    Alzheimer's disease associated AKAP9 I2558M mutation alters posttranslational modification and interactome of tau and cellular functions in CRISPR-edited human neuronal cells.
    Alzheimers Dement. 2021;17 Suppl 2:e058592.
    >> Share

  790. PRATER KE, Green KJ, Chiou KL, Smith CL, et al
    Microglia subtype transcriptomes differ between Alzheimer Disease and control human postmortem brain samples.
    Alzheimers Dement. 2021;17 Suppl 2:e058474.
    >> Share

  791. CZAPLICKI AM, Gaitan JM, Bendlin BB, Johnson SC, et al
    The Interaction between Ventricle to Brain Ratio and Serum Klotho on Cognition in Older Adults at Risk for Alzheimer's Disease.
    Alzheimers Dement. 2021;17 Suppl 12:e058632.
    >> Share

  792. BABATOPE EY, Acosta-Franco JA, Garcia-Vazquez MS, Ramirez-Acosta AA, et al
    Applying a deep learning approach focusing on spatiotemporal features in early diagnosis of Alzheimer's disease.
    Alzheimers Dement. 2021;17 Suppl 12:e058635.
    >> Share

  793. MCINTYRE CC, Okonkwo OC, Gaitan JM, Bendlin BB, et al
    Effect of insulin resistance on the association between cardiorespiratory fitness and cognition in adults at risk for Alzheimer's disease.
    Alzheimers Dement. 2021;17 Suppl 12:e058683.
    >> Share

  794. WANG RP, Leung WK, Goto T, Ho JY, et al
    IL-1 beta and TNF-alpha play an essential role in modulating the risk of both periodontitis and Alzheimer's disease.
    Alzheimers Dement. 2021;17 Suppl 12:e058464.
    >> Share

  795. MEMUDU AE, Waziri RJ
    An investigative study to demonstrate the link between combined intake of marijuana and codeine in Alzheimer's disease pathology.
    Alzheimers Dement. 2021;17 Suppl 12:e058465.
    >> Share

  796. RISHITHA N, Muthuraman A
    Therapeutic investigation of alpha napthoflavone in the intracerebroventricular injection of L-cysteine induced vascular dementia in rats.
    Alzheimers Dement. 2021;17 Suppl 12:e058344.
    >> Share

  797. ABDULKADIR TS, Isa AS, Dawud FA, Ayo JO, et al
    Effect of taurine and camel milk on amyloid beta peptide concentration and oxidative stress changes in aluminium chloride-induced Alzheimer's disease rats.
    Alzheimers Dement. 2021;17 Suppl 12:e058642.
    >> Share

  798. OKHUEVBIE DO, Awolaja S, Balogun Z
    Evaluation of the effect of Donepezil hydrochloride on Ethanol-induced hippocampal damage.
    Alzheimers Dement. 2021;17 Suppl 12:e058353.
    >> Share

  799. K C S, Kakoty VK, Taliyan R
    Development and Validation of PEG-PCL Based Nanoformulation of Rosiglitazone and Evaluation of its Brain Selectivity in Mice Model of Alzheimer's disease.
    Alzheimers Dement. 2021;17 Suppl 12:e058674.
    >> Share

  800. TORT-MERINO A, Tarnanas I, Bugler M, Harms R, et al
    ALTOIDA-iADL for the diagnosis of Mild Cognitive Impairment and early Alzheimer's disease.
    Alzheimers Dement. 2021;17 Suppl 12:e057982.
    >> Share

  801. ROWE EM, Louadi S, Koch E, Kuhlmann N, et al
    A Month in Neurodegenerative Disease Research (AMiNDR): The evolution of an open-access podcast series for Alzheimer's researchers.
    Alzheimers Dement. 2021;17 Suppl 11:e053287.
    >> Share

  802. YUAN F, Lopez RP, Crane M, Montgomery A, et al
    Feasibility and acceptance of robotic care of Alzheimer's disease and related dementia.
    Alzheimers Dement. 2021;17 Suppl 11:e052585.
    >> Share

  803. KUHNEL L, Bouteloup V, Lespinasse J, Chene G, et al
    Personalized prediction of progression in pre-dementia patients based on individual biomarker profile: A development and validation study.
    Alzheimers Dement. 2021;17:1938-1949.
    >> Share

  804. GOLD BT, Shao X, Sudduth TL, Jicha GA, et al
    Water exchange rate across the blood-brain barrier is associated with CSF amyloid-beta 42 in healthy older adults.
    Alzheimers Dement. 2021;17:2020-2029.
    >> Share

  805. XU Y, Chen Z, Wey HY, Liang Y, et al
    Molecular imaging of NAD(+) -dependent deacetylase SIRT1 in the brain.
    Alzheimers Dement. 2021;17:1988-1997.
    >> Share

    November 2021
  806. VERBERK IMW, Misdorp EO, Koelewijn J, Ball AJ, et al
    Characterization of pre-analytical sample handling effects on a panel of Alzheimer's disease-related blood-based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group.
    Alzheimers Dement. 2021 Nov 29. doi: 10.1002/alz.12510.
    >> Share

  807. MURCHISON AG
    Hypothesis: Modulation of microglial phenotype in Alzheimer's disease drives neurodegeneration.
    Alzheimers Dement. 2021 Nov 17. doi: 10.1002/alz.12503.
    >> Share

  808. JIA L, Yang J, Zhu M, Pang Y, et al
    A metabolite panel that differentiates Alzheimer's disease from other dementia types.
    Alzheimers Dement. 2021 Nov 17. doi: 10.1002/alz.12484.
    >> Share

  809. WEINTRAUB S, Karpouzian-Rogers T, Peipert JD, Nowinski C, et al
    ARMADA: Assessing reliable measurement in Alzheimer's disease and cognitive aging project methods.
    Alzheimers Dement. 2021 Nov 17. doi: 10.1002/alz.12497.
    >> Share

  810. JUTKOWITZ E, Halladay C, Tsai J, Hooshyar D, et al
    Prevalence of Alzheimer's disease and related dementias among veterans experiencing housing insecurity.
    Alzheimers Dement. 2021 Nov 10. doi: 10.1002/alz.12476.
    >> Share

  811. HORGUSLUOGLU E, Neff R, Song WM, Wang M, et al
    Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease.
    Alzheimers Dement. 2021 Nov 10. doi: 10.1002/alz.12468.
    >> Share

  812. BOADA M, Lopez OL, Olazaran J, Nunez L, et al
    Neuropsychological, neuropsychiatric, and quality-of-life assessments in Alzheimer's disease patients treated with plasma exchange with albumin replacement from the randomized AMBAR study.
    Alzheimers Dement. 2021 Nov 2. doi: 10.1002/alz.12477.
    >> Share

  813. EZZATI A, Abdulkadir A, Jack CR Jr, Thompson PM, et al
    Predictive value of ATN biomarker profiles in estimating disease progression in Alzheimer's disease dementia.
    Alzheimers Dement. 2021;17:1855-1867.
    >> Share

  814. TAHIRA AC, Verjovski-Almeida S, Ferreira ST
    Dementia is an age-independent risk factor for severity and death in COVID-19 inpatients.
    Alzheimers Dement. 2021;17:1818-1831.
    >> Share

    October 2021
  815. TOSUN D, Demir Z, Veitch DP, Weintraub D, et al
    Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum.
    Alzheimers Dement. 2021 Oct 14. doi: 10.1002/alz.12480.
    >> Share

  816. MEYERS EA, Amouyel P, Bovenkamp DE, Carrillo MC, et al
    Commentary: Global Alzheimer's disease and Alzheimer's disease related dementia research funding organizations support and engage the research community throughout the COVID-19 pandemic.
    Alzheimers Dement. 2021 Oct 1. doi: 10.1002/alz.12472.
    >> Share


  817. Alzheimer's Disease Interventions: Implications of therapeutic promises amidst questions and doubts about clinically meaningful outcomes.
    Alzheimers Dement. 2021;17:1591-1594.
    >> Share

  818. DE MAULEON A, Ismail Z, Rosenberg P, Miller D, et al
    Agitation in Alzheimer's disease: Novel outcome measures reflecting the International Psychogeriatric Association (IPA) agitation criteria.
    Alzheimers Dement. 2021;17:1687-1697.
    >> Share

  819. DAMOTTE V, van der Lee SJ, Chouraki V, Grenier-Boley B, et al
    Plasma amyloid beta levels are driven by genetic variants near APOE, BACE1, APP, PSEN2: A genome-wide association study in over 12,000 non-demented participants.
    Alzheimers Dement. 2021;17:1663-1674.
    >> Share

  820. BANGEN KJ, Thomas KR, Weigand AJ, Edmonds EC, et al
    Elevated plasma neurofilament light predicts a faster rate of cognitive decline over 5 years in participants with objectively-defined subtle cognitive decline and MCI.
    Alzheimers Dement. 2021;17:1756-1762.
    >> Share

  821. MEZ J, Alosco ML, Daneshvar DH, Saltiel N, et al
    Validity of the 2014 traumatic encephalopathy syndrome criteria for CTE pathology.
    Alzheimers Dement. 2021;17:1709-1724.
    >> Share

  822. GALVIN JE, Chrisphonte S, Cohen I, Greenfield KK, et al
    Characterization of dementia with Lewy bodies (DLB) and mild cognitive impairment using the Lewy body dementia module (LBD-MOD).
    Alzheimers Dement. 2021;17:1675-1686.
    >> Share

  823. YANG C, Li X, Zhang J, Chen Y, et al
    Early prevention of cognitive impairment in the community population: The Beijing Aging Brain Rejuvenation Initiative.
    Alzheimers Dement. 2021;17:1610-1618.
    >> Share

    September 2021
  824. FRANZEN S, Smith JE, van den Berg E, Rivera Mindt M, et al
    Diversity in Alzheimer's disease drug trials: The importance of eligibility criteria.
    Alzheimers Dement. 2021 Sep 30. doi: 10.1002/alz.12433.
    >> Share

  825. PICARD C, Nilsson N, Labonte A, Auld D, et al
    Apolipoprotein B is a novel marker for early tau pathology in Alzheimer's disease.
    Alzheimers Dement. 2021 Sep 29. doi: 10.1002/alz.12442.
    >> Share

  826. JICHA GA, Abner EL, Arnold SE, Carrillo MC, et al
    Committee on High-quality Alzheimer's Disease Studies (CHADS) consensus report.
    Alzheimers Dement. 2021 Sep 29. doi: 10.1002/alz.12461.
    >> Share

  827. CUMMINGS JL, Goldman DP, Simmons-Stern NR, Ponton E, et al
    The costs of developing treatments for Alzheimer's disease: A retrospective exploration.
    Alzheimers Dement. 2021 Sep 28. doi: 10.1002/alz.12450.
    >> Share

  828. VEITCH DP, Weiner MW, Aisen PS, Beckett LA, et al
    Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease.
    Alzheimers Dement. 2021 Sep 28. doi: 10.1002/alz.12422.
    >> Share

  829. WANG C, Wang Z, Xie B, Shi X, et al
    Binaural processing deficit and cognitive impairment in Alzheimer's disease.
    Alzheimers Dement. 2021 Sep 27. doi: 10.1002/alz.12464.
    >> Share

  830. MATTKE S, Hanson M
    Expected wait times for access to a disease-modifying Alzheimer's treatment in the United States.
    Alzheimers Dement. 2021 Sep 27. doi: 10.1002/alz.12470.
    >> Share

  831. PHILLIPS JS, Nitchie FJ 4th, Da Re F, Olm CA, et al
    Rates of longitudinal change in (18) F-flortaucipir PET vary by brain region, cognitive impairment, and age in atypical Alzheimer's disease.
    Alzheimers Dement. 2021 Sep 13. doi: 10.1002/alz.12456.
    >> Share

  832. ZHANG L, Du Rietz E, Kuja-Halkola R, Dobrosavljevic M, et al
    Attention-deficit/hyperactivity disorder and Alzheimer's disease and any dementia: A multi-generation cohort study in Sweden.
    Alzheimers Dement. 2021 Sep 9. doi: 10.1002/alz.12462.
    >> Share

  833. CHATTERJEE P, Pedrini S, Ashton NJ, Tegg M, et al
    Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease.
    Alzheimers Dement. 2021 Sep 8. doi: 10.1002/alz.12447.
    >> Share

  834. MARTERSTECK A, Sridhar J, Coventry C, Weintraub S, et al
    Relationships among tau burden, atrophy, age, and naming in the aphasic variant of Alzheimer's disease.
    Alzheimers Dement. 2021 Sep 8. doi: 10.1002/alz.12445.
    >> Share

    </